• Abanmi A, Harthi FA, Baqami RA, Assaf SA, Zouman A, Arfin M, Tariq M. Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Arch. Dermatol. Res. 298: 347-352 (2006). *

• Abbas M, Bobo LD, Hsieh YH, Berka N, Dunston G, Bonney G, Apprey V, Quinn TC, West SK. Human leukocyte antigen (HLA)-B, -DRB1 and -DQB1 allotypes associated with disease and protection in trachoma endemic villages. Invest. Ophthalmol. Vis. Sci. 50: 1734-1738 (2009). *

• Abdallah H, Leffler D, Dennis M, Kelly CP. Refractory celiac disease. Curr. Gastroenterol. Rep. 9: 401-405 (2007).

• Abida O, Zitouni M, Kallel-Sellami M, Mahfoudh N, Kammoun A, Ben Ayed M, Masmoudi A, Mokni M, Fezzaa B, Ben Osman A, Kammoun MR, Turki H, Makni H, Gilbert D, Joly P, Tron F, Makni S, Masmoudi H. Tunisian endemic pemphigus foliaceus is associated with the HLA-DR3 gene: anti-desmoglein 1 antibody-positive healthy subjects bear protective alleles. Br. J. Dermatol. 161: 522-527 (2009). *

• Abraham RS, Wen L, Marietta EV, David CS. Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model. J. Immunol. 166: 1370-1379 (2001). *

• Abreu-Velez AM, Loebl AM, Howard MS. Autoreactivity to sweat and sebaceous glands and skin homing T cells in lupus profundus. Clin. Immunol. 132: 420-414 (2009). *

• Adamopoulos AB. Inflammatory bowel disease (IBD) and the liver. Annals of Gastroenterology 19: 146-151 (2006). *

• Adhiah AH, Jasim HA, Fadhil AM. HLA antigens and inflammatory bowel disease in a sample of Iraqi patients. East. Mediterr. Health J. 14: 1155-1163 (2008).

• Affes H, Mahfoudh N, Kammoun A, Masmoudi A, Marrekchi S, Turki H, Makni H. HLA- A, B, DR and DQ alleles study in Tunisian patients with atopic dermatitis. Tunis. Med. 85: 834-838 (2007).

• Aggarwal R, Stamm L, Zhao W, Fernandez-Vina M, Senitzer D, Berka N. A novel HLA-B allele, B*4093, sharing sequences with B*4006 and B*0702 in an Asian Indian donor. Tissue Antigens 72: 492-494 (2008). *

• Agrawal S, Gupta A, Yachha SK, Muller-Myhsok B, Mehrotra P, Agarwal SS. Association of human leucocyte-DR and DQ antigens in coeliac disease: a family study. J. Gastroenterol. Hepatol. 15: 771-774 (2000). *

• Agrawal S, Khan F, Bharadwaj U. Human genetic variation studies and HLA class II loci. Int. J. Immunogenet. 34: 247-252 (2007). *

• Ahmed AR, Yunis EJ, Khatri K, Wagner R, Notani G, Awdeh Z, Alper CA. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. U.S.A. 87: 7658-7662 (1990). *

• Akaishi PM, Cruz AA, Silva FL, De Lourdes Veronesi Rodrigues M, Maciel LM, Donadi EA. The role of major histocompatibility complex alleles in the susceptibility of Brazilian patients to develop the myogenic type of Graves' orbitopathy. Thyroid 18: 443-447 (2008).

• Akar A, Orkunoglu E, Sengul A, Ozata M, Gur AR. HLA class II alleles in patients with alopecia areata. Eur. J. Dermatol. 12: 236-239 (2002).

• Akesson K, Carlsson A, Ivarsson SA, Johansson C, Weidby BM, Ludvigsson J, Gustavsson B, Lernmark A, Kockum I. The non-inherited maternal HLA haplotype affects the risk for type 1 diabetes. Int. J. Immunogenet. 36: 1-8 (2009). *

• Akimoto S, Abe M, Ishikawa O, Takagi H, Mori M. HLA-DRB1 and DQB1 genes in anticentromere antibody positive patients with SSc and primary biliary cirrhosis. Ann. Rheum. Dis. 60: 639-640 (2001). *

• Al Attia HM, Santhosh A. A probe into the HLA-DR and DQ of Arab patients with primary antiphospholipid (Hughes) syndrome. Rheumatol. Int. 28: 193-195 (2007). *

• Al-Harbi EM, Abbassi AJ, Tamim H, al-Jenaidi F, Kooheji M, Kamal M, al-Mahroos S, al-Nasir F, Motala AA, Almawi WY. Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients. Clin. Diagn. Lab. Immunol. 11: 292-296 (2004). *

• Al-Jenaidi FA, Wakim-Ghorayeb SF, Al-Abbasi A, Arekat MR, Irani-Hakime N, Najm P, Al-Ola K, Motala AA, Almawi WY. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs. J. Clin. Endocrinol. Metab. 90: 5104-5109 (2005). *

• Al-Ola K, Mahdi N, Al-Subaie AM, Ali ME, Al-Absi IK, Almawi WY. Evidence for HLA class II susceptible and protective haplotypes for osteomyelitis in pediatric patients with sickle cell anemia. Tissue Antigens 71: 453-457 (2008). *

• Al-Toma A, Goerres MS, Meijer JW, Pena AS, Crusius JB, Mulder CJ. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin. Gastroenterol. Hepatol. 4: 315-319 (2006).

• Al-toma A, Verbeek WH, Mulder CJ. The management of complicated celiac disease. Dig. Dis. 25: 230-236 (2007).

• Al-Tonbary Y, Abdel-Razek N, Zaghloul H, Metwaly S, El-Deek B, El-Shawaf R. HLA class II polymorphism in Egyptian children with lymphomas. Hematology 9: 139-145 (2004).

• Alaez C, Lin L, Flores-A H, Vazquez M, Munguia A, Mignot E, Haro R, Baker H, Gorodezky C. Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexicans patients: a relationship between HLA and gender is suggested. BMC Med. Genet. 9: 79 (2008). *

• Alaez C, Vazquez-Garcia MN, Gorodezky C. DQA1 and DQB1 promoter diversity and linkage disequilibrium with class II haplotypes in Mexican Mestizo population. Genes Immun. 2: 216-221 (2001). *

• Alarida K, Harown J, Di Pierro MR, Drago S, Catassi C. HLA-DQ2 and -DQ8 genotypes in celiac and healthy Libyan children. Dig. Liver Dis. Oct 9 [Epub ahead of print] (2009).

• Alexander J, Lord JD, Yeh MM, Cuevas C, Bakthavatsalam R, Kowdley KV. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 14: 245-251 (2008). *

• Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 7: 813-818 (2006).

• Ali AA, Moatter T, Baig JA, Iqbal A, Hussain A, Iqbal MP. Polymorphism of HLA-DR and HLA-DQ in rheumatoid arthritis patients and clinical response to methotrexate - a hospital-based study. J. Pak. Med. Assoc. 56: 452-456 (2006).

• Alizadeh BZ, Eerligh P, van der Slik AR, Shastry A, Zhernakova A, Valdigem G, Bruining JG, Sanjeevi CB, Wijmenga C, Roep BO, Koeleman BP. MICA marks additional risk factors for type 1 diabetes on extended HLA haplotypes: an association and meta-analysis. Mol. Immunol. 44: 2806-2812 (2007). *

• Alizadeh M, Babron MC, Birebent B, Matsuda F, Quelvennec E, Liblau R, Cournu-Rebeix I, Momigliano-Richiardi P, Sequeiros J, Yaouanq J, Genin E, Vasilescu A, Bougerie H, Trojano M, Martins Silva B, Maciel P, Clerget-Darpoux F, Clanet M, Edan G, et al. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann. Neurol. 54: 119-122 (2003). *

• Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum. Immunol. 39: 41-48 (1994).

• Alper CA. The human immune response to hepatitis B surface antigen. Exp. Clin. Immunogenet. 12: 171-181 (1995).

• Alper CA, Larsen CE, Dubey DP, Awdeh ZL, Fici DA, Yunis EJ. The haplotype structure of the human major histocompatibility complex. Hum. Immunol. 67: 73-84 (2006). *

• Alper CA, Marcus-Bagley D, Awdeh Z, Kruskall MS, Eisenbarth GS, Brink SJ, Katz AJ, Stein R, Bing DH, Yunis EJ, Schur PH. Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SC01, DR3] conserved extended haplotype. Tissue Antigens 56: 207-216 (2000). *

• Alsaeid K, Haider MZ, Sharma PN, Ayoub EM. The prevalence of human leukocyte antigen (HLA) DR/DQ/DP alleles in Kuwaiti children with oligoarticular juvenile idiopathic arthritis. Rheumatol. Int. 26: 224-228 (2006). *

• Alvarado-Guerri R, Cabrera CM, Garrido F, Lopez-Nevot MA. TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an Eastern Andalusian population. Hum. Immunol. 66: 921-930 (2005).

• Alves C, Toralles MB, Carvalho GC. HLA class II polymorphism in patients with type 1 diabetes mellitus from a Brazilian racially admixtured population. Ethn. Dis. 19: 420-424 (2009).

• Alves C, Veiga S, Souza T, Toralles MB, da Silva-Bacellar AL. The role of the human histocompatibility antigens in the pathogenesis of neurological disorders. Rev. Neurol. 44: 298-302 (2007).

• Alves-Leon SV, Papais-Alvarenga R, Magalhaes M, Alvarenga M, Thuler LC, Fernandez Y Fernandez O. Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol. Scand. 115: 306-311 (2007).

• Alves-Leon SV, Veluttini-Pimentel ML, Gouveia ME, Malfetano FR, Gaspareto EL, Alvarenga MP, Frugulhetti I, Quirico-Santos T. Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study. Arq. Neuropsiquiatr. 67: 643-651 (2009).

• Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, Fingerlin TE, Kretowski A, Erlich HA, Fain PR, Rewers MJ, Eisenbarth GS. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes 57: 770-776 (2008). *

• Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes 55: 1265-1269 (2006). *

• Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J. Autoimmun. 25: S40-S45 (2005).

• Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS. Extreme genetic risk for type 1A diabetes. Proc. Natl. Acad. Sci. U.S.A. 103: 14074-14079 (2006). *

• Aminkeng F, Van Autreve JE, Koeleman BP, Quartier E, Van Schravendijk C, Gorus FK, Van der Auwera BJ; Belgian Diabetes Registry. TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum. Immunol. 68: 690-697 (2007).

• Amirzargar A, Mytilineos J, Yousefipour A, Farjadian S, Scherer S, Opelz G, Ghaderi A. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients. Eur. J. Immunogenet. 25: 297-301 (1998). *

• Amirzargar AA, Mohseni N, Shokrgozar MA, Arjang Z, Ahmadi N, Yousefi Behzadi M, Amanzadeh A, Shokri F. HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine. Iran. J. Immunol. 5: 92-99 (2008).

• Amundsen SS, Adamovic S, Hellqvist A, Nilsson S, Gudjónsdóttir AH, Ascher H, Ek J, Larsson K, Wahlstrom J, Lie BA, Sollid LM, Naluai AT. A comprehensive screen for SNP associations on chromosome region 5q31-33 in Swedish/Norwegian celiac disease families. Eur. J. Hum. Genet. 15: 980-987 (2007). *

• Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjogren's syndrome. Semin. Arthritis Rheum. 31: 396-405 (2002). *

• Anaya JM, Correa PA, Mantilla RD, Jimenez F, Kuffner T, McNicholl JM. Rheumatoid arthritis in African Colombians from Quibdo. Semin. Arthritis Rheum. 31: 191-198 (2001). *

• Anaya JM, Mantilla RD, Correa PA. Immunogenetics of primary Sjogren's syndrome in Colombians. Semin. Arthritis Rheum. 34: 735-743 (2005). *

• Anaya JM, Rivera D, Palacio LG, Arcos-Burgos M, Correa PA. D6S439 microsatellite identifies a new susceptibility region for primary Sjogren's syndrome. J. Rheumatol. 30: 2152-2156 (2003).

• Anderson RP. Coeliac disease: current approach and future prospects. Intern. Med. J. 38: 790-799 (2008). *

• Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat. Med. 6: 337-342 (2000). *

• Anderson RP, van Heel DA, Tye-Din JA, Barnardo M, Salio M, Jewell DP, Hill AV. T cells in peripheral blood after gluten challenge in coeliac disease. Gut 54: 1217-1223 (2005). *

• Anderson RP, van Heel DA, Tye-Din JA, Jewell DP, Hill AV. Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease. Gut 55: 485-491 (2006). *

• Ando T, Ishikawa T, Kato H, Yoshida N, Naito Y, Kokura S, Yagi N, Takagi T, Handa O, Kitawaki J, Nakamura N, Hasegawa G, Fukui M, Imamoto E, Nakamura C, Oyamada H, Isozaki Y, Matsumoto N, Nagao Y, Okita M, Nakajima Y, Kurokawa M, Nukina M, Ohta M, et al. Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection. Int. J. Cancer 125: 2595-2602 (2009). *

• Andrade RJ, Lucena MI, Alonso A, Garcia-Cores M, Garcia-Ruiz E, Benitez R, Fernandez MC, Pelaez G, Romero M, Corpas R, Duran JA, Jimenez M, Rodrigo L, Nogueras F, Martin-Vivaldi R, Navarro JM, Salmeron J, de la Cuesta FS, Hidalgo R. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 39: 1603-1612 (2004). *

• Andreoni A, Bondani M, Nardo L. Time-resolved FRET method for typing polymorphic alleles of the human leukocyte antigen system by using a single DNA probe. Photochem. Photobiol. Sci. 8: 1202-1206 (2009).

• Annese V, Latiano A, Bovio P, Forabosco P, Piepoli A, Lombardi G, Andreoli A, Astegiano M, Gionchetti P, Riegler G, Sturniolo GC, Clementi M, Rappaport E, Fortina P, Devoto M, Gasparini P, Andriulli A. Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus - a GISC study. Eur. J. Hum. Genet. 7: 567-573 (1999). *

• Arai T, Michalski JP, McCombs CC, Elston RC, McCarthy CF, Stevens FM. T cell receptor gamma gene polymorphisms and class II human lymphocyte antigen genotypes in patients with celiac disease from the west of Ireland. Am. J. Med. Sci. 309: 171-178 (1995).

• Araujo MB, Leonardi LS, Boin IF, Leonardi MI, Magna LA, Donadi EA, Kraemer MH. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes. Transplant. Proc. 36: 953-955 (2004). *

• Arellanes-Garcia L, Bautista N, Mora P, Ortega-Larrocea G, Burguet A, Gorodezky C. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. Ocul. Immunol. Inflamm. 6: 93-100 (1998).

• Arentz-Hansen EH, McAdam SN, Molberg O, Kristiansen C, Sollid LM. Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease. Gut 46: 46-51 (2000). *

• Arentz-Hansen H, Fleckenstein B, Molberg O, Scott H, Koning F, Jung G, Roepstorff P, Lundin KE, Sollid LM. The molecular basis for oat intolerance in patients with celiac disease. Plos. Med. 1: e1 (2004). *

• Arentz-Hansen H, Korner R, Molberg O, Quarsten H, Vader W, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, McAdam SN. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 191: 603-612 (2000). *

• Arentz-Hansen H, McAdam SN, Molberg O, Fleckenstein B, Lundin KE, Jorgensen TJ, Jung G, Roepstorff P, Sollid LM. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 123: 803-809 (2002). *

• Arias-Carrion O. Hypocretin system and narcolepsy. Rev. Med. Chil. 137: 1209-1216 (2009).

• Arnaiz-Villena A, Martinez-Laso J, Corell A, Allende L, Rosal M, Gomez-Reino JJ, Vicario JL. Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome. Eur. J. Immunogenet. 23: 211-219 (1996).

• Arnett FC, Bias WB, Reveille JD. Genetic studies in Sjogren's syndrome and systemic lupus erythematosus. J. Autoimmun. 2: 403-413 (1989).

• Arnett FC, Gourh P, Shete S, Ahn CW, Honey R, Agarwal SK, Tan FK, McNearney T, Fischbach M, Fritzler MJ, Mayes MD, Reveille JD. Major histocompatibility complex (MHC) class II alleles, haplotypes, and epitopes which confer susceptibility or protection in the fibrosing autoimmune disease systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases … Ann. Rheum. Dis. Jul 12 [Epub ahead of print] (2009).

• Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, Cameron HD, Paxton G, Hodge TJ, Weathers PE, Reveille JD. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum. 39: 1362-1370 (1996).

• Aron Y, Polla BS, Bienvenu T, Dall'ava J, Dusser D, Hubert D. HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am. J. Respir. Crit. Care Med. 159: 1464-1468 (1999). *

• Aron Y, Swierczewski E, Lockhart A. A simple and rapid micromethod for genomic DNA extraction from jugal epithelial cells. Application to human lymphocyte antigen typing in one large family of atopic/asthmatic probands. Allergy 49: 788-790 (1994).

• Arranz E, Garrote JA. Immunology of celiac disease. Gastroenterol. Hepatol. Feb 1 [Epub ahead of print] (2010).

• Artlett CM, O'Hanlon TP, Lopez AM, Song YW, Miller FW, Rider LG. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals. Arthritis Rheum. 48: 2567-2572 (2003). *

• Ashman RF, Schaffer FM, Kemp JD, Yokoyama WM, Zhu ZB, Cooper MD, Volanakis JE. Genetic and immunologic analysis of a family containing five patients with common-variable immune deficiency or selective IgA deficiency. J. Clin. Immunol. 12: 406-414 (1992).

• Aslanian FM, Marques MT, Matos HJ, Pontes LF, Porto LC, Azevedo LM, Filgueira AL. HLA markers in familial lichen sclerosus. J. Dtsch. Dermatol. Ges. 4: 842-847 (2006). *

• Assassi S, Del Junco D, Sutter K, McNearney TA, Reveille JD, Karnavas A, Gourh P, Estrada-Y-Martin RM, Fischbach M, Arnett FC, Mayes MD. Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum. 61: 1403-1411 (2009). *

• Atan D, Turner SJ, Kilmartin DJ, Forrester JV, Bidwell J, Dick AD, Churchill AJ. Cytokine gene polymorphism in sympathetic ophthalmia. Invest. Ophthalmol. Vis. Sci. 46: 4245-4250 (2005). *

• Atar D, Dyrberg T, Michelsen B, Karlsen A, Kofod H, Mřlvig J, Lernmark A. Site-specific antibodies distinguish single amino acid substitutions in position 57 in HLA-DQ beta-chain alleles associated with insulin-dependent diabetes. J. Immunol. 143: 533-538 (1989).

• Atouf O, Benbouazza K, Brick C, Bzami F, Bennani N, Amine B, Hajja-Hassouni N, Essakali M. HLA polymorphism and early rheumatoid arthritis in the Moroccan population. Joint Bone Spine 75: 554-558 (2008). *

• Avila-Portillo LM, Vargas-Alarcon G, Andrade F, Alarcon-Segovia D, Granados J. Linkage disequilibrium of HLA-DR3 and HLA-DR4 with HLA-B alleles in Mexican patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 12: 497-502 (1994).

• Awata T, Kanazawa Y. Genetic markers for insulin-dependent diabetes mellitus in Japanese. Diabetes Res. Clin. Pract. 24: S83-S87 (1994).

• Aycan Z, Berberoglu M, Adiyaman P, Ergur AT, Ensari A, Evliyaoglu O, Siklar Z, Ocal G. Latent autoimmune diabetes mellitus in children (LADC) with autoimmune thyroiditis and celiac disease. J. Pediatr. Endocrinol. Metab. 17: 1565-1569 (2004).

• Aydogan K, Karadogan SK, Akdag I, Tunali S. HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria. Clin. Exp. Dermatol. 31: 424-429 (2006). *

• Aziz S, Muzaffar R, Zafar MN, Mehnaz A, Mubarak M, Abbas Z, Naqvi SA, Rizvi AH. Celiac disease in children with persistent diarrhea and failure to thrive. J. Coll. Physicians Surg. Pak. 17: 554-557 (2007).

• Baba N, Kobashi H, Yamamoto K, Terada R, Suzuki T, Hakoda T, Okano N, Shimada N, Fujioka S, Iwasaki Y, Shiratori Y. Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray. Transl. Res. 148: 103-113 (2006). *

• Baccar A, Loueslati BY, Troudi W, Hmida S, Dridi A, Jridi A, Mrad K, Ben Romdhane K, Ben Ammar Elgaaied A. Are HLA DQB1 alleles correlated with breast cancer histopronostic parameters in Tunisia? Tunis. Med. 87: 372-374 (2009).

• Bach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J. Autoimmun. 10: 375-386 (1997).

• Badenhoop K. Genetic markers in thyroid autoimmune diseases. Z. Arztl. Fortbild. Qualitatssich. 98 Suppl. 5: 13-15 (2004).

• Badenhoop K, Donner H, Pani M, Rau H, Siegmund T, Braun J. Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a German population. Exp. Clin. Endocrinol. Diabetes 107 Suppl. 3: S89-S92 (1999).

• Badenhoop K, Kahles H, Seidl C, Kordonouri O, Lopez ER, Walter M, Rosinger S, Ziegler A, Bohm BO; Diabetes Genetics Consortium. MHC-environment interactions leading to type 1 diabetes: feasibility of an analysis of HLA DR-DQ alleles in relation to manifestation periods and dates of birth. Diabetes Obes. Metab. 11 Suppl. 1: 88-91 (2009). *

• Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Usadel KH, Gale EA, Bottazzo GF. TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32: 445-448 (1989).

• Badenhoop K, Tonjes RR, Rau H, Donner H, Rieker W, Braun J, Herwig J, Mytilineos J, Kurth R, Usadel KH. Endogenous retroviral long terminal repeats of the HLA-DQ region are associated with susceptibility to insulin-dependent diabetes mellitus. Hum. Immunol. 50: 103-110 (1996).

• Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J. Clin. Endocrinol. Metab. 80: 2112-2117 (1995). *

• Bahammam AS, Gadelrab MO, Owais SM, Alswat K, Hamam KD. Clinical characteristics and HLA typing of a family with Kleine-Levin syndrome. Sleep Med. 9: 575-578 (2008).

• Baisch JM, Capra JD. Linkage disequilibrium within the HLA complex does not extend into HLA-DP. Scand. J. Immunol. 37: 499-503 (1993).

• Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med. 322: 1836-1841 (1990).

• Bakhtadze E, Cervin C, Lindholm E, Borg H, Nilsson P, Arnqvist HJ, Bolinder J, Eriksson JW, Gudbjornsdottir S, Nystrom L, Agardh CD, Landin-Olsson M, Sundkvist G, Groop LC. Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients. Diabetologia 51: 2224-2232 (2008). *

• Balas A, Aviles MJ, Alonso-Nieto M, Zarapuz L, Blanco L, Garcia-Sanchez F, Vicario JL. HLA-DQA1 introns 2 and 3 sequencing: DQA1 sequencing-based typing and characterization of a highly polymorphic microsatellite at intron 3 of DQA1*0505. Hum. Immunol. 66: 903-911 (2005).

• Balas A, Garcia-Sanchez F, Vicario JL. A new DQA1 allele (DQA1*0510) in a Spanish celiac disease patient. Tissue Antigens Dec 30 [Epub ahead of print] (2009). *

• Balducci-Silano PL, Layrisse Z, Dominguez E, Amaro R, Gunczler P, Lanes R, Zaro R. HLA-DQA1 and DQB1 allele and genotype contribution to IDDM susceptibility in an ethnically mixed population. Eur. J. Immunogenet. 21: 405-414 (1994).

• Balducci-Silano PL, Layrisse ZE. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in an ethnically mixed population. Associations with other HLA-alleles. J. Autoimmun. 8: 425-437 (1995).

• Baldwin GC, Mickelson EM, Hansen JA, Nisperos B, Antonelli P, Nepom BS, Nepom GT. Electrophoretic variation between class II molecules expressed on HLA-DRw8 homozygous typing cells reveals multiple distinct haplotypes. Immunogenetics 21: 49-60 (1985).

• Balladares S, Alaez C, Pujol J, Duran C, Navarro JL, Gorodezky C. Distribution of TAP gene polymorphisms and extended MHC haplotypes in Mexican Mestizos and in Seri Indians from northwest Mexico. Genes Immun. 3: 78-85 (2002). *

• Ballardini G, Bianchi FB, Mirakian R, Fallani M, Pisi E, Bottazzo GF. HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease. Clin. Exp. Immunol. 70: 35-46 (1987). *

• Bansil S, Cook SD, Rohowsky-Kochan C. Multiple sclerosis: immune mechanism and update on current therapies. Ann. Neurol. 37 Suppl. 1: S87-S101 (1995).

• Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, Eisenbarth GS. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J. Autoimmun. 13: 143-148 (1999).

• Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M. Major histocompatibility complex class I chain-related gene a polymorphisms and extended haplotypes are associated with familial alopecia areata. J. Invest. Dermatol. 126: 74-78 (2006). *

• Barbeau WE, Bassaganya-Riera J, Hontecillas R. Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetes. Med. Hypotheses 68: 607-619 (2007).

• Barbeau WE, Novascone MA, Elgert KD. Is celiac disease due to molecular mimicry between gliadin peptide-HLA class II molecule-T cell interactions and those of some unidentified superantigen? Mol. Immunol. 34: 535-541 (1997).

• Barcellos LF, May SL, Ramsay PP, Quach HL, Lane JA, Nititham J, Noble JA, Taylor KE, Quach DL, Chung SA, Kelly JA, Moser KL, Behrens TW, Seldin MF, Thomson G, Harley JB, Gaffney PM, Criswell LA. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet. 5: e1000696 (2009). *

• Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, Goodin DS, Pelletier D, Lincoln RR, Bucher P, Swerdlin A, Pericak-Vance MA, Haines JL, Hauser SL; Multiple Sclerosis Genetics Group. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am. J. Hum. Genet. 72: 710-716 (2003). *

• Barcellos LF, Oksenberg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S, Garcia ME, Lincoln RR, Pericak-Vance MA, Haines JL, Hauser SL; Multiple Sclerosis Genetics Group. Genetic basis for clinical expression in multiple sclerosis. Brain 125: 150-158 (2002). *

• Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Ucelli A, Savettieri G, Lincoln RL, Deloa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum. Mol. Genet. 15: 2813-2824 (2006). *

• Barcellos LF, Thomson G, Carrington M, Schafer J, Begovich AB, Lin P, Xu XH, Min BQ, Marti D, Klitz W. Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients. JAMA 278: 1256-1261 (1997).

• Bardella MT, Valenti L, Pagliari C, Peracchi M, Fare M, Fracanzani AL, Fargion S. Searching for coeliac disease in patients with non-alcoholic fatty liver disease. Dig. Liver Dis. 36: 333-336 (2004).

• Barker JM. Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening. J. Clin. Endocrinol. Metab. 91: 1210-1217 (2006). *

• Barker JM, Liu E. Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv. Pediatr. 55: 349-365 (2008).

• Barker JM, Triolo TM, Aly TA, Baschal EE, Babu SR, Kretowski A, Rewers MJ, Eisenbarth GS. Two single nucleotide polymorphisms identify highest-risk diabetes human leukocyte antigen genotype: potential for rapid screening. Diabetes 57: 3152-3155 (2008). *

• Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, Hoffenberg E, Nelson JC, Gottlieb PA, Rewers M, Eisenbarth GS. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 28: 850-855 (2005). *

• Barnes DS. Intrahepatic cholestatic liver disease. http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm (2002). *

• Barnetche T, Constantin A, Gourraud PA, Abbal M, Garnier JG, Cantagrel A, Cambon-Thomsen A. Microsatellite typing of the human leucocyte antigen region: analytical approach and contribution to rheumatoid arthritis immunogenetic studies. Tissue Antigens 68: 390-398 (2006). *

• Bartoccioni E, Scuderi F, Augugliaro A, Chiatamone Ranieri S, Sauchelli D, Alboino P, Marino M, Evoli A. HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. Neurology 72: 195-197 (2009).

• Baschal EE, Aly TA, Jasinski JM, Steck AK, Johnson KN, Noble JA, Erlich HA, Eisenbarth GS; Diabetes Genetics Consortium. The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes. Diabetes Obes. Metab. 11 Suppl. 1: 25-30 (2009). *

• Baschal EE, Eisenbarth GS. Extreme genetic risk for type 1A diabetes in the post-genome era. J. Autoimmun. 31: 1-6 (2008).

• Basso D, Guariso G, Fogar P, Navaglia F, Zambon CF, Plebani M. Insights in the laboratory diagnosis of celiac disease. Lupus 15: 462-465 (2006). *

• Bastian HM, Alarcon GS, Roseman JM, McGwin G Jr, Vila LM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxford) 46: 683-689 (2007). *

• Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes. Eur. J. Immunogenet. 30: 223-227 (2003). *

• Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, Gershwin ME. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 43: 71-77 (1994).

• Bejrachandra S, Kitayaporn D, Kaewkungwal J, Piya-Anant M, Permpikul P, Sirikong M, Siriboonrit U, Chandanayingyong D. HLA class II (DRB1, DQA1 and DQB1) allele and haplotype frequencies among HIV-infection discordant Thai couples. Asian Pac. J. Allergy Immunol. 22: 143-151 (2004).

• Bell J, Rassenti L, Smoot S, Smith K, Newby C, Hohlfeld R, Toyka K, McDevitt H, Steinman L. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet 1: 1058-1060 (1986).

• Bennani N, Atouf O, Benseffaj N, Brick C, Essakalli M. HLA polymorphism and Behcet's disease in Moroccan population. Pathol. Biol. (Paris) 57: 403-409 (2009).

• Bennetts BH, Teutsch SM, Buhler MM, Heard RN, Stewart GJ. HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients. Hum. Immunol. 60: 886-893 (1999).

• Bennetts BH, Teutsch SM, Heard RN, Dunckley H, Stewart GJ. TAP2 polymorphisms in Australian multiple sclerosis patients. J. Neuroimmunol. 59: 113-121 (1995).

• Bentley G, Higuchi R, Hoglund B, Goodridge D, Sayer D, Trachtenberg EA, Erlich HA. High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens 74: 393-403 (2009). *

• Berg L, Ronnelid J, Sanjeevi CB, Lampa J, Klareskog L. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Arthritis Res. 2: 75-84 (2000). *

• Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020 (2004). *

• Bergseng E, Sidney J, Sette A, Sollid LM. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules. Hum. Immunol. 69: 94-100 (2008).

• Bergseng E, Xia J, Kim CY, Khosla C, Sollid LM. Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the celiac disease associated HLA-DQ2 molecule. J. Biol. Chem. 280: 21791-21796 (2005). *

• Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J. Hepatol. 30: 237-241 (1999). *

• Bethune MT, Crespo-Bosque M, Bergseng E, Mazumdar K, Doyle L, Sestak K, Sollid LM, Khosla C. Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem. Biol. 16: 868-881 (2009). *

• Bettencourt BF, Santos MR, Fialho RN, Couto AR, Peixoto MJ, Pinheiro JP, Spinola H, Mora MG, Santos C, Brehm A, Bruges-Armas J. Evaluation of two methods for computational HLA haplotypes inference using a real dataset. BMC Bioinformatics 9: 68 (2008). *

• Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, McHugh NJ. Clinical and HLA-class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK adult-onset Caucasian myositis. Ann. Rheum. Dis. 68: 1621-1625 (2009).

• Bettinotti MP, Hartung K, Deicher H, Messer G, Keller E, Weiss EH, Albert ED. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 37: 449-454 (1993).

• Bevan S, Popat S, Braegger CP, Busch A, O'Donoghue D, Falth-Magnusson K, Ferguson A, Godkin A, Hogberg L, Holmes G, Hosie KB, Howdle PD, Jenkins H, Jewell D, Johnston S, Kennedy NP, Kerr G, Kumar P, Logan RF, Love AH, Marsh M, Mulder CJ, Sjoberg K, et al. Contribution of the MHC region to the familial risk of coeliac disease. J. Med. Genet. 36: 687-690 (1999). *

• Bevan S, Popat S, Houlston RS. Relative power of linkage and transmission disequilibrium test strategies to detect non-HLA linked coeliac disease susceptibility genes. Gut 45: 668-671 (1999). *

• Bhatnagar S, Tandon N. Diagnosis of celiac disease. Indian J. Pediatr. 73: 703-709 (2006). *

• Bhattacharya P, Sengupta S. Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03. Tissue Antigens 70: 283-293 (2007). *

• Biagi F, Bianchi PI, Campanella J Dr, Badulli C, Martinetti M, Klersy C, Alvisi C, Corazza GR Prof. The prevalence and the causes of minimal intestinal lesions in patients complaining of symptoms suggestive of enteropathy. A follow-up study. J. Clin. Pathol. 61: 1116-1168 (2008).

• Biagi F, Ellis HJ, Parnell ND, Shidrawi RG, Thomas PD, O'Reilly N, Corazza GR, Ciclitira PJ. A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation? Aliment. Pharmacol. Ther. 13: 945-950 (1999). *

• Bieda K, Pani MA, van der Auwera B, Seidl C, Tonjes RR, Gorus F, Usadel KH, Badenhoop K. A retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) modifies type I diabetes susceptibility on high risk DQ haplotypes. Diabetologia 45: 443-447 (2002). *

• Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA, Rica I, Vitoria JC, Gaztambide S, Noble J, Fain PR, Awdeh ZL, Alper CA, Castano L. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun. 7: 550-554 (2006). *

• Bilbao JR, Martin-Pagola A, Calvo B, Perez de Nanclares G, Gepv-N, Castano L. Contribution of MIC-A polymorphism to type 1 diabetes mellitus in Basques. Ann. N. Y. Acad. Sci. 958: 321-324 (2002). *

• Bilbao JR, Villoslada P, Martin-Pagola A, Castano L. No evidence of pancreatic autoimmunity among patients with multiple sclerosis. Ann. N. Y. Acad. Sci. 1037: 133-137 (2004). *

• Billen EV, Voorter CE, Christiaans MH, van den Berg-Loonen EM. Luminex donor-specific crossmatches. Tissue Antigens 71: 507-513 (2008). *

• Binder V, Orholm M. Familial occurrence and inheritance studies in inflammatory bowel disease. Neth. J. Med. 48: 53-56 (1996).

• Bioque G, Bouma G, Crusius JB, Koutroubakis I, Kostense PJ, Meuwissen SG, Pena AS. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 105-110 (1996).

• Bishof NA, Welch TR, Beischel LS, Carson D, Donnelly PA. DP polymorphism in HLA-A1,-B8,-DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus. Pediatr. Nephrol. 7: 243-246 (1993).

• Bittencourt PL, Farias AQ, Porta G, Cancado EL, Miura I, Pugliese R, Kalil J, Goldberg AC, Carrilho FJ. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J. Clin. Gastroenterol. 42: 300-305 (2008).

• Bittencourt PL, Goldberg AC, Cancado EL, Porta G, Carrilho FJ, Farias AQ, Palacios SA, Chiarella JM, Abrantes-Lemos CP, Baggio VL, Laudanna AA, Kalil J. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am. J. Gastroenterol. 94: 1906-1913 (1999). *

• Bittencourt PL, Palacios SA, Farias AQ, Abrantes-Lemos CP, Cancado EL, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 18: 1061-1066 (2003). *

• Bjorck S, Brundin C, Lorinc E, Lynch KF, Agardh D. Screening detects a high proportion of celiac disease in young HLA-genotyped children. J. Pediatr. Gastroenterol. Nutr. 50: 49-53 (2010).

• Bjorkbacka H, Lavant EH, Fredrikson GN, Melander O, Berglund G, Carlson JA, Nilsson J. Weak associations between human leucocyte antigen genotype and acute myocardial infarction. J. Intern. Med. Dec 14 [Epub ahead of print] (2009). *

• Bjornvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jorgensen K, Njolstad PR, Ek J, Ascher H, Gudjonsdottir AH, Lie BA, Skinningsrud B, Akselsen HE, Ronningen KS, Sollid LM, Undlien DE. FOXP3 polymorphisms in type 1 diabetes and coeliac disease. J. Autoimmun. 27: 140-144 (2006).

• Bjornvold M, Undlien DE, Joner G, Dahl-Jorgensen K, Njolstad PR, Akselsen HE, Gervin K, Ronningen KS, Stene LC. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia 51: 589-596 (2008). *

• Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J. Immunol. 169: 5595-600 (2002). *

• Blank C, Sabri M, Di Lorenzo C. Pediatric gastric and duodenal disorders. Curr. Opin. Gastroenterol. 20: 551-555 (2004).

• Blomhoff A, Olsson M, Johansson S, Akselsen HE, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE, Lie BA. Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1(*)03 and DRB1(*)04 haplotypes. Genes Immun. 7: 130-140 (2006). *

• Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broome U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. Scand. J. Gastroenterol. 36: 886-890 (2001). *

• Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1996. Vox. Sang. 73: 105-130 (1997).

• Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1996. Hum. Immunol. 53: 98-128 (1997).

• Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1996. Tissue Antigens 49: 297-321 (1997).

• Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1996. Eur. J. Immunogenet. 24: 105-151 (1997).

• Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1998. Hum. Immunol. 60: 361-395 (1999).

• Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1998. Tissue Antigens 53: 407-446 (1999). *

• Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1998. Eur. J. Immunogenet. 26: 81-116 (1999).

• Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 1998. Vox. Sang. 77: 164-191 (1999).

• Boehm BO, Manfras B, Rosak C, Schoffling K, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain is protective against future development of insulin-dependent (type 1) diabetes mellitus. Klin. Wochenschr. 69: 146-150 (1991).

• Boehm BO, Manfras B, Seidl S, Holzberger G, Kuhnl P, Rosak C, Schoffling K, Trucco M. The HLA-DQ beta non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease. Tissue Antigens 37: 130-132 (1991).

• Boehm BO, Seissler J, Gluck M, Manfras BJ, Thomas H, Schmidt K, Rudert WA, Usadel KH, Trucco M, Scherbaum WA. The level and the persistence of islet cell antibodies in healthy schoolchildren are associated with polymorphic residues of the HLA-DQ beta chain. Dis. Markers 9: 273-280 (1991).

• Boehncke WH, Loeliger C, Kuehnl P, Kalbacher H, Bohm BO, Gall H. Identification of HLA-DR and -DQ alleles conferring susceptibility to pollen allergy and pollen associated food allergy. Clin. Exp. Allergy 28: 434-441 (1998). *

• Boger CP, Thomas PW, Nicholas DS, Surgenor SL, Snook JA. Determinants of endomysial antibody status in untreated coeliac disease. Eur. J. Gastroenterol. Hepatol. 19: 890-895 (2007).

• Bogunia-Kubik K, Lange A. Development of the HLA proficiency testing for Central and East Europe. Int. J. Immunogenet. 35: 409-416 (2008). *

• Bohme J, Carlsson B, Wallin J, Moller E, Persson B, Peterson PA, Rask L. Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J. Immunol. 137: 941-947 (1986).

• Bolognesi E, Karell K, Percopo S, Coto I, Greco L, Mantovani V, Suoraniemi E, Partanen J, Mustalahti K, Maki M, Momigliano-Richiardi P. Additional factor in some HLA DR3/DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens 61: 308-316 (2003). *

• Bolsover WJ, Hall MA, Vaughan RW, Welsh KI, Ciclitira PJ. A family study confirms that the HLA-DP associations with celiac disease are the result of an extended HLA-DR3 haplotype. Hum. Immunol. 31: 100-108 (1991).

• Bolstad AI, Wassmuth R, Haga HJ, Jonsson R. HLA markers and clinical characteristics in Caucasians with primary Sjogren's syndrome. J. Rheumatol. 28: 1554-1562 (2001).

• Boniotto M, Braida L, Baldas V, Not T, Ventura A, Vatta S, Radillo O, Tedesco F, Percopo S, Montico M, Amoroso A, Crovella S. Evidence of a correlation between mannose binding lectin and celiac disease: a model for other autoimmune diseases. J. Mol. Med. 83: 308-315 (2005). *

• Bonnekoh B, Pommer AJ, Bockelmann R, Hofmeister H, Philipsen L, Gollnick H. Topo-proteomic in situ analysis of psoriatic plaque under efalizumab treatment. Skin Pharmacol. Physiol. 20: 237-252 (2007).

• Bourgey MM, Calcagno GG, Tinto NN, Gennarelli DD, Margaritte-Jeannin PP, Greco LL, Limongelli MG, Esposito OO, Marano CC, Troncone RR, Spampanato AA, Clerget-Darpoux FF, Sacchetti L. HLA-related genetic risk for coeliac disease. Gut 56: 1054-1059 (2007). *

• Bovin LF, Rieneck K, Workman C, Nielsen H, Sorensen SF, Skjodt H, Florescu A, Brunak S, Bendtzen K. Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. Immunol. Lett. 93: 217-226 (2004).

• Boy MF, La Nasa G, Balestrieri A, Cherchi MV, Usai P. Distribution of HLA-DPB1, -DQB1 -DQA1 alleles among Sardinian celiac patients. Dis. Markers 12: 199-204 (1995).

• Boyton RJ. Regulation of immunity in bronchiectasis. Med. Mycol. 47 Suppl. 1: S175-S182 (2009).

• Bracken S, Byrne G, Kelly J, Jackson J, Feighery C. Altered gene expression in highly purified enterocytes from patients with active coeliac disease. BMC Genomics 9: 377 (2008). *

• Bradley DS, Nabozny GH, Cheng S, Zhou P, Griffiths MM, Luthra HS, David CS. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J. Clin. Invest. 100: 2227-2234 (1997). *

• Braegger CP, MacDonald TT. The immunologic basis for celiac disease and related disorders. Semin. Gastrointest. Dis. 7: 124-133 (1996).

• Brandao LC, Vatta S, Guimaraes R, Segat L, Araujo J, de Lima FJ, Arraes LC, Not T, Crovella S. Rapid genetic screening for major HLA risk haplotypes in patients with type 1 diabetes from North East Brazil. Hum. Immunol. Dec 22 [Epub ahead of print] (2009).

• Bratland E, Skinningsrud B, Undlien DE, Mozes E, Husebye ES. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 94: 5117-5124 (2009).

• Braun WE. HLA molecules in autoimmune diseases. Clin. Biochem. 25: 187-191 (1992). *

• Breslin NP, Todd A, Kilgallen C, O'Morain C. Monozygotic twins with Crohn's disease and ulcerative colitis: a unique case report. Gut 41: 557-560 (1997). *

• Brett PM, Yasuda N, Yiannakou JY, Herbst F, Ellis HJ, Vaughan R, Nicholls RJ, Ciclitira PJ. Genetic and immunological markers in pouchitis. Eur. J. Gastroenterol. Hepatol. 8: 951-955 (1996).

• Brett PM, Yiannakou JY, Morris MA, Bronson SR, Mathew C, Curtis D, Ciclitira PJ. A pedigree-based linkage study of coeliac disease: failure to replicate previous positive findings. Ann. Hum. Genet. 62: 25-32 (1998). *

• Brick C, Belgnaoui FZ, Atouf O, Aoussar A, Bennani N, Senouci K, Hassam B, Essakalli M. Pemphigus and HLA in Morocco. Transfus. Clin. Biol. 14: 402-406 (2007).

• Britten AC, Mijovic CH, Barnett AH, Kelly MA. Differential expression of HLA-DQ alleles in peripheral blood mononuclear cells: alleles associated with susceptibility to and protection from autoimmune type 1 diabetes. Int. J. Immunogenet. 36: 47-57 (2009). *

• Bronson PG, Ramsay PP, Thomson G, Barcellos LF; Diabetes Genetics Consortium. Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes. Diabetes Obes. Metab. 11 Suppl. 1: 74-83 (2009). *

• Broome U, Glaumann H, Hultcrantz R, Forsum U. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis. Scand. J. Gastroenterol. 25: 54-58 (1990).

• Brorsson C, Hansen NT, Lage K, Bergholdt R, Brunak S, Pociot F; Diabetes Genetics Consortium. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data. Diabetes Obes. Metab. 11 Suppl. 1: 60-66 (2009). *

• Brozzetti A, Marzotti S, Tortoioli C, Bini V, Giordano R, Dotta F, Betterle C, De Bellis A, Arnaldi G, Toscano V, Arvat E, Bellastella A, Mantero F, Falorni A. Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies. Eur. J. Endocrinol. Nov 2 [Epub ahead of print] (2009).

• Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC, Zanni D, Penco S, Boiani E, Ghirardello A, Caforio AL, Bergantin A, Tombini V, Moreo A, Ashtamkar L, Doria A, Shoenfeld Y, Livneh A. Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients. Lupus 14: 670-674 (2005).

• Bruck P, Bartsch W, Penna-Martinez M, Kahles H, Seidl C, Bohme A, Badenhoop K, Ramos-Lopez E. Polymorphisms of CXCR3-binding chemokines in type 1 diabetes. Hum. Immunol. 70: 552-555 (2009).

• Bruck P, Ramos-Lopez E, Bartsch W, Bohme A, Badenhoop K. TIM-3 polymorphisms in type 1 diabetes families. J. Hum. Genet. 53: 559-564 (2008). *

• Brydak-Godowska J, Moneta-Wielgos J, Pauk-Domanska M, Drobecka-Brydak E, Samsel A, Kecik M, Kowalewski C, Mackiewicz W, Kecik D. Diagnostics and farmacological treatment of ocular cicatrical pemphigoid. Klin. Oczna. 107: 725-727 (2005).

• Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, Palmgren J, Hillert J. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE 2: e664 (2007). *

• Buc M, Bucova M, Javor J, Krivosikova M, Stuchlikova M, Shawkatova I, Michalkova D, Barak L, Jancova E, Petrek M. Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population. Endocr. Regul. 40: 1-6 (2006). *

• Buc M, Fazekasova H, Cechova E, Hegyi E, Kolibasova K, Ferencik S. Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo. Eur. J. Dermatol. 8: 13-15 (1998).

• Bugawan TL, Angelini G, Larrick J, Auricchio S, Ferrara GB, Erlich HA. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Nature 339: 470-473 (1989). *

• Bugawan TL, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix CM, Petrone A, Buzzetti R, Pozzilli P, Erlich HA. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens 59: 452-469 (2002). *

• Butty V, Campbell C, Mathis D, Benoist C; the Diabetes Prevention Trial-Type 1 Study Group. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). Diabetes 57: 2348-2359 (2008). *

• Buyse I, Sandkuyl LA, Zamani Ghabanbasani M, Gu XX, Bouillon R, Bex M, Dooms L, Emonds MP, Duhamel M, Marynen P, et al. Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population. Diabetologia 37: 808-817 (1994).

• Caballero A, Bravo MJ, Nieto A, Colmenero JD, Alonso A, Martin J. TNFA promoter polymorphism and susceptibility to brucellosis. Clin. Exp. Immunol. 121: 480-483 (2000). *

• Caffrey C, Hitman GA, Niven MJ, Cassell PG, Kumar P, Fry L, Mackintosh P, Gallagher R, Feighery C, Weir D, et al. HLA-DP and coeliac disease: family and population studies. Gut 31: 663-667 (1990). *

• Caillat-Zucman S, Gimenez JJ, Wambergue F, Albouze G, Lebkiri B, Naret C, Moynot A, Jungers P, Bach JF. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int. 53: 1626-1630 (1998). *

• Caillier SJ, Briggs F, Cree BA, Baranzini SE, Fernandez-Vina M, Ramsay PP, Khan O, Royal W 3rd, Hauser SL, Barcellos LF, Oksenberg JR. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J. Immunol. 181: 5473-5480 (2008). *

• Caliz R, Atsumi T, Kondeatis E, Amengual O, Khamashta MA, Vaughan RW, Lanchbury JS, Hughes GR. HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology (Oxford) 40: 31-36 (2001). *

• Calvo B, Castano L, Marcus-Bagley D, Fici DA, Awdeh Z, Alper CA. The [HLA-B18, F1C30, DR3] conserved extended haplotype carries a susceptibility gene for IgD deficiency. J. Clin. Immunol. 20: 216-220 (2000). *

• Camarca A, Anderson RP, Mamone G, Fierro O, Facchiano A, Costantini S, Zanzi D, Sidney J, Auricchio S, Sette A, Troncone R, Gianfrani C. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J. Immunol. 182: 4158-4166 (2009).

• Camarena A, Juarez A, Mejia M, Estrada A, Carrillo G, Falfan R, Zuniga J, Navarro C, Granados J, Selman M. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am. J. Respir. Crit. Care Med. 163: 1528-1533 (2001). *

• Cambon-Thomsen A, Roth MP. Genetics of autoimmune diseases. Rev. Prat. 44: 43-52 (1994).

• Cameron PU, Mallal SA, French MA, Dawkins RL. Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum. Immunol. 29: 282-295 (1990).

• Candore G, Balistreri CR, Campagna AM, Colombo A, Cuppari I, DI-Carlo D, Grimaldi MP, Orlando V, Piazza G, Vasto S, Lio D, Caruso C. Genetic control of immune response in carriers of ancestral haplotype 8.1: the study of chemotaxis. Ann. N. Y. Acad. Sci. 1089: 509-515 (2006). *

• Candore G, Campagna AM, Cuppari I, Carlo DD, Mineo C, Caruso C. Genetic control of immune response in carriers of the 8.1 ancestral haplotype: correlation with levels of IgG subclasses: its relevance in the pathogenesis of autoimmune diseases. Ann. N. Y. Acad. Sci. 1110: 151-158 (2007). *

• Candore G, Lio D, Colonna Romano G, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun. Rev. 1: 29-35 (2002).

• Cao MY, Thonnard J, Deggouj N, Gersdorff M, Philippe M, Osselaer JC, Tomasi JP. HLA class II-associated genetic susceptibility in idiopathic progressive sensorineural hearing loss. Ann. Otol. Rhinol. Laryngol. 105: 628-633 (1996).

• Capilla A, Donat E, Planelles D, Espinos C, Ribes-Koninckx C, Palau F. Genetic analyses of celiac disease in a Spanish population confirm association with CELIAC3 but not with CELIAC4. Tissue Antigens 70: 324-329 (2007). *

• Caputo M, Cerrone GE, Lopez AP, Villalba A, Krochik GA, Cedola FN, Targovnik HM, Frechtel GD. Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA). Autoimmunity 38: 277-281 (2005).

• Cardenas A, Kelly CP. Celiac sprue. Semin. Gastrointest. Dis. 13: 232-244 (2002).

• Cardoso CB, Uthida-Tanaka AM, Magalhaes RF, Magna LA, Kraemer MH. Association between psoriasis vulgaris and MHC-DRB, -DQB genes as a contribution to disease diagnosis. Eur. J. Dermatol. 15: 159-163 (2005).

• Cariappa A, Sands B, Forcione D, Finkelstein D, Podolsky DK, Pillai S. Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease. Gut 43: 210-215 (1998). *

• Carrier CM, Mollen N, Rothman WC, Rodriguez de Cordoba S, Rey-Campos J, Ginsberg-Fellner F, Carpenter C, Rubinstein P. Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships. Hum. Immunol. 24: 51-63 (1989).

• Cassiani-Ingoni R, Cabral ES, Lunemann JD, Garza Z, Magnus T, Gelderblom H, Munson PJ, Marques A, Martin R. Borrelia burgdorferi induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-class II expression. J. Neuropathol. Exp. Neurol. 65: 540-548 (2006).

• Castano-Rodriguez N, Diaz-Gallo LM, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmun. Rev. 7: 322-330 (2008).

• Castellanos-Rubio A, Martin-Pagola A, Santin I, Hualde I, Aransay AM, Castano L, Vitoria JC, Bilbao JR. Combined functional and positional gene information for the identification of susceptibility variants in celiac disease. Gastroenterology 134: 738-746 (2008). *

• Castro F, Acevedo E, Ciusani E, Angulo JA, Wollheim FA, Sandberg-Wollheim M. Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis. Ann. Rheum. Dis. 60: 791-795 (2001). *

• Cavan DA, Jacobs KH, Penny MA, Kelly MA, Mijovic C, Jenkins D, Fletcher JA, Barnett AH. Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population. Diabetologia 36: 252-257 (1993).

• Cavestro GM, Frulloni L, Neri TM, Seghini P, Nouvenne A, Zanetti A, Bovo P, Di Mario F, Okolicsanyi L, Cavallini G. Association of HLA-DRB1*0401 allele with chronic pancreatitis. Pancreas 26: 388-391 (2003).

• Cejkova P, Novota P, Cerna M, Kolostova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients. Int. J. Immunogenet. 35: 133-140 (2008). *

• Cerna M. Genetics of autoimmune diabetes mellitus. Wien. Med. Wochenschr. 158: 2-12 (2008). *

• Cerna M, Kolostova K, Novota P, Romzova M, Cejkova P, Pinterova D, Pruhova S, Treslova L, Andel M. Autoimmune diabetes mellitus with adult onset and type 1 diabetes mellitus in children have different genetic predispositions. Ann. N. Y. Acad. Sci. 1110: 140-150 (2007). *

• Cervin C, Lyssenko V, Bakhtadze E, Lindholm E, Nilsson P, Tuomi T, Cilio CM, Groop L. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 57: 1433-1437 (2008). *

• Chabas D, Foulon C, Gonzalez J, Nasr M, Lyon-Caen O, Willer JC, Derenne JP, Arnulf I. Eating disorder and metabolism in narcoleptic patients. Sleep 30: 1267-1273 (2007). *

• Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, McHugh NJ. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC class II alleles in systemic lupus erythematosus. J. Rheumatol. 35: 77-83 (2008).

• Chan SH, Lin YN, Wee GB, Koh WH, Boey ML. HLA class 2 genes in Singaporean Chinese rheumatoid arthritis. Br. J. Rheumatol. 33: 713-717 (1994).

• Chang KY, Unanue ER. Prediction of HLA-DQ8 beta cell peptidome using a computational program and its relationship to autoreactive T cells. Int. Immunol. 21: 705-713 (2009).

• Chang M, Green PH. Genetic testing before serologic screening in relatives of patients with celiac disease as a cost containment method. J. Clin. Gastroenterol. 43: 43-50 (2009).

• Chang Y, Fan TX, Santana Z, Day NK. Identification of a novel allele HLA-DQB1*0622. Tissue Antigens 70: 439-444 (2007). *

• Chantarangsu S, Mushiroda T, Mahasirimongkol S, Kiertiburanakul S, Sungkanuparph S, Manosuthi W, Tantisiriwat W, Charoenyingwattana A, Sura T, Chantratita W, Nakamura Y. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients. Pharmacogenet. Genomics 19: 139-146 (2009).

• Charmley P, Nepom BS, Concannon P. HLA and T cell receptor beta-chain DNA polymorphisms identify a distinct subset of patients with pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 37: 695-701 (1994).

• Chauffert M, Cisse A, Chevenne D, Parfait B, Michel S, Trivin F. HLA-DQ beta 1 typing and non-Asp57 alleles in the aborigine population of Senegal. Diabetes Care 18: 677-680 (1995).

• Chedid A, Mendenhall CL, Moritz TE. The antigenic heterogeneity of the bile duct epithelium in alcoholic liver disease. VA Cooperative Study Group 275. Arch. Pathol. Lab. Med. 123: 411-414 (1999). *

• Chen L, Fong SY, Lam CW, Tang NL, Ng MH, Li AM, Ho CK, Cheng SH, Lau KM, Wing YK. The familial risk and HLA susceptibility among narcolepsy patients in Hong Kong Chinese. Sleep 30: 851-858 (2007). *

• Chen QY, Huang W, She JX, Baxter F, Volpe R, Maclaren NK. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. J. Clin. Endocrinol. Metab. 84: 3182-3186 (1999). *

• Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J. Clin. Endocrinol. Metab. 85: 1545-1549 (2000). *

• Chen YW, Shi R, Geraci N, Shrestha S, Gordish-Dressman H, Pachman LM. Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis. BMC Immunol. 9: 43 (2008). *

• Chen Z, de Kauwe AL, Keech C, Wijburg O, Simpfendorfer K, Alexander WS, McCluskey J. Humanized transgenic mice expressing HLA DR4-DQ3 haplotype: reconstitution of phenotype and HLA-restricted T-cell responses. Tissue Antigens 68: 210-219 (2006). *

• Cheong KY, Allcock RJ, Eerligh P, Witt CS, Christiansen FT, McCann V, Price P. Localization of central MHC genes influencing type I diabetes. Hum. Immunol. 62: 1363-1370 (2001).

• Chernavsky AC, Paez MC, Periolo N, Correa P, Guillen L, Niveloni SI, Maurino E, Bai JC, Anaya JM. The simultaneous presence of IL-1B and TNFA two-positions risk haplotypes enhances the susceptibility for celiac disease. Cytokine 42: 48-54 (2008).

• Chiba M, Fukushima T, Horie Y, Iizuka M, Masamune O. No Mycobacterium paratuberculosis detected in intestinal tissue, including Peyer's patches and lymph follicles, of Crohn's disease. J. Gastroenterol. 33: 482-487 (1998).

• Chin MW, Mallon DF, Cullen DJ, Olynyk JK, Mollison LC, Pearce CB. Screening for coeliac disease using anti-tissue transglutaminase antibody assays, and prevalence of the disease in an Australian community. Med. J. Aust. 190: 429-432 (2009).

• Chinoy H, Lamb JA, Ollier WE, Cooper RG. An update on the immunogenetics of idiopathic inflammatory myopathies: major histocompatibility complex and beyond. Curr. Opin. Rheumatol. 21: 588-593 (2009).

• Chinoy H, Payne D, Poulton KV, Fertig N, Betteridge Z, Gunawardena H, Davidson JE, Oddis CV, McHugh NJ, Wedderburn LR, Ollier WE, Cooper RG; on behalf of the UK Adult Onset Myositis Immunogenetic Collaboration & UK Juvenile Dermatomyositis Research Group. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Rheumatology (Oxford) 48: 1213-1217 (2009).

• Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV, Ollier WE, Cooper RG; for the UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC). Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatology (Oxford) 46: 1411-1416 (2007). *

• Chmurova N, Parnicka Z, Svecova D, Manova A, Simaljakova M. Dermatitis herpetiformis in siblings. Bratisl. Lek. Listy. 108: 519-521 (2007).

• Cho BY, Chung JH, Shong YK, Chang YB, Han H, Lee JB, Lee HK, Koh CS. A strong association between thyrotropin receptor-blocking antibody-positive atrophic autoimmune thyroiditis and HLA-DR8 and HLA-DQB1*0302 in Koreans. J. Clin. Endocrinol. Metab. 77: 611-615 (1993). *

• Cho JH. Update on the genetics of inflammatory bowel disease. Curr. Gastroenterol. Rep. 3: 458-463 (2001).

• Cho SW, Cheong JY, Ju YS, Oh do H, Suh YJ, Lee KW. Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype level. J. Korean Med. Sci. 23: 838-844 (2008).

• Choi HB, Roh SY, Choi EJ, Yoon HY, Kim SY, Hong YS, Kim DW, Kim TG. Association of HLA alleles with non-Hodgkin's lymphoma in Korean population. Int. J. Hematol. 87: 203-209 (2008).

• Choi JH, Lee KW, Kim CW, Park CS, Lee HY, Hur GY, Kim SH, Hong CS, Jang AS, Park HS. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma. Int. Arch. Allergy Immunol. 150: 156-163 (2009).

• Cholongitas E, Papatheodoridis GV, Zappoli P, Giannakopoulos A, Patch D, Marelli L, Shusang V, Kalambokis G, Shirling G, Rolando N, Burroughs AK. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis. Liver Transpl. 13: 552-557 (2007). *

• Choonhakarn C, Romphruk A, Puapairoj C, Jirarattanapochai K, Romphruk A, Leelayuwat C. Haplotype associations of the major histocompatibility complex with psoriasis in Northeastern Thais. Int. J. Dermatol. 41: 330-334 (2002).

• Chou HT, Chen CH, Chen JY, Chang KC. Association of HLA DRB1-DQA1-DQB1 haplotypes with rheumatic heart disease in Taiwan. Int. J. Cardiol. 128: 434-435 (2008).

• Chowdhury ZM, McDermott MF, Davey S, Hassan Z, Sinnott PJ, Hemmatpour SK, Sherwin S, Ali L, Aganna E, Allotey RA, North BV, Cassell PG, Azad Khan AK, Hitman GA. Genetic susceptibility to fibrocalculous pancreatic diabetes in Bangladeshi subjects: a family study. Genes Immun. 3: 5-8 (2002). *

• Christensen T, Petersen T, Thiel S, Brudek T, Ellermann-Eriksen S, Moller-Larsen A. Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway. J. Neuroimmunol. 183: 175-188 (2007).

• Chu CC, Lin CY, Trejaut JA, Wu MM, Lin M. HLA-DQB1*0317 is a novel allele with an unusual DR-DQ haplotype. Tissue Antigens 69: 370-372 (2007). *

• Ciccocioppo R, Di Sabatino A, Corazza GR. The immune recognition of gluten in coeliac disease. Clin. Exp. Immunol. 140: 408-416 (2005). *

• Ciccocioppo R, Ricci G, Rovati B, Pesce I, Mazzocchi S, Piancatelli D, Cagnoni A, Millimaggi D, Danova M, Corazza GR. Reduced number and function of peripheral dendritic cells in coeliac disease. Clin. Exp. Immunol. 140: 487-496 (2007). *

• Ciccocioppo R, Rossi M, Pesce I, Ricci G, Millimaggi D, Maurano F, Corazza GR. Effects of gliadin stimulation on bone marrow-derived dendritic cells from HLA-DQ8 transgenic mice. Dig. Liver Dis. 40: 927-935 (2008).

• Cinek O, Drevinek P, Sumnik Z, Bendlova B, Vavrinec J. Association of insulin gene variants with type 1 diabetes mellitus in Czech population. Cas. Lek. Cesk. 143: 318-322 (2004).

• Cinova J, Palova-Jelinkova L, Smythies LE, Cerna M, Pecharova B, Dvorak M, Fruhauf P, Tlaskalova-Hogenova H, Smith PD, Tuckova L. Gliadin peptides activate blood monocytes from patients with celiac disease. J. Clin. Immunol. 27: 201-209 (2007). *

• Cintado A, Sorell L, Galvan JA, Martinez L, Castaneda C, Fragoso T, Camacho H, Ferrer A, Companioni O, Benitez J, Nazabal M, Novoa LI, Duenas M. HLA DQA1*0501 and DQB1*02 in Cuban celiac patients. Hum. Immunol. 67: 639-642 (2006).

• Coakley G, Brooks D, Iqbal M, Kondeatis E, Vaughan R, Loughran TP Jr, Panayi GS, Lanchbury JS. Major histocompatility complex haplotypic associations in Felty's syndrome and large granular lymphocyte syndrome are secondary to allelic association with HLA-DRB1 *0401. Rheumatology (Oxford) 39: 393-398 (2000). *

• Cocco E, Murru MR, Melis C, Schirru L, Solla E, Lai M, Rolesu M, Marrosu MG. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients. J. Neurol. 251: 1085-1088 (2004). *

• Coelho FM, Pradella-Hallinan M, Alves GR, Bittencourt LR, Pedrazzoli Neto M, Moreira F, Tufik S. A study of T CD4, CD8 and B lymphocytes in narcoleptic patients. Arq. Neuropsiquiatr. 65: 423-427 (2007).

• Coelho FM, Pradella-Hallinan M, Predazzoli Neto M, Bittencourt LR, Tufik S. Prevalence of the HLA-DQB1*0602 allele in narcolepsy and idiopathic hypersomnia patients seen at a sleep disorders outpatient unit in Sao Paulo. Rev. Bras. Psiquiatr. 31: 10-14 (2009).

• Cofie MD DQ, Rogers MD R, Draelos MD FACE MT, Olansky MD FACE L, Scofield MD RH. Syndrome of type II polyglandular autoimmunity associated with HLA-DR4 in a large kindred, including HLA-DR3/DR4 heterozygosity in the probands, identical twins with identical manifestations. Endocr. Pract. 1: 395-398 (1995).

• Cohen N, Brautbar C, Font MP, Dausset J, Cohen D. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics 23: 84-89 (1986).

• Collier PM, Wojnarowska F, Welsh K, McGuire W, Black MM. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br. J. Dermatol. 141: 867-875 (1999).

• Collin P, Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. Am. J. Clin. Dermatol. 4: 13-20 (2003).

• Collin P, Syrjanen J, Partanen J, Pasternack A, Kaukinen K, Mustonen J. Celiac disease and HLA DQ in patients with IgA nephropathy. Am. J. Gastroenterol. 97: 2572-2576 (2002). *

• Collin P, Wahab PJ, Murray JA. Intraepithelial lymphocytes and coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19: 341-350 (2005).

• Colombe BW, Lou CD, Price VH. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J. Investig. Dermatol. Symp. Proc. 4: 216-219 (1999). *

• Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD. HLA class II antigen associations help to define two types of alopecia areata. J. Am. Acad. Dermatol. 33: 757-764 (1995).

• Colombel JF, Gower-Rousseau C. Etiology of Crohn disease. Current data. Presse. Med. 23: 558-560 (1994).

• Comabella M, Craig DW, Camina-Tato M, Morcillo C, Lopez C, Navarro A, Rio J; BiomarkerMS Study Group, Montalban X, Martin R. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE 3: e3490 (2008). *

• Comabella M, Fernandez-Arquero M, Río J, Guinea A, Fernandez M, Cenit MC, de la Concha EG, Montalban X. HLA class I and II alleles and response to treatment with interferon-beta in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 210: 116-119 (2009).

• Congia M, Frau F, Lampis R, Frau R, Mele R, Cucca F, Muntoni F, Porcu S, Boi F, Contu L, et al. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201. Tissue Antigens 39: 78-83 (1992).

• Contreas G, Valletta E, Ulmi D, Cantoni S, Pinelli L. Screening of coeliac disease in north Italian children with type 1 diabetes: limited usefulness of HLA-DQ typing. Acta Paediatr. 93: 628-632 (2004).

• Cook AD, Stockman A, Brand CA, Tait BD, Mackay IR, Muirden KD, Bernard CC, Rowley MJ. Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis. Arthritis Rheum. 42: 2569-2576 (1999). *

• Coppin H, Ribouchon MT, Fontaine B, Edan G, Clanet M, Roth MP; French Multiple Sclerosis Genetics Group. A vulnerability locus to multiple sclerosis maps to 7p15 in a region syntenic to an EAE locus in the rat. Genes Immun. 5: 72-75 (2004). *

• Cordovado SK, Hancock LN, Simone AE, Hendrix M, Mueller PW. High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404. Tissue Antigens 65: 448-458 (2005). *

• Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM, Hancock LN, Cleary PA, Mueller PW. Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes 57: 518-522 (2008). *

• Corper AL, Stratmann T, Apostolopoulos V, Scott CA, Garcia KC, Kang AS, Wilson IA, Teyton L. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288: 505-511 (2000). *

• Cortes LM, Baltazar LM, Lopez-Cardona MG, Olivares N, Ramos C, Salazar M, Sandoval L, Lorenz MG, Chakraborty R, Paterson AD, Rivas F. HLA class II haplotypes in Mexican systemic lupus erythematosus patients. Hum. Immunol. 65: 1469-1476 (2004).

• Corzo D, Yunis JJ, Salazar M, Lieberman JA, Howard A, Awdeh Z, Alper CA, Yunis EJ. The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups. Blood 86: 3835-3840 (1995). *

• Cosentino A, Gambelunghe G, Tortoioli C, Falorni A. CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann. N. Y. Acad. Sci. 958: 337-340 (2002). *

• Costantini S, Rossi M, Colonna G, Facchiano AM. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease. J. Mol. Graph. Model. 23: 419-431 (2005). *

• Craig D, Robins G, Howdle PD. Advances in celiac disease. Curr. Opin. Gastroenterol. 23: 142-148 (2007).

• Creary LE, Girdlestone J, Zamora J, Brown J, Navarrete CV. Molecular typing of HLA genes using whole genome amplified DNA. Transfusion 49: 57-63 (2009).

• Cree BA, Reich DE, Khan O, De Jager PL, Nakashima I, Takahashi T, Bar-Or A, Tong C, Hauser SL, Oksenberg JR. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch. Neurol. 66: 226-233 (2009).

• Crocchiolo R, Ciceri F, Fleischhauer K, Oneto R, Bruno B, Pollichieni S, Sacchi N, Sormani MP, Fanin R, Bandini G, Bonifazi F, Bosi A, Rambaldi A, Alessandrino PE, Falda M, Bacigalupo A. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry. Bone Marrow Transplant. 44: 571-577 (2009).

• Crovella S, Brandao L, Guimaraes R, de Lima Filho JL, Arraes LC, Ventura A, Not T. Speeding up coeliac disease diagnosis in the developing countries. Dig. Liver Dis. 39: 900-902 (2007).

• Csak T, Folhoffer A, Horvath A, Halasz J, Diczhazi C, Schaff Z, Szalay F. Holmes-Adie syndrome, autoimmune hepatitis and celiac disease: a case report. World J. Gastroenterol. 12: 1485-1487 (2006). *

• Cucca F, Congia M, Trowsdale J, Powis SH. Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: no association in a population with a high disease incidence. Tissue Antigens 44: 234-240 (1994).

• Cucca F, Contu D, Zavattari P, Murru D. Correlation between major histocompatibility complex (MHC)-class II and type 1 diabetes. Minerva Endocrinol. 28: 111-122 (2003).

• Cucca F, Dudbridge F, Loddo M, Mulargia AP, Lampis R, Angius E, De Virgiliis S, Koeleman BP, Bain SC, Barnett AH, Gilchrist F, Cordell H, Welsh K, Todd JA. The HLA-DPB1-associated component of the IDDM1 and its relationship to the major loci HLA-DQB1, -DQA1, and -DRB1. Diabetes 50: 1200-1205 (2001). *

• Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, Barnett AH, Todd JA. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum. Mol. Genet. 10: 2025-2037 (2001). *

• Cucca F, Zhu ZB, Khanna A, Cossu F, Congia M, Badiali M, Lampis R, Frau F, De Virgiliis S, Cao A, Arnone M, Piras P, Campbell RD, Cooper MD, Volanakis JE, Powis SH. Evaluation of IgA deficiency in Sardinians indicates a susceptibility gene is encoded within the HLA class III region. Clin. Exp. Immunol. 111: 76-80 (1998). *

• Cuddihy RM, Schaid DS, Bahn RS. Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease. Thyroid 6: 261-265 (1996).

• Culver DA, Newman LS, Kavuru MS. Gene-environment interactions in sarcoidosis: challenge and opportunity. Clin. Dermatol. 25: 267-275 (2007).

• Cummins AG, Roberts-Thomson IC. Prevalence of celiac disease in the Asia-Pacific region. J. Gastroenterol. Hepatol. 24: 1347-1351 (2009). *

• Czaja AJ. Autoimmune hepatitis. Part B: diagnosis. Expert Rev. Gastroenterol. Hepatol. 1: 129-143 (2007).

• Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 23: 255-262 (2007).

• Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am. J. Gastroenterol. 97: 2051-2057 (2002). *

• Czaja AJ, Santrach PJ, Moore SB. HLA-DQ associations in type 1 autoimmune hepatitis. Mayo Clin. Proc. 70: 1154-1160 (1995). *

• D'Arienzo R, Maurano F, Luongo D, Mazzarella G, Stefanile R, Troncone R, Auricchio S, Ricca E, David C, Rossi M. Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity. Immunol. Lett. 119: 78-83 (2008).

• D'Arienzo R, Stefanile R, Maurano F, Luongo D, Bergamo P, Mazzarella G, Troncone R, Auricchio S, David C, Rossi M. A deregulated immune response to gliadin causes a decreased villus height in DQ8 transgenic mice. Eur. J. Immunol. 39: 3552-3561 (2009). *

• da Silva SA, Mazini PS, Reis PG, Sell AM, Tsuneto LT, Peixoto PR, Visentainer JE. HLA-DR and HLA-DQ alleles in patients from the south of Brazil: markers for leprosy susceptibility and resistance. BMC Infect. Dis. 9: 134 (2009). *

• Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J. Rheumatol. 25: 2140-2145 (1998).

• Dai CY, Chuang WL, Hsieh MY, Huang JF, Lin YY, Chu PY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML. Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients. Antiviral Res. Nov 18 [Epub ahead of print] (2009).

• Dam-Tuxen R, Riise E. Antibodies against a class II HLA-peptide complex raised by active immunization of mice with antigen mimicking peptides. Scand. J. Immunol. 70: 93-100 (2009). *

• Danze PM, Colombel JF, Jacquot S, Loste MN, Heresbach D, Ategbo S, Khamassi S, Perichon B, Semana G, Charron D, Cezard JP. Association of HLA class II genes with susceptibility to Crohn's disease. Gut 39: 69-72 (1996). *

• Das P, Abraham R, David C. HLA transgenic mice as models of human autoimmune diseases. Rev. Immunogenet. 2: 105-114 (2000).

• Das P, Bradley DS, Geluk A, Griffiths MM, Luthra HS, David CS. An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice. Hum. Immunol. 60: 575-582 (1999).

• Date Y, Seki N, Kamizono S, Higuchi T, Hirata T, Miyata K, Ohkuni M, Tatsuzawa O, Yokota S, Joo K, Ueda K, Sasazuki T, Kimura A, Itoh K, Kato H. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum. 42: 2577-2582 (1999). *

• Dauvilliers Y, Arnulf I. Narcolepsy with cataplexy. Rev. Neurol. (Paris) 164: 634-645 (2008).

• David CS, Taneja V. Role of major histocompatibility complex genes in murine collagen-induced arthritis: a model for human rheumatoid arthritis. Am. J. Med. Sci. 327: 180-187 (2004).

• de Andrade M, Jackow CM, Dahm N, Hordinsky M, Reveille JD, Duvic M. Alopecia areata in families: association with the HLA locus. J. Investig. Dermatol. Symp. Proc. 4: 220-223 (1999). *

• De Carlo E, Tamagno G, Martini C, Maffei P, Rubello D, Luca M, Sicolo N. Autoimmune diabetes mellitus, Hodgkin's disease and Graves' ophthalmopathy in a patient with 8.1 ancestral haplotype. Horm. Metab. Res. 36: 97-100 (2004).

• De Juan D, Martín-Villa JM, Gomez-Reino JJ, Vicario JL, Corell A, Martinez-Laso J, Benmammar D, Arnaiz-Villena A. Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility. Hum. Genet. 91: 579-584 (1993).

• de Kauwe AL, Chen Z, Anderson RP, Keech CL, Price JD, Wijburg O, Jackson DC, Ladhams J, Allison J, McCluskey J. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J. Immunol. 182: 7440-7450 (2009).

• de la Concha EG. Celiac disease: etiology and susceptibility. An. R. Acad. Nac. Med. (Madr.) 124: 813-824 (2007).

• de la Concha EG, Arroyo R, Crusius JB, Campillo JA, Martin C, Varela de Seijas E, Pena AS, Claveria LE, Fernandez-Arquero M. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J. Neuroimmunol. 80: 172-178 (1997).

• de la Concha EG, Fernandez-Arquero M, Conejero L, Lazaro F, Mendoza JL, Sevilla MC, Diaz-Rubio M, Ruiz de Leon A. Presence of a protective allele for achalasia on the central region of the major histocompatibility complex. Tissue Antigens 56: 149-153 (2000). *

• De la Concha EG, Fernandez-Arquero M, Gual L, Vigil P, Martinez A, Urcelay E, Ferreira A, Garcia-Rodriguez MC, Fontan G. MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes. J. Immunol. 169: 4637-4643 (2002). *

• De La Concha EG, Fernandez-Arquero M, Martinez A, Vidal F, Vigil P, Conejero L, Garcia-Rodriguez MC, Fontan G. HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID). Clin. Exp. Immunol. 116: 516-520 (1999). *

• De La Concha EG, Fernandez-Arquero M, Santa-Cruz S, Lopez-Nava G, Figueredo MA, Diaz-Rubio M, Garcia-Paredes J. Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC). Clin. Exp. Immunol. 108: 392-395 (1997). *

• de la Concha EG, Fernandez-Arquero M, Vigil P, Rubio A, Maluenda C, Polanco I, Fernandez C, Figueredo MA. Celiac disease and TNF promoter polymorphisms. Hum. Immunol. 61: 513-517 (2000).

• de la Paz Bettinotti M, Kolek A, Brunnler G, Haas P, Paul C, Hochberger M, Bartova A, Kimura A, Sasazuki T, Albert ED. Polymorphism of the 5' flanking region of the HLA-DQA1 gene in coeliac disease. Eur. J. Immunogenet. 20: 399-407 (1993).

• De Palma G, Capilla A, Nadal I, Nova E, Pozo T, Varea V, Polanco I, Castillejo G, Ribes-Koninckx C, Garrote JA, Calvo C, Garcia-Novo MD, Cilleruelo ML, Lopez A, Palau F, Sanz Y. Interplay between human leukocyte antigen genes and the microbial colonization process of the newborn intestine. Curr. Issues Mol. Biol. 12: 1-10 (2009).

• De Re V, Caggiari L, De Vita S, Mazzaro C, Lenzi M, Galli M, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Cannizzaro R, Guidoboni M, Dolcetti R. Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. Dig. Liver Dis. 39 Suppl. 1: S65-S71 (2007).

• de Rooij AM, Florencia Gosso M, Haasnoot GW, Marinus J, Verduijn W, Claas FH, van den Maagdenberg AM, van Hilten JJ. HLA-B62 and HLA-DQ8 are associated with complex regional pain syndrome with fixed dystonia. Pain 145: 82-85 (2009).

• de Vijlder HC, Westerhof W, Schreuder GM, de Lange P, Claas FH. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res. 17: 270-274 (2004). *

• de Vries N, Ronningen KS, Tilanus MG, Bouwens-Rombouts A, Segal R, Egeland T, Thorsby E, van de Putte LB, Brautbar C. HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. Tissue Antigens 41: 26-30 (1993).

• de Vries RR, Huizinga TW, Toes RE. Redefining the HLA and RA association: to be or not to be anti-CCP positive. J. Autoimmun. 25: S21-S25 (2005).

• Degli-Esposti MA, Abraham LJ, McCann V, Spies T, Christiansen FT, Dawkins RL. Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics 36: 345-356 (1992).

• Degli-Esposti MA, Leelayuwat C, Dawkins RL. Ancestral haplotypes carry haplotypic and haplospecific polymorphisms of BAT1: possible relevance to autoimmune disease. Eur. J. Immunogenet. 19: 121-127 (1992).

• Dekker JW, Easteal S, Jakobsen IB, Gao X, Stewart GJ, Buhler MM, Hawkins BR, Higgins DA, Yu YL, Serjeantson SW. HLA-DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high-risk DQB1*0602 allele. Tissue Antigens 41: 31-36 (1993).

• Deleeuw RJ, Zettl A, Klinker E, Haralambieva E, Trottier M, Chari R, Ge Y, Gascoyne RD, Chott A, Muller-Hermelink HK, Lam WL. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132: 1902-1911 (2007). *

• Delgado JC, Baena A, Thim S, Goldfeld AE. Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia. J. Immunol. 176: 1090-1097 (2006). *

• Delgado-Vega AM, Castiblanco J, Gomez LM, Diaz-Gallo LM, Rojas-Villarraga A, Anaya JM. BCL2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. Ann. Rheum. Dis. Mar 11 [Epub ahead of print] (2009).

• Dema B, Martinez A, Fernandez-Arquero M, Maluenda C, Polanco I, Angeles Figueredo M, de la Concha EG, Urcelay E, Nunez C. Autoimmune disease association signals in CIITA and KIAA0350 are not involved in celiac disease susceptibility. Tissue Antigens 73: 326-329 (2009). *

• Demoulins-Giacco N, Gagey V, Teillac-Hamel D, Fraitag S, Caillat-Zucman S, Schmitz J, de Prost Y. Dermatitis herpetiformis occuring in patients with celiac disease in childhood. Arch. Pediatr. 3: 541-548 (1996).

• Deng CT, Cai J, Tarsitani C, El-Awar N, Lachmann N, Ozawa M. HLA class II DQ epitopes. Clin. Transpl. 2006: 115-122 (2006).

• Desai M, Zeggini E, Horton VA, Owen KR, Hattersley AT, Levy JC, Walker M, Gillespie KM, Bingley PJ, Hitman GA, Holman RR, McCarthy MI, Clark A. An association analysis of the HLA gene region in latent autoimmune diabetes in adults. Diabetologia 50: 68-73 (2007). *

• Desai SN, White DM, O'Shea KM, Brown ML, Cywin CL, Spero DM, Panzenbeck MJ. An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity. Eur. J. Pharmacol. 538: 168-174 (2006). *

• Deschamps I, Khalil I. The role of the HLA system in the genetics of type I diabetes mellitus. Diabete. Metab. 18: 253-263 (1992).

• Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 51: 593-604 (1998).

• Dezi R, Niveloni S, Sugai E, Pedreira S, Smecuol E, Vazquez H, Doldan I, Cabanne A, Boerr L, Valero J, Kogan Z, Maurino E, Bai JC. Gluten sensitivity in the rectal mucosa of first-degree relatives of celiac disease patients. Am. J. Gastroenterol. 92: 1326-1330 (1997).

• Dezsofi A, Szebeni B, Hermann CS, Kapitany A, Veres G, Sipka S, Korner A, Madacsy L, Korponay-Szabo I, Rajczy K, Arato A. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both. J. Pediatr. Gastroenterol. Nutr. 47: 283-287 (2008). *

• Diaz de Entresotos Villazan L, de la Rubia Fernandez L, Lopez Hoyos M, Ruiz de Alegria C, Sanchez Velasco P, Fernandez Garcia P. Study of celiac disease in the pediatric population of Cantabria (Spain) and first-degree relatives. Gastroenterol. Hepatol. 31: 53-58 (2008).

• Dib SA, Gomes MB. Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function. Diabetol. Metab. Syndr. 1: 25 (2009). *

• Dickey W. Joint BAPEN and British Society of Gastroenterology Symposium on 'Coeliac disease: basics and controversies'. Coeliac disease in the twenty-first century. Proc. Nutr. Soc. 68: 234-241 (2009). *

• Dieterich W, Esslinger B, Schuppan D. Pathomechanisms in celiac disease. Int. Arch. Allergy Immunol. 132: 98-108 (2003).

• Ding Y, Shen H, Wang X, Fan X, Wu X, Yang X. The polymorphism of HLA-DR and -DQ allelic genes associated with intrahepatic cholestasis of pregnancy. Genet. Test. 12: 215-220 (2008).

• Diosdado B, Monsuur AJ, Mearin ML, Mulder C, Wijmenga C. The downstream modulator of interferon-gamma, STAT1 is not genetically associated to the Dutch coeliac disease population. Eur. J. Hum. Genet. 14: 1120-1124 (2006). *

• Diosdado B, van Oort E, Wijmenga C. "Coelionomics": towards understanding the molecular pathology of coeliac disease. Clin. Chem. Lab. Med. 43: 685-695 (2005). *

• Diosdado B, Wijmenga C. Molecular mechanisms of the adaptive, innate and regulatory immune responses in the intestinal mucosa of celiac disease patients. Expert Rev. Mol. Diagn. 5: 681-700 (2005).

• Dittmar M, Ide M, Wurm M, Kahaly GJ. Early onset of polyglandular failure is associated with HLA-DRB1*03. Eur. J. Endocrinol. 159: 55-60 (2008).

• Djilali-Saiah I, Benini V, Daniel S, Assan R, Bach JF, Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens 48: 87-92 (1996).

• Djilali-Saiah I, Benini V, Schmitz J, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Absence of primary association between DM gene polymorphism and insulin-dependent diabetes mellitus or celiac disease. Hum. Immunol. 49: 22-27 (1996).

• Djilali-Saiah I, Bertin E, Larger E, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Major histocompatibility class II genes polymorphism in insulin dependent diabetes mellitus with or without associated thyroid autoimmunity. Hum. Immunol. 59: 176-182 (1998).

• Djilali-Saiah I, Caillat-Zucman S, Schmitz J, Chaves-Vieira ML, Bach JF. Polymorphism of antigen processing (TAP, LMP) and HLA class II genes in celiac disease. Hum. Immunol. 40: 8-16 (1994).

• Djilali-Saiah I, Fakhfakh A, Louafi H, Caillat-Zucman S, Debray D, Alvarez F. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J. Hepatol. 45: 844-850 (2006). *

• Djilali-Saiah I, Renous R, Caillat-Zucman S, Debray D, Alvarez F. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J. Hepatol. 40: 904-909 (2004).

• Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot JF, Bach JF, Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 43: 187-189 (1998). *

• Dobrovolna M, Vrana M, Brdicka R, Loudova M. Significance of confirmatory testing of HLA system in unrelated haematopoietic stem cell donors. Cas. Lek. Cesk. 145: 32-35 (2006).

• Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, McFarlane IG, Johnson PJ, Eddleston AL, Mowat AP, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 19: 609-615 (1994).

• Doherty DG, Underhill JA, Donaldson PT, Manabe K, Mieli-Vergani G, Eddleston AL, Vergani D, Demaine AG, Williams R. Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis. Autoimmunity 18: 243-249 (1994).

• Dolinsek J, Urlep D, Karell K, Partanen J, Micetic-Turk D. The prevalence of celiac disease among family members of celiac disease patients. Wien. Klin. Wochenschr. 116 Suppl. 2: 8-12 (2004).

• Donaldson P. HLA system and other genetic markers in PSC. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 71-72. October 15-16 (2003). *

• Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 48: 397-402 (2001). *

• Donaldson PT. Immunogenetics in liver diseases. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 23-24. September 12 - 13 (2003). *

• Donaldson PT. Basic concepts in PSC. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 73-75 (2005). *

• Donaldson PT. The role of genetics in immunopathogenesis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 47-48 (2004). *

• Donaldson PT. Immunogenetics in liver disease. Baillieres Clin. Gastroenterol. 10: 533-549 (1996).

• Donaldson PT. Chapter 17. Immunogenetics of autoimmune liver disease: risk factors for susceptibility and progression. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 221-234 (2007). *

• Donaldson PT, Baragiotta A, Heneghan MA, Floreani A, Venturi C, Underhill JA, Jones DE, James OF, Bassendine MF. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 44: 667-674 (2006). *

• Donaldson PT, Clare M, Constantini PK, Hadzic N, Mieli-Vergani G, Howard E, Kelley D. HLA and cytokine gene polymorphisms in biliary atresia. Liver 22: 213-219 (2002). *

• Donaldson PT, Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 35: 555-564 (2002).

• Donat E, Planelles D, Capilla-Villanueva A, Montoro JA, Palau F, Ribes-Koninckx C. Allelic distribution and the effect of haplotype combination for HLA type II loci in the celiac disease population of the Valencian community (Spain). Tissue Antigens 73: 255-261 (2009).

• Donn RP, Thomson W, Pepper L, Carthy D, Farhan A, Ryder C, Southwood T, Holt L, Ollier W. Antinuclear antibodies in early onset pauciarticular juvenile chronic arthritis (JCA) are associated with HLA-DQB1*0603: a possible JCA-associated human leucocyte antigen haplotype. Br. J. Rheumatol. 34: 461-465 (1995).

• Donner H, Tonjes RR, Bontrop RE, Kurth R, Usadel KH, Badenhoop K. MHC diversity in Caucasians, investigated using highly heterogeneous noncoding sequence motifs at the DQB1 locus including a retroviral long terminal repeat element, and its comparison to nonhuman primate homologues. Immunogenetics 51: 898-904 (2000).

• Donner H, Tonjes RR, Van der Auwera B, Siegmund T, Braun J, Weets I, Herwig J, Kurth R, Usadel KH, Badenhoop K. The presence or absence of a retroviral long terminal repeat influences the genetic risk for type 1 diabetes conferred by human leukocyte antigen DQ haplotypes. Belgian Diabetes Registry. J. Clin. Endocrinol. Metab. 84: 1404-1408 (1999). *

• Doolan A, Donaghue K, Fairchild J, Wong M, Williams AJ. Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes. Diabetes Care 28: 806-809 (2005). *

• Dorak MT, Shao W, Machulla HK, Lobashevsky ES, Tang J, Park MH, Kaslow RA. Conserved extended haplotypes of the major histocompatibility complex: further characterization. Genes Immun. 7: 450-467 (2006). *

• Dorak MT, Yee LJ, Tang J, Shao W, Lobashevsky ES, Jacobson LP, Kaslow RA. HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma. J. Med. Virol. 76: 302-310 (2005). *

• Dorn SD, Matchar DB. Cost-effectiveness analysis of strategies for diagnosing celiac disease. Dig. Dis. Sci. 53: 680-688 (2008). *

• Dorum S, Qiao SW, Sollid LM, Fleckenstein B. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. J. Proteome Res. 8: 1748-1755 (2009). *

• Douroudis K, Tarassi K, Athanassiades T, Giannakopoulos F, Kominakis A, Thalassinos N, Papasteriades Ch. HLA alleles as predisposal factors for postmenopausal osteoporosis in a Greek population. Tissue Antigens 69: 592-596 (2007). *

• Doytchinova IA, Flower DR. In silico identification of supertypes for class II MHCs. J. Immunol. 174: 7085-7095 (2005). *

• Drouet M, Delpuget-Bertin N, Vaillant L, Chauchaix S, Boulanger MD, Bonnetblanc JM, Bernard P. HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians. Eur. J. Dermatol. 8: 330-333 (1998).

• Duarte-Rey C, Pardo AL, Rodríguez-Velosa Y, Mantilla RD, Anaya JM, Rojas-Villarraga A. HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis. Autoimmun. Rev. 8: 325-331 (2009).

• Dubois P, Hunt K, van Heel D. Sex differences in HLA DQ in celiac disease. Am. J. Gastroenterol. 104: 784 (2009). *

• Dubois-Laforgue D, Timsit J, Djilali-Saiah I, Boitard C, Caillat-Zucman S. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects. Hum. Immunol. 57: 104-109 (1997).

• Dudek NL, Maier S, Chen ZJ, Mudd PA, Mannering SI, Jackson DC, Zeng W, Keech CL, Hamlin K, Pan ZJ, Davis-Schwarz K, Workman-Azbill J, Bachmann M, McCluskey J, Farris AD. T cell epitopes of the La/SSB autoantigen in humanized transgenic mice expressing the HLA class II haplotype DRB1*0301/DQB1*0201. Arthritis Rheum. 56: 3387-3398 (2007). *

• Duerr RH. Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research. Gastroenterology 132: 2045-2049 (2007). *

• Dunckley H, Jazwinska EC, Gatenby PA, Serjeantson SW. DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma. Tissue Antigens 33: 418-420 (1989).

• Dunne C, Crowley J, Hagan R, Rooney G, Lawlor E. HLA-A, B, Cw, DRB1, DQB1 and DPB1 alleles and haplotypes in the genetically homogenous Irish population. Int. J. Immunogenet. 35: 295-302 (2008). *

• Dunne C, McGuigan C, Crowley J, Hagan R, Rooney G, Kelleher J, Hutchinson M, Lawlor E. Human leucocyte antigen class II polymorphism in Irish patients with multiple sclerosis. Tissue Antigens 68: 257-262 (2006). *

• Dunstan SJ, Stephens HA, Blackwell JM, Duc CM, Lanh MN, Dudbridge F, Phuong CX, Luxemburger C, Wain J, Ho VA, Hien TT, Farrar J, Dougan G. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J. Infect. Dis. 183: 261-268 (2001). *

• Duquesnoy RJ, Awadalla Y, Lomago J, Jelinek L, Howe J, Zern D, Hunter B, Martell J, Girnita A, Zeevi A. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes. Transpl. Immunol. 18: 352-360 (2008).

• Durinovic-Bello I, Jelinek E, Schlosser M, Eiermann T, Boehm BO, Karges W, Marchand L, Polychronakos C. Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals. Diabetes 54: S18-S24 (2005). *

• Durupinar B, Okten G. HLA tissue types in nonresponders to hepatitis B vaccine. Indian J. Pediatr. 63: 369-373 (1996).

• Duvefelt K, Anderson M, Fogdell-Hahn A, Hillert J. A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501. Tissue Antigens 63: 13-20 (2004). *

• Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveille JD. HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. Arch. Dermatol. 127: 64-68 (1991).

• Duyar H, Dengjel J, de Graaf KL, Wiesmuller KH, Stevanovic S, Weissert R. Peptide motif for the rat MHC class II molecule RT1.D(a): similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule. Immunogenetics 57: 69-76 (2005). *

• Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, Risch N, Ebers GC. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum. Mol. Genet. 14: 2019-2026 (2005). *

• Eberhardt K, Fex E, Johnson U, Wollheim FA. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann. Rheum. Dis. 55: 34-39 (1996). *

• Edinur HA, Zafarina Z, Spínola H, Nurhaslindawaty AR, Panneerchelvam S, Norazmi MN. HLA polymorphism in six Malay sub-ethnic groups in Malaysia. Hum. Immunol. 70: 518-526 (2009).

• Eerligh P, Koeleman BP, Dudbridge F, Jan Bruining G, Roep BO, Giphart MJ. Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes. Genes Immun. 5: 36-40 (2004). *

• Eiermann TH, Bettens F, Tiberghien P, Schmitz K, Beurton I, Bresson-Hadni S, Ammann RW, Goldmann SF, Vuitton DA, Gottstein B, Kern P. HLA and alveolar echinococcosis. Tissue Antigens 52: 124-129 (1998).

• Eike MC, Becker T, Humphreys K, Olsson M, Lie BA. Conditional analyses on the T1DGC MHC dataset: novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B. Genes Immun. 10: 56-67 (2009). *

• Eike MC, Humphreys K, Becker T, Olsson M, Lie BA; Diabetes Genetics Consortium. Three microsatellites from the T1DGC MHC data set show highly significant association with type 1 diabetes, independent of the HLA-DRB1, -DQA1 and -DQB1 genes. Diabetes Obes. Metab. 11 Suppl. 1: 17-24 (2009). *

• Eike MC, Olsson M, Undlien DE, Dahl-Jorgensen K, Joner G, Ronningen KS, Thorsby E, Lie BA. Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families. Genes Immun. 10: 141-150 (2009). *

• Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C, Lind L, Holmgren G, Holmberg M, Asplund K, Holmberg D. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur. J. Hum. Genet. 11: 81-84 (2003). *

• Eken C, Gasser O, Zenhaeusern G, Oehri I, Hess C, Schifferli JA. Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. J. Immunol. 180: 817-824 (2008). *

• El-Awar N, Terasaki PI, Cai J, Deng CT, Ozawa M, Nguyen A. Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens. Clin. Transpl. 2007: 175-194 (2007).

• El-Chennawi FA, Auf FA, Metwally SS, Mosaad YM, El-Wahab MA, Tawhid ZE. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunol. Invest. 37: 661-674 (2008). *

• El-Chennawi FA, Kamel HA, Mosaad YM, El-Sherbini SM, El-Billey NA. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling. Hematology 11: 227-234 (2006).

• El-Gabalawy HS, Goldbach-Mansky R, Smith D 2nd, Arayssi T, Bale S, Gulko P, Yarboro C, Wilder RL, Klippel JH, Schumacher HR Jr. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum. 42: 1696-1705 (1999). *

• Elagin RB, Balijepalli S, Diacovo MJ, Baekkeskov S, Jaume JC. Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice. J. Autoimmun. 33: 50-57 (2009).

• Elam MB, Cowan GS Jr, Rooney RJ, Hiler ML, Yellaturu CR, Deng X, Howell GE, Park EA, Gerling IC, Patel D, Corton JC, Cagen LM, Wilcox HG, Gandhi M, Bahr MH, Allan MC, Wodi LA, Cook GA, Hughes TA, Raghow R. Hepatic gene expression in morbidly obese women: implications for disease susceptibility. Obesity (Silver Spring) 17: 1563-1573 (2009). *

• Eller E, Vardi P, Babu SR, Bugawan TL, Erlich HA, Yu L, Fain PR. Celiac disease and HLA in a Bedouin kindred. Hum. Immunol. 67: 940-950 (2006).

• Eller E, Vardi P, McFann KK, Babu SR, Yu L, Bugawan TL, Erlich HA, Eisenbarth GS, Fain PR. Differential effects of DRB1(*)0301 and DQA1(*)0501-DQB1(*)0201 on the activation and progression of islet cell autoimmunity. Genes Immun. 8: 628-633 (2007). *

• Ellis HJ, Pollock EL, Engel W, Fraser JS, Rosen-Bronson S, Wieser H, Ciclitira PJ. Investigation of the putative immunodominant T cell epitopes in coeliac disease. Gut 52: 212-217 (2003). *

• Endreffy E, Laszlo, Szabo A, Roman F, Kurti K, Kalman M, Rasko I. Molecular genetic studies in monogenic and polygenic human diseases. Acta Biol. Hung. 48: 121-128 (1997).

• Endres RO, Redman H, Marcus N. Identification of the HLA-Cw*0774 and DQB1*060105 alleles. Tissue Antigens Oct 21 [Epub ahead of print] (2009). *

• Eoli M, Pandolfo M, Amoroso A, Salmaggi A, Zaffaroni M, Gasparini P, DiDonato S, Milanese C, Zeviani M. Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families. Eur. J. Hum. Genet. 3: 303-311 (1995).

• Erichsen MM, Lovas K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J. Clin. Endocrinol. Metab. 94: 4882-4890 (2009).

• Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippila C, Ahonen S, Nevalainen J, Veijola R, Pekkanen J, Ilonen J, Simell O, Knip M, Virtanen SM. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin. Exp. Allergy 39: 875-882 (2009). *

• Erlich H, Bugawan T, Begovich A, Scharf S. Analysis of HLA class II polymorphism using polymerase chain reaction. Arch. Pathol. Lab. Med. 117: 482-485 (1993).

• Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P; for the TIDGC. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium Families. Diabetes 57: 1084-1092 (2008). *

• Erlich HA. HLA class II sequences and genetic susceptibility to insulin dependent diabetes mellitus. Baillieres Clin. Endocrinol. Metab. 5: 395-411 (1991).

• Erlich HA, Bugawan TL, Scharf S, Nepom GT, Tait B, Griffith RL. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes 39: 96-103 (1990).

• Erlich HA, Griffith RL, Bugawan TL, Ziegler R, Alper C, Eisenbarth G. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes. Diabetes 40: 478-481 (1991).

• Erlich HA, Lohman K, Mack SJ, Valdes AM, Julier C, Mirel D, Noble JA, Morahan GE, Rich SS; for the Type I Diabetes Genetics Consortium. Association analysis of SNPs in the IL4R locus with type I diabetes. Genes Immun. 10: S33-S41 (2009).

• Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W, Beshkov Y, Costin G, Pressman S, Bugawan T, et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat. Genet. 3: 358-364 (1993). *

• Esposito C, Caputo I, Troncone R. New therapeutic strategies for coeliac disease: tissue transglutaminase as a target. Curr. Med. Chem. 14: 2572-2580 (2007).

• Esteve M, Rosinach M, Fernandez-Banares F, Farre C, Salas A, Alsina M, Vilar P, Abad-Lacruz A, Forne M, Marine M, Santaolalla R, Espinos JC, Viver JM. Spectrum of gluten sensitive enteropathy in first degree relatives of coeliac patients: clinical relevance of lymphocytic enteritis. Gut 55: 1739-1745 (2006). *

• Ettinger RA, Liu AW, Nepom GT, Kwok WW. Beta 57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus. J. Immunol. 165: 3232-3238 (2000). *

• Etzensperger R, McMahon RM, Jones EY, Fugger L. Dissection of the multiple sclerosis associated DR2 haplotype. J. Autoimmun. 31: 201-207 (2008).

• Fain PR, Babu SR, Bennett DC, Spritz RA. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res. 19: 51-57 (2006). *

• Fajardo-Dolci G, Solorio-Abreu J, Romero-Alvarez JC, Zavaleta-Villa B, Cerezo-Camacho O, Jimenez-Lucio R, Olivo-Diaz A. DQA1 and DQB1 association and nasal polyposis. Otolaryngol. Head Neck Surg. 135: 243-247 (2006).

• Fakler JW, Schmitt-Egenolf M, Vejbaesya S, Boehncke WH, Sterry W, Eiermann TH. Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis. Hum. Immunol. 40: 299-302 (1994).

• Fallang LE, Bergseng E, Hotta K, Berg-Larsen A, Kim CY, Sollid LM. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat. Immunol. 10: 1096-1101 (2009). *

• Fallang LE, Roh S, Holm A, Bergseng E, Yoon T, Fleckenstein B, Bandyopadhyay A, Mellins ED, Sollid LM. Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM. J. Immunol. 181: 5451-5461 (2008). *

• Falorni A. Immunologic and genetic aspects of latent autoimmune diabetes in the adult. Minerva Endocrinol. 28: 297-312 (2003).

• Fan XY, Li JZ, Yao SQ, Yan JD, Li CL, Ma QK. Relationship between pneumoconiosis and the polymorphisms of HLA-DRB1*, DQB1* genes. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 23: 278-281 (2005).

• Farid NR, Thompson C. HLA and autoimmune endocrine disease 1985. Mol. Biol. Med. 3: 85-97 (1986).

• Farjadian S, Ghaderi A. HLA class II genetic diversity in Arabs and Jews of Iran. Iran J. Immunol. 4: 85-93 (2007).

• Farjadian S, Ghaderi A. HLA class II similarities in Iranian Kurds and Azeris. Int. J. Immunogenet. 34: 457-463 (2007). *

• Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Welsh KI, Eddleston AL, Williams R. Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 16: 390-395 (1992).

• Farre C, Humbert P, Vilar P, Varea V, Aldeguer X, Carnicer J, Carballo M, Gassull MA. Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group. Dig. Dis. Sci. 44: 2344-2349 (1999). *

• Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 128: S68-S73 (2005). *

• Fasano A. Surprises from celiac disease. Sci. Am. 301: 54-61 (2009).

• Fei H, Scharf S, Erlich H, Peebles C, Tan E, Fox R. Relationship between HLA D region gene and primary Sjogren's syndrome. Zhonghua Yi Xue Za Zhi 71: 555-559 (1991).

• Fei HM, Kang H, Scharf S, Erlich H, Peebles C, Fox R. Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjogren's syndrome and autoantibody production. J. Clin. Lab. Anal. 5: 382-391 (1991).

• Feld J, Heathcote E. Epidemiology of autoimmune liver disease. J. Gastroenterol. Hepatol. 18: 1118-1128 (2003). *

• Fennessy M, Metcalfe K, Hitman GA, Niven M, Biro PA, Tuomilehto J, Tuomilehto-Wolf E. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 37: 937-944 (1994).

• Fernandes TA, Fukai R, Souza CA, Lorand-Metze I, Magna LA, Kraemer MH. Molecular identification of the HLA-DRB1-DQB1 for diagnosis and follow-up of acute leukemias. Blood Cells Mol. Dis. Jan 3 [Epub ahead of print] (2010).

• Fernandez L, Fernandez-Arquero M, Gual L, Lazaro F, Maluenda C, Polanco I, Figueredo MA, Gomez de la Concha E. Triplet repeat polymorphism in the transmembrane region of the MICA gene in celiac disease. Tissue Antigens 59: 219-222 (2002). *

• Fernandez O, Fernandez V, Alonso A, Caballero A, Luque G, Bravo M, Leon A, Mayorga C, Leyva L, de Ramon E. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain. J. Neurol. 251: 440-444 (2004).

• Fernandez O, Fernandez V, Martinez-Cabrera V, Mayorga C, Alonso A, Leon A, Arnal C, Hens M, Luque G, de Ramon E, Caballero A, Leyva L. Multiple sclerosis in Gypsies from southern Spain: prevalence, mitochondrial DNA haplogroups and HLA class II association. Tissue Antigens 71: 426-433 (2008). *

• Fernandez O, R-Antiguedad A, Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, Guerrero M, Papais-Alvarenga M, Fernandez-Sanchez V, Leyva L. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J. Neurol. Jul 8 [Epub ahead of print] (2009).

• Fernandez Salazar LI, de la Torre Ferrera N, Velayos Jimenez B, Nocito Colon M, Gonzalez Hernandez JM, Garrote Adrados JA. Diagnostic problems in adult celiac disease. Rev. Esp. Enferm. Dig. 100: 24-28 (2008). *

• Fernandez-Arquero M, Caldes T, Casado E, Maluenda C, Figueredo MA, De La Concha EG. Polymorphism within the HLA-DQB1*02 promoter associated with susceptibility to coeliac disease. Eur. J. Immunogenet. 25: 1-3 (1998).

• Fernandez-Arquero M, Figueredo MA, Maluenda C, de la Concha EG. HLA-linked genes acting as additive susceptibility factors in celiac disease. Hum. Immunol. 42: 295-300 (1995).

• Fernandez-Arquero M, Lopez-Nava G, Garcia Paredes J, Martinez A, De la Concha EG, Figueredo MA, Conejero L, Vigil P, Diaz Rubio M. Pancolitis and genetic markers in the Spanish population. Rev. Esp. Enferm. Dig. 91: 269-276 (1999).

• Fernandez-Banares F, Esteve M, Farre C, Salas A, Alsina M, Casalots J, Espinos J, Forne M, Viver JM. Predisposing HLA-DQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis. Eur. J. Gastroenterol. Hepatol. 17: 1333-1338 (2005).

• Fernandez-Banares F, Esteve M, Salas A, Alsina M, Farre C, Gonzalez C, Buxeda M, Forne M, Rosinach M, Espinos JC, Maria Viver J. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am. J. Gastroenterol. 102: 2520-2528 (2007). *

• Fernandez-Mestre MT, Vargas V, Montagnani S, Cotua M, Ogando V, Layrisse Z. HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis. Hum. Immunol. 65: 54-59 (2004).

• Fernandez-Vina M, Ramirez LC, Raskin P, Stastny P. Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans. Tissue Antigens 41: 57-64 (1993).

• Fernando MM, Stevens CR, Sabeti PC, Walsh EC, McWhinnie AJ, Shah A, Green T, Rioux JD, Vyse TJ. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet. 3: e192 (2007). *

• Ferrara F, Quaglia S, Caputo I, Esposito C, Lepretti M, Pastore S, Giorgi R, Martelossi S, Dal Molin G, Di Toro N, Ventura A, Not T. Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. Clin. Exp. Immunol. 159: 217-223 (2010). *

• Ferreira AC, Gomes KB, Sampaio IB, Oliveira VC, Pardini VC, Godard AL. Type 1 diabetes susceptibility determined by HLA alleles and CTLA-4 and insulin genes polymorphisms in Brazilians. Arq. Bras. Endocrinol. Metabol. 53: 368-373 (2009).

• Ferstl B, Zacher T, Lauer B, Blagitko-Dorfs N, Carl A, Wassmuth R. Allele-specific quantification of HLA-DQB1 gene expression by real-time reverse transcriptase-polymerase chain reaction. Genes Immun. 5: 405-416 (2004). *

• Festenstein H, Awad J, Hitman GA, Cutbush S, Groves AV, Cassell P, Ollier W, Sachs JA. New HLA DNA polymorphisms associated with autoimmune diseases. Nature 322: 64-67 (1986). *

• Fialho RN, Martins L, Pinheiro JP, Bettencourt BF, Couto AR, Santos MR, Peixoto MJ, Garrett F, Leal J, Tomas AM, Bruges-Armas J. Role of HLA, KIR and cytokine gene polymorphisms in leptospirosis. Hum. Immunol. 70: 915-920 (2009).

• Field SF, Nejentsev S, Walker NM, Howson JM, Godfrey LM, Jolley JD, Hardy MP, Todd JA. Sequencing-based genotyping and association analysis of the MICA and MICB genes in type 1 diabetes. Diabetes 57: 1753-1756 (2008). *

• Fietta P, Manganelli P, Zanetti A, Neri TM. Familial giant cell arteritis and polymyalgia rheumatica: aggregation in 2 families. J. Rheumatol. 29: 1551-1555 (2002). *

• Figueiredo JF, Rodrigues Mde L, Deghaide NH, Donadi EA. HLA profile in patients with AIDS and tuberculosis. Braz. J. Infect. Dis. 12: 278-280 (2008). *

• Fijal B, Ricci D, Vercammen E, Palmer PA, Fotiou F, Fife D, Lindholm A, Broderick E, Francke S, Wu X, Colaianne J, Cohen N. Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia. Pharmacogenomics 9: 157-167 (2008).

• Fimmers R, Neugebauer M, Dennert J, Wienker T, Baur MP. Association and sibpair analysis for the HLA, Gm, Km, and insulin polymorphisms in multiplex IDDM families. Genet. Epidemiol. 6: 107-112 (1989).

• Fine KD, Do K, Schulte K, Ogunji F, Guerra R, Osowski L, McCormack J. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am. J. Gastroenterol. 95: 1974-1982 (2000). *

• Finn TP, Jones RE, Rich C, Dahan R, Link J, David CS, Chou YK, Offner H, Vandenbark AA. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes. J. Neurosci. Res. 78: 100-114 (2004).

• Fiore M, Pera C, Delfino L, Scotese I, Ferrara GB, Pignata C. DNA typing of DQ and DR alleles in IgA-deficient subjects. Eur. J. Immunogenet. 22: 403-411 (1995).

• Fisher M, Pusey CD, Vaughan RW, Rees AJ. Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes. Kidney Int. 51: 222-229 (1997).

• Fletcher J, Mijovic C, Odugbesan O, Jenkins D, Bradwell AR, Barnett AH. Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes. Diabetologia 31: 864-870 (1988).

• Flynn JC, Gardas A, Wan Q, Gora M, Alsharabi G, Wei WZ, Giraldo AA, David CS, Kong YM, Banga JP. Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice. Clin. Exp. Immunol. 137: 503-512 (2004). *

• Flynn JC, Meroueh C, Snower DP, David CS, Kong YM. Depletion of CD4CD25 regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Clin. Exp. Immunol. 147: 547-554 (2007). *

• Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55: 140-148 (2000). *

• Foley PJ, McGrath DS, Puscinska E, Petrek M, Kolek V, Drabek J, Lympany PA, Pantelidis P, Welsh KI, Zielinski J, du Bois RM. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am. J. Respir. Cell. Mol. Biol. 25: 272-277 (2001). *

• Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc. Natl. Acad. Sci. U.S.A. 97: 12717-12722 (2000). *

• Forbes LV, Brown LJ, Scott RS. HLA-DQ beta typing and non-Asp57 alleles in IDDM and nondiabetic subjects in New Zealand. Diabetes Care 16: 1179-1183 (1993).

• Forsberg G, Fahlgren A, Horstedt P, Hammarstrom S, Hernell O, Hammarstrom ML. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am. J. Gastroenterol. 99: 894-904 (2004). *

• Fortes MD, Machado IV, Gil G, Fernandez-Mestre M, Dagher L, Leon RV, Bianco NE, Tassinari P. Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela. Liver Int. 27: 1409-1416 (2007). *

• Fox RI. Epidemiology, pathogenesis, animal models, and treatment of Sjogren's syndrome. Curr. Opin. Rheumatol. 6: 501-508 (1994).

• Fox RI, Luppi M, Kang HI, Pisa P. Reactivation of Epstein-Barr virus in Sjogren's syndrome. Springer Semin. Immunopathol. 13: 217-231 (1991).

• Fracchia M, Galatola G, Corradi F, Dall'Omo AM, Rovera L, Pera A, Vitale C, Bertero MT. Coeliac disease associated with Sjogren's syndrome, renal tubular acidosis, primary biliary cirrhosis and autoimmune hyperthyroidism. Dig. Liver Dis. 36: 489-491 (2004).

• Francis DA, Batchelor JR, McDonald WI, Dodi IA, Hing SN, Hern JE, Downie AW. HLA genetic determinants in familial MS. A study from the Grampian region of Scotland. Tissue Antigens 29: 7-12 (1987).

• Fraser JS, King AL, Ellis HJ, Moodie SJ, Bjarnason I, Swift J, Ciclitira PJ. An algorithm for family screening for coeliac disease. World J. Gastroenterol. 12: 7805-7809 (2006). *

• Freiberger T, Litzman J, Vondruskova E. Role of aspartic acid at position 57 of the HLA-DQ beta chain in sporadic and familial forms of selective IgA deficiency. Cas. Lek. Cesk. 140: 770-773 (2001).

• Frezza D, Giambra V, Tolusso B, De Santis M, Bosello S, Vettori S, Triolo G, Valentini G, Ferraccioli G. Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann. Rheum. Dis. 66: 1210-1215 (2007). *

• Fronek Z, Cheung MM, Hanbury AM, Kagnoff MF. Molecular analysis of HLA DP and DQ genes associated with dermatitis herpetiformis. J. Invest. Dermatol. 97: 799-802 (1991).

• Frost A, Band M, Conway G. Serological screening for coeliac disease in adults with Turner syndrome: prevalence and clinical significance of endomysium antibody positivity. Eur. J. Endocrinol. 160: 675-679 (2009).

• Fugger L, Michie SA, Rulifson I, Lock CB, McDevitt GS. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc. Natl. Acad. Sci. U.S.A. 91: 6151-6155 (1994). *

• Fugger L, Svejgaard A. The HLA-DQ7 and -DQ8 associations in DR4-positive rheumatoid arthritis patients. A combined analysis of data available in the literature. Tissue Antigens 50: 494-500 (1997).

• Gaber SA, Mazzola G, Berrino M, Canale L, Cornaglia M, Ghali I, Sergio Curtoni E, Amoroso A. Human leukocyte antigen class II polymorphisms and genetic susceptibility of IDDM in Egyptian children. Diabetes Care 17: 1341-1344 (1994).

• Galgani A, Petrone A, Spoletini M, Hodge A, Del Buono ML, Locatelli M, Buzzetti R; Diabfin Study Group. HLA class II typing in newborns reveals a low frequency of the DRB1*04 allele and a high frequency of DRB1*11 allele in three regions of continental Italy. Hum. Immunol. 65: 366-372 (2004).

• Galligan CL, Baig E, Bykerk V, Keystone EC, Fish EN. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes Immun. 8: 480-491 (2007). *

• Galvan JA, Lemos G, Fernandez de Cossio ME, Ruenes C, Martinez Y, Tejeda Y, Roca J, Palenzuela DO, Novoa LI, Nazabal M. Silent celiac disease in a cohort of healthy adults. Autoimmunity 42: 705-708 (2009).

• Gambelunghe G, Brozzetti A, Ghaderi M, Candeloro P, Tortoioli C, Falorni A. MICA gene polymorphism in the pathogenesis of type 1 diabetes. Ann. N. Y. Acad. Sci. 1110: 92-98 (2007). *

• Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P, Sanjeevi CB. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 84: 3701-3707 (1999). *

• Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin. Endocrinol. (Oxf.) 52: 565-573 (2000). *

• Gambelunghe G, Gerli R, Bartoloni Bocci E, Del Sindaco P, Ghaderi M, Sanjeevi CB, Bistoni O, Bini V, Falorni A. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology (Oxford) 44: 287-292 (2005). *

• Gambelunghe G, Ghaderi M, Cosentino A, Falorni A, Brunetti P, Falorni A, Sanjeevi CB. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 43: 507-514 (2000). *

• Ganesh R Dr, Arvindkumar R, Vasanthi T. Infantile-onset diabetes mellitus: a 1-year follow-up study. Clin. Pediatr. (Phila.) 48: 271-274 (2009).

• Gao J, Lin Y, Qiu C, Liu Y, Ma Y, Liu Y. Association between HLA-DQA1, -DQB1 gene polymorphisms and susceptibility to asthma in northern Chinese subjects. Chin. Med. J. (Engl.) 116: 1078-1082 (2003).

• Gao XH, Barnardo MC, Winsey S, Ahmad T, Cook J, Agudelo JD, Zhai N, Powell JJ, Fuggle SV, Wojnarowska F. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated … J. Invest. Dermatol. 125: 895-899 (2005). *

• Gao XJ, Brautbar C, Gazit E, Segal R, Naparstek Y, Livneh A, Stastny P. A variant of HLA-DR4 determines susceptibility to rheumatoid arthritis in a subset of Israeli Jews. Arthritis Rheum. 34: 547-551 (1991).

• Garcia D, Angel B, Carrasco E, Albala C, Santos JL, Perez-Bravo F. VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile. Diabetes Res. Clin. Pract. 77: 134-140 (2007).

• Garcia-Gonzalez E, Castro-Llamas J, Karchmer S, Zuniga J, de Oca DM, Ambaz M, Bolanos R, Granados J. Class II major histocompatibility complex typing across the ethnic barrier in pemphigoid gestationis. A study in Mexicans. Int. J. Dermatol. 38: 46-51 (1999). *

• Gardiner KR, Crockard AD, Halliday MI, Rowlands BJ. Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease. Gut 35: 511-516 (1994). *

• Garrity-Park MM, Loftus Jr EV, Sandborn WJ, Bryant S, Smyrk TC. MHC class II alleles in ulcerative colitis-associated colorectal cancer. Gut 58: 1226-1233 (2009). *

• Garrote J, Arranz E, Gomez-Gonzalez E, Leon A, Farre C, Calvo C, Bernardo D, Fernandez-Salazar L, Blanco-Quiros A. IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: differences between DQ2 positive and negative patients. Allergol. Immunopathol. (Madr.) 33: 245-249 (2005).

• Garrote JA, Arranz E, Telleria JJ, Castro J, Calvo C, Blanco-Quiros A. TNF alpha and LT alpha gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive population. Immunogenetics 54: 551-555 (2002). *

• Geleijns K, Schreuder GM, Jacobs BC, Sintnicolaas K, van Koningsveld R, Meulstee J, Laman JD, van Doorn PA. HLA class II alleles are not a general susceptibility factor in Guillain-Barre syndrome. Neurology 64: 44-49 (2005).

• Gencik M, Borgmann S, Zahn R, Albert E, Sitter T, Epplen JT, Fricke H. Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin. Exp. Immunol. 117: 412-417 (1999). *

• Germenis AE, Yiannaki EE, Zachou K, Roka V, Barbanis S, Liaskos C, Adam K, Kapsoritakis AN, Potamianos S, Dalekos GN. Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clin. Diagn. Lab. Immunol. 12: 941-948 (2005). *

• Gersuk VH, Nepom GT. A real-time polymerase chain reaction assay for the rapid identification of the autoimmune disease-associated allele HLA-DQB1*0602. Tissue Antigens 73: 335-340 (2009). *

• Ghabaee M, Bayati A, Amri Saroukolaei S, Sahraian MA, Sanaati MH, Karimi P, Houshmand M, Sadeghian H, Hashemi Chelavi L. Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. Cell. Mol. Neurobiol. 29: 109-114 (2009).

• Ghabanbasani MZ, Gu XX, Spaepen M, Vandevyver C, Raus J, Marynen P, Carton H, Cassiman JJ. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis. J. Neuroimmunol. 59: 77-82 (1995).

• Ghaderi M, Gambelunghe G, Tortoioli C, Brozzetti A, Jatta K, Gharizadeh B, De Bellis A, Pecori Giraldi F, Terzolo M, Betterle C, Falorni A. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency. J. Clin. Endocrinol. Metab. 91: 4107-4111 (2006). *

• Gianfrani C, Siciliano RA, Facchiano AM, Camarca A, Mazzeo MF, Costantini S, Salvati VM, Maurano F, Mazzarella G, Iaquinto G, Bergamo P, Rossi M. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 133: 780-789 (2007). *

• Giannitti C, Morozzi G, D'Alfonso S, Bellisai F, Galeazzi M. Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection. Reumatismo 60: 192-198 (2008).

• Gil-Carrasco F, Vargas-Alarcon G, Zuniga J, Tinajero-Castaneda O, Hernandez-Martinez B, Hernandez-Pacheco G, Rodríguez-Reyna TS, Hesiquio R, Gamboa R, Granados J. HLA-DRB and HLA-DQB loci in the genetic susceptibility to develop glaucoma in Mexicans. Am. J. Ophthalmol. 128: 297-300 (1999). *

• Gilchrist FC, Bunn C, Foley PJ, Lympany PA, Black CM, Welsh KI, du Bois RM. Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes Immun. 2: 76-81 (2001). *

• Gilhar A, Kalish RS. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun. Rev. 5: 64-69 (2006).

• Gillespie KM, Dix RJ, Williams AJ, Newton R, Robinson ZF, Bingley PJ, Gale EA, Shield JP. Islet autoimmunity in children with Down's syndrome. Diabetes 55: 3185-3188 (2006). *

• Giraud M, Beaurain G, Eymard B, Tranchant C, Gajdos P, Garchon HJ. Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci. Genes Immun. 5: 398-404 (2004). *

• Giza S. HLADQB105 association with Hashimotos thyroiditis in children of Northern Greek origin. Indian Pediatr. 45: 493-496 (2008). *

• Gjersten HA, Lundin KE, Kwok WW, Nepom GT, Thorsby E. Allorecognition of HLA-DQw8 molecules: influence of single amino acid substitutions. Tissue Antigens 39: 95-98 (1992).

• Gjertsen HA, Sollid LM, Ek J, Thorsby E, Lundin KE. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand. J. Immunol. 39: 567-574 (1994).

• Gladman DD, Farewell VT, Pellett F, Schentag C, Rahman P. HLA is a candidate region for psoriatic arthritis. Evidence for excessive HLA sharing in sibling pairs. Hum. Immunol. 64: 887-889 (2003).

• Glisic S, Klinker M, Waukau J, Jailwala P, Jana S, Basken J, Wang T, Alemzadeh R, Hagopian W, Ghosh S. Genetic association of HLA DQB1 with CD4+CD25+(high) T-cell apoptosis in type 1 diabetes. Genes Immun. 10: 334-340 (2009).

• Godkin A, Friede T, Davenport M, Stevanovic S, Willis A, Jewell D, Hill A, Rammensee HG. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int. Immunol. 9: 905-911 (1997). *

• Goldberg AC, Bittencourt PL, Mougin B, Cancado EL, Porta G, Carrilho F, Kalil J. Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus. Hum. Immunol. 62: 165-169 (2001).

• Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J. Clin. Endocrinol. Metab. 90: 4904-4911 (2005). *

• Goldstein E, Hermann R, Renfors TJ, Nanto-Salonen KM, Korhonen T, Karkkainen M, Veijola RK, Knip M, Simell TT, Simell OG. From genetic risk awareness to overt type 1 diabetes: parental stress in a placebo-controlled prevention trial. Diabetes Care 32: 2181-2183 (2009).

• Goldstein R, Moulds JM, Smith CD, Sengar DP. MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus. J. Rheumatol. 23: 1173-1179 (1996).

• Goldstein R, Sengar DP. Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus. Arthritis Rheum. 36: 1121-1127 (1993).

• Gombos Z, Hermann R, Kiviniemi M, Nejentsev S, Reimand K, Fadeyev V, Peterson P, Uibo R, Ilonen J. Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations. Eur. J. Endocrinol. 157: 757-761 (2007). *

• Gomez LM, Ruiz-Narvaez EA, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM. TNF microsatellites polymorphism is associated with rheumatoid arthritis. Confirming evidence in north-western Colombians. Clin. Exp. Rheumatol. 25: 443-448 (2007).

• Gonzalez S, Rodrigo L, Lopez-Vazquez A, Fuentes D, Agudo-Ibanez L, Rodriguez-Rodero S, Fdez-Morera JL, Martinez-Borra J, Lopez-Larrea C. Association of MHC class I related gene B (MICB) to celiac disease. Am. J. Gastroenterol. 99: 676-680 (2004). *

• Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER. Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology 7: 889-892 (1987).

• Gorodezky C, Alaez C, Murguia A, Rodriguez A, Balladares S, Vazquez M, Flores H, Robles C. HLA and autoimmune diseases: type 1 diabetes (T1D) as an example. Autoimmun. Rev. 5: 187-194 (2006).

• Gorski J, Niven MJ, Sachs JA, Mach B, Cassell PG, Festenstein H, Awad J, Hitman GA. HLA-DR alpha, -DX alpha, and DR beta III gene association studies in DR3 individuals. Hum. Immunol. 20: 273-278 (1987).

• Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, Sibilia J, Mariette X. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 48: 2240-2245 (2003). *

• Graham RR, Ortmann W, Rodine P, Espe K, Langefeld C, Lange E, Williams A, Beck S, Kyogoku C, Moser K, Gaffney P, Gregersen PK, Criswell LA, Harley JB, Behrens TW. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur. J. Hum. Genet. 15: 823-830 (2007). *

• Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, Paparo F, Gasperi V, Limongelli MG, Cotichini R, D'Agate C, Tinto N, Sacchetti L, Tosi R, Stazi MA. The first large population based twin study of coeliac disease. Gut 50: 624-628 (2002). *

• Greco L, Veneziano A, Di Donato L, Zampella C, Pecoraro M, Paladini D, Paparo F, Vollaro A, Martinelli P. Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy. Gut 53: 149-151 (2004). *

• Green PH, Jabri B. Celiac disease. Annu. Rev. Med. 57: 207-221 (2006). *

• Gregory WL, Mehal W, Dunn AN, Cavanagh G, Chapman R, Fleming KA, Daly AK, Idle JR, James OF, Bassendine MF. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q. J. Med. 86: 393-399 (1993).

• Grennan DM, Sanders PA. Rheumatoid arthritis. Baillieres Clin. Rheumatol. 2: 585-601 (1988).

• Griffioen M, van der Meijden ED, Slager EH, Honders MW, Rutten CE, van Luxemburg-Heijs SA, von dem Borne PA, van Rood JJ, Willemze R, Falkenburg JH. Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity. Proc. Natl. Acad. Sci. U.S.A. 105: 3837-3842 (2008). *

• Griffith ME, Pusey CD. HLA genes in ANCA-associated vasculitides. Exp. Clin. Immunogenet. 14: 196-205 (1997).

• Grubic Z, Zunec R, Cecuk-Jelicic E, Kastelan D, Kerhin-Brkljacic V, Kastelan A. High resolution molecular typing of HLA class II region in the population of the island of Krk, Croatia. Coll. Antropol. 23: 577-588 (1999).

• Grubic Z, Zunec R, Cecuk-Jelicic E, Kerhin-Brkljacic V, Kastelan A. Polymorphism of HLA-A, -B, -DRB1, -DQA1 and -DQB1 haplotypes in a Croatian population. Eur. J. Immunogenet. 27: 47-51 (2000). *

• Grubic Z, Zunec R, Kastelan M, Cecuk-Jelicic E, Gruber F, Kastelan A. HLA class II haplotypic association and DQCAR microsatellite polymorphisms in Croatian patients with psoriasis. Coll. Antropol. 26: 61-67 (2002).

• Grubic Z, Zunec R, Naipal A, Kastelan A, Giphart MJ. Molecular analysis of HLA class II polymorphism in Croatians. Tissue Antigens 46: 293-298 (1995).

• Grubic Z, Zunec R, Peros-Golubicic T, Tekavec-Trkanjec J, Martinez N, Alilovic M, Smojver-Jezek S, Kerhin-Brkljacic V. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease. Tissue Antigens 70: 301-306 (2007). *

• Grunewald J, Eklund A. Gender specific manifestations of Lofgren's syndrome. Am. J. Respir. Crit. Care Med. 175: 40-44 (2007). *

• Grunewald J, Olerup O, Persson U, Ohrn MB, Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc. Natl. Acad. Sci. U.S.A. 91: 4965-4969 (1994). *

• Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J. Cell. Mol. Med. 9: 741-744 (2005). *

• Gueant-Rodriguez RM, Gueant JL, Viola M, Tramoy D, Gaeta F, Romano A. Association of tumor necrosis factor-alpha -308G>A polymorphism with IgE-mediated allergy to betalactams in an Italian population. Pharmacogenomics J. 8: 162-168 (2008). *

• Guerin V, Leniaud L, Pedron B, Guilmin-Crepon S, Tubiana-Rufi N, Sterkers G. HLA-associated genetic resistance and susceptibility to type I diabetes in French North Africans and French natives. Tissue Antigens 70: 214-218 (2007). *

• Guggenbuhl P, Jean S, Jego P, Grosbois B, Chales G, Semana G, Lancien G, Veillard E, Pawlotsky Y, Perdriger A. Primary Sjogren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes. J. Rheumatol. 25: 900-905 (1998).

• Guja C, Guja L, Nutland S, Rance H, Sebastien M, Todd JA, Ionescu-Tirgoviste C. Type 1 diabetes genetic susceptibility encoded by HLA DQB1 genes in Romania. J. Cell. Mol. Med. 8: 249-256 (2004). *

• Guja C, Guja L, Nutland S, Rance H, Todd JA, Ionescu-Tirgoviste C. Strong association of insulin gene INS-VNTR polymorphisms with type 1 diabetes in the Romanian population. Rom. J. Intern. Med. 42: 313-323 (2004).

• Gullstrand C, Wahlberg J, Ilonen J, Vaarala O, Ludvigsson J. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study. Pediatr. Diabetes 9: 182-190 (2008).

• Gulwani-Akolkar B, Akolkar PN, Lin XY, Heresbach D, Manji R, Katz S, Yang SY, Silver J. HLA class II alleles associated with susceptibility and resistance to Crohn's disease in the Jewish population. Inflamm. Bowel Dis. 6: 71-76 (2000). *

• Gunnarsson I, Kanerud L, Pettersson E, Lundberg I, Lindblad S, Ringertz B. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Br. J. Rheumatol. 36: 1089-1094 (1997).

• Gupta M, Graham J, McNeeny B, Zarghami M, Landin-Olsson M, Hagopian WA, Palmer J, Lernmark A, Sanjeevi CB. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus. Ann. N. Y. Acad. Sci. 1079: 229-239 (2006). *

• Gupta M, Ludvigsson J, Sanjeevi CB. Frequency of MICA in all babies in Southeast Sweden (ABIS) positive for high-risk HLA-DQ associated with type 1 diabetes. Ann. N. Y. Acad. Sci. 1037: 138-144 (2004). *

• Gupta M, Nikitina-Zake L, Zarghami M, Landin-Olsson M, Kockum I, Lernmark A, Sanjeevi CB. Association between the transmembrane region polymorphism of MHC class I chain related gene-A and type 1 diabetes mellitus in Sweden. Hum. Immunol. 64: 553-561 (2003).

• Haas JP, Kimura A, Andreas A, Hochberger M, Keller E, Brunnler G, Bettinotti MP, Nevinny-Stickel C, Hildebrandt B, Sierp G, et al. Polymorphism in the upstream regulatory region of DQA1 genes and DRB1, QAP, DQA1, and DQB1 haplotypes in the German population. Hum. Immunol. 39: 31-40 (1994).

• Haas JP, Metzler M, Frank C, Haefner R, Wassmuth R. HLA-DQA1 gene expression profiling in oligoarticular JIA. Autoimmunity 42: 389-391 (2009).

• Habior A, Lewartowska A, Orlowska J, Zych W, Sankowska M, Bauer A, Butruk E. Association of coeliac disease with primary biliary cirrhosis in Poland. Eur. J. Gastroenterol. Hepatol. 15: 159-164 (2003).

• Habior A, Rawa T, Orlowska J, Sankowska M, Lewartowska A, Tilszer A, Pawlak J, Krawczyk M, Butruk E. Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings. Eur. J. Gastroenterol. Hepatol. 14: 787-791 (2002).

• Hacsek G, Arato A, Savilahti E, Paszti I. Characteristics of HLA II antigen expression in the rectal mucosa of children suffering from ulcerative colitis and Crohn disease. Orv. Hetil. 136: 2279-2282 (1995).

• Hadithi M, de Boer H, Meijer JW, Willekens F, Kerckhaert JA, Heijmans R, Pena AS, Stehouwer CD, Mulder CJ. Coeliac disease in Dutch patients with Hashimoto's thyroiditis and vice versa. World J. Gastroenterol. 13: 1715-1722 (2007). *

• Hadithi M, von Blomberg BM, Crusius JB, Bloemena E, Kostense PJ, Meijer JW, Mulder CJ, Stehouwer CD, Pena AS. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann. Intern. Med. 147: 294-302 (2007). *

• Hadj Kacem H, Kaddour N, Adyel FZ, Bahloul Z, Ayadi H. HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjogren's syndrome. Rheumatology (Oxford) 40: 1370-1374 (2001). *

• Hadjivassiliou M, Boscolo S, Tongiorgi E, Grunewald RA, Sharrack B, Sanders DS, Woodroofe N, Davies-Jones GA. Cerebellar ataxia as a possible organ-specific autoimmune disease. Mov. Disord. 23: 1370-1377 (2008). *

• Haegert DG, Muntoni F, Murru MR, Costa G, Francis GS, Marrosu MG. HLA-DQA1 and -DQB1 associations with multiple sclerosis in Sardinia and French Canada: evidence for immunogenetically distinct patient groups. Neurology 43: 548-552 (1993).

• Haegert DG, Swift FV, Benedikz J. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology 46: 1107-1111 (1996).

• Hajeer AH, Sawidan FA, Bohlega S, Saleh S, Sutton P, Shubaili A, Tahan AA, Al Jumah M. HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis. Int. J. Immunogenet. 36: 169-172 (2009). *

• Hall MA, Lanchbury JS, Bolsover WJ, Welsh KI, Ciclitira PJ. Celiac disease is associated with an extended HLA-DR3 haplotype which includes HLA-DPw1. Hum. Immunol. 27: 220-228 (1990).

• Hall MA, Lanchbury JS, Bolsover WJ, Welsh KI, Ciclitira PJ. HLA association with dermatitis herpetiformis is accounted for by a cis or transassociated DQ heterodimer. Gut 32: 487-490 (1991). *

• Hall MA, Lanchbury JS, Lee JS, Welsh KI, Ciclitira PJ. HLA-DQ2 second-domain polymorphisms may explain increased trans-associated risk in celiac disease and dermatitis herpetiformis. Hum. Immunol. 38: 284-292 (1993).

• Hall RP, Ward FE, Wenstrup RJ. An HLA class II region restriction fragment length polymorphism (RFLP) in patients with dermatitis herpetiformis: association with HLA-DP phenotype. J. Invest. Dermatol. 95: 172-177 (1990).

• Haller K, Kisand K, Pisarev H, Salur L, Laisk T, Nemvalts V, Uibo R. Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group. Tissue Antigens 69: 121-127 (2007). *

• Hallmayer J, Faraco J, Lin L, Hesselson S, Winkelmann J, Kawashima M, Mayer G, Plazzi G, Nevsimalova S, Bourgin P, Hong SS, Honda Y, Honda M, Hogl B, Longstreth WT Jr, Montplaisir J, Kemlink D, Einen M, Chen J, Musone SL, Akana M, Miyagawa T, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet. 41: 708-711 (2009). *

• Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kampe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J. Clin. Endocrinol. Metab. 87: 2568-2574 (2002). *

• Han YN, Yang JL, Zheng SG, Tang Q, Zhu W. Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients. World J. Gastroenterol. 11: 5721-5724 (2005). *

• Haraldsen G, Sollid LM, Bakke O, Farstad IN, Kvale D, Molberg, Norstein J, Stang E, Brandtzaeg P. Major histocompatibility complex class II-dependent antigen presentation by human intestinal endothelial cells. Gastroenterology 114: 649-656 (1998). *

• Harbo HF, Celius EG, Vartdal F, Spurkland A. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 53: 106-110 (1999). *

• Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sorensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63: 237-247 (2004). *

• Harbo HF, Riccio ME, Lorentzen AR, Utsi E, Myhr KM, Mellgren SI, Flĺm ST, Thorsby E, Sanchez-Mazas A, Lie BA. Norwegian Sami differs significantly from other Norwegians according to their HLA profile. Tissue Antigens Dec 30 [Epub ahead of print] (2009). *

• Harbo HF, Utsi E, Lorentzen AR, Kampman MT, Celius EG, Myhr KM, Lie BA, Mellgren SI, Thorsby E. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami. Tissue Antigens 69: 299-304 (2007). *

• Harding A. Fine-tuning our defenses. The Scientist May, 2007 (http://www.the-scientist.com/2007/05/01/s56/1/) (2007).

• Harfouch-Hammoud E, Walk T, Otto H, Jung G, Bach JF, van Endert PM, Caillat-Zucman S. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes. Diabetes 48: 1937-1947 (1999). *

• Harris KM, Fasano A, Mann DL. Cutting edge: IL-1 controls the IL-23 response induced by gliadin, the etiologic agent in celiac disease. J. Immunol. 181: 4457-4460 (2008). *

• Hashimoto K, Maruyama H, Nishiyama M, Asaba K, Ikeda Y, Takao T, Iwasaki Y, Kumon Y, Suehiro T, Tanimoto N, Mizobuchi M, Nakamura T. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population. Horm. Res. 64: 253-260 (2005).

• Hassan AB, Nikitina-Zake L, Padyukov L, Karlsson G, Gupta M, Lundberg IE, Sanjeevi CB. MICA4/HLA-DRB1*04/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients. Hum. Immunol. 64: 290-296 (2003).

• Hauache OM, Reis AF, Oliveira CS, Vieira JG, Sjoroos M, Ilonen J. Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes. Dis. Markers 21: 139-145 (2005).

• Hautekeete ML, Horsmans Y, Van Waeyenberge C, Demanet C, Henrion J, Verbist L, Brenard R, Sempoux C, Michielsen PP, Yap PS, Rahier J, Geubel AP. HLA association of amoxicillin-clavulanate-induced hepatitis. Gastroenterology 117: 1181-1186 (1999). *

• He F, Guo R, Du X, Lu ZS, Weng JY, Lin W. Inhibitory effects of anti-CII TA M1-RNA on IFN-gamma induced major histocompatibility complex class II antigens expression on cultured human chondrocytes. Transpl. Immunol. 17: 231-236 (2007).

• Heard RN, Cullen C, Middleton D, Hawkins SA, Francis DA, Hern JE, McDonald WI, Batchelor JR, Lechler RI. An allelic cluster of DQ alpha restriction fragments is associated with multiple sclerosis: evidence that a second haplotype may influence disease susceptibility. Hum. Immunol. 25: 111-123 (1989).

• Heier MS, Evsiukova T, Vilming S, Gjerstad MD, Schrader H, Gautvik K. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway. Sleep 30: 969-973 (2007). *

• Heinold A, Bauer M, Opelz G, Scherer S, Schmidt AH, Tran TH. Identification and characterization of three novel HLA alleles, HLA-A*240214, HLA-A*3215 and HLA-DQB1*060302. Tissue Antigens 70: 511-514 (2007). *

• Helenius LM, Hallikainen D, Helenius I, Meurman JH, Koskimies S, Tervahartiala P, Kivisaari L, Hietanen J, Suuronen R, Lindqvist C, Leirisalo-Repo M. HLA-DRB1* alleles and temporomandibular joint erosion in patients with various rheumatic diseases. Scand. J. Rheumatol. 33: 24-29 (2004).

• Henderson KN, Reid HH, Borg NA, Broughton SE, Huyton T, Anderson RP, McCluskey J, Rossjohn J. The production and crystallization of the human leukocyte antigen class II molecules HLA-DQ2 and HLA-DQ8 complexed with deamidated gliadin peptides implicated in coeliac disease. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 63: 1021-1025 (2007). *

• Henderson KN, Tye-Din JA, Reid HH, Chen Z, Borg NA, Beissbarth T, Tatham A, Mannering SI, Purcell AW, Dudek NL, van Heel DA, McCluskey J, Rossjohn J, Anderson RP. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity 27: 23-34 (2007). *

• Heresbach D, Alizadeh M, Bretagne JF, Gautier A, Quillivic F, Lemarchand B, Gosselin M, Genetet B, Semana G. Investigation of the association of major histocompatibility complex genes, including HLA class I, class II and TAP genes, with clinical forms of Crohn's disease. Eur. J. Immunogenet. 23: 141-151 (1996).

• Hermann R, Bartsocas CS, Soltesz G, Vazeou A, Paschou P, Bozas E, Malamitsi-Puchner A, Simell O, Knip M, Ilonen J. Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence. Diabetes Metab. Res. Rev. 20: 322-329 (2004). *

• Hermann R, Lipponen K, Kiviniemi M, Kakko T, Veijola R, Simell O, Knip M, Ilonen J. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 49: 1198-1208 (2006). *

• Hermann R, Soltesz G. Predictive genetic screening for type-1 diabetes in the Hungarian population. Orv. Hetil. 145: 337-342 (2004).

• Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, Sipilä I, Akerblom HK, Ilonen J. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 62: 162-169 (2003). *

• Hernandez-Charro B, Donat E, Miner I, Aranburu E, Sanchez-Valverde F, Ramos-Arroyo MA. Modifying effect of HLA haplotypes located trans to DQB1*02-DRB1*03 in celiac patients of Southern Europe. Tissue Antigens 71: 213-218 (2008). *

• Herr M, Dudbridge F, Zavattari P, Cucca F, Guja C, March R, Campbell RD, Barnett AH, Bain SC, Todd JA, Koeleman BP. Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. Hum. Mol. Genet. 9: 1291-1301 (2000). *

• Herrera M, Chertkoff L, Palavecino E, Mota A, Guala MC, Fainboim L, Satz ML. Restriction fragment length polymorphism in HLA class II genes of Latin-American Caucasian celiac disease patients. Hum. Immunol. 26: 272-280 (1989).

• Hervonen K, Karell K, Holopainen P, Collin P, Partanen J, Reunala T. Concordance of dermatitis herpetiformis and celiac disease in monozygous twins. J. Invest. Dermatol. 115: 990-993 (2000). *

• Heward JM, Allahabadia A, Sheppard MC, Barnett AH, Franklyn JA, Gough SC. Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501. Clin. Endocrinol. (Oxf.) 51: 115-118 (1999). *

• Heward JM, Mijovic CH, Kelly MA, Morrison E, Barnett AH. HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica. Eur. J. Immunogenet. 29: 47-52 (2002). *

• Higgins R, Lowe D, Hathaway M, Lam F, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Zehnder D, Briggs D. Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation. Transplantation 87: 882-888 (2009).

• Hiraide A, Imazeki F, Yokosuka O, Kanda T, Kojima, H, Fukai K, Suzuki Y, Hata A, Saisho H. Fas polymorphisms influence susceptibility to autoimmune hepatitis. Am. J. Gastroenterol. 100: 1322-1329 (2005). *

• Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, Song YW, Mimori T, Targoff IN. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 56: 1295-1303 (2007). *

• Hirata I, Murano M, Ishiguro T, Toshina K, Wang FY, Katsu K. HLA genotype and development of gastric cancer in patients with Helicobacter pylori infection. Hepatogastroenterology 54: 990-994 (2007).

• Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, Gu X, Walker EJ, Jing K, Juran BD, Mason AL, Myers RP, Peltekian KM, Ghent CN, Coltescu C, Atkinson EJ, Heathcote EJ, Lazaridis KN, Amos CI, Siminovitch KA. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 360: 2544-2555 (2009). *

• Hirv K, Bloch K, Fischer M, Einsiedler B, Schrezenmeier H, Mytilineos J. Prediction of duration and success rate of unrelated hematopoietic stem cell donor searches based on the patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies. Bone Marrow Transplant. 44: 433-440 (2009).

• Hirv K, Seyfarth M, Uibo R, Kull K, Salupere R, Latza U, Rink L. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers. Scand. J. Gastroenterol. 34: 1025-1032 (1999). *

• Hitman GA, Niven MJ, Festenstein H, Cassell PG, Awad J, Walker-Smith J, Leonard JN, Fry L, Ciclitira P, Kumar P, et al. HLA class II alpha chain gene polymorphisms in patients with insulin-dependent diabetes mellitus, dermatitis herpetiformis, and celiac disease. J. Clin. Invest. 79: 609-615 (1987). *

• Hlavaty T, Persoons P, Vermeire S, Ferrante M, Pierik M, Van Assche G, Rutgeerts P. Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease. Inflamm. Bowel Dis. 12: 199-204 (2006). *

• Hoa BK, Hang NT, Kashiwase K, Ohashi J, Lien LT, Horie T, Shojima J, Hijikata M, Sakurada S, Satake M, Tokunaga K, Sasazuki T, Keicho N. HLA-A, -B, -C, -DRB1 and -DQB1 alleles and haplotypes in the Kinh population in Vietnam. Tissue Antigens 71: 127-134 (2008). *

• Hodak E, Lapidoth M, Kohn K, David D, Brautbar B, Kfir K, Narinski N, Safirman S, Maron M, Klein K. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients. Br. J. Dermatol. 145: 974-980 (2001). *

• Hogen Esch CE, Csizmadia GD, van Hoogstraten IM, Schreurs MW, Mearin ML, VON Blomberg BM. Childhood coeliac disease: towards an improved serological mass screening strategy. Aliment. Pharmacol. Ther. Dec 25 [Epub ahead of print] (2009). *

• Hohjoh H, Nakayama T, Ohashi J, Miyagawa T, Tanaka H, Akaza T, Honda Y, Juji T, Tokunaga K. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 54: 138-145 (1999). *

• Holdsworth R, Hurley CK, Marsh SG, Lau M, Noreen HJ, Kempenich JH, Setterholm M, Maiers M. The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens 73: 95-170 (2009). *

• Holm K, Savilahti E, Koskimies S, Lipsanen V, Maki M. Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells. Gut 35: 55-60 (1994). *

• Holmberg H, Vaarala O, Sadauskaite-Kuehne V, Ilonen J, Padaiga Z, Ludvigsson J. Higher prevalence of autoantibodies to insulin and GAD(65) in Swedish compared to Lithuanian children with type 1 diabetes. Diabetes Res. Clin. Pract. 72: 308-314 (2006).

• Holopainen P, Arvas M, Sistonen P, Mustalahti K, Collin P, Maki M, Partanen J. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study. Tissue Antigens 53: 470-475 (1999). *

• Holopainen P, Mustalahti K, Uimari P, Collin P, Maki M, Partanen J. Candidate gene regions and genetic heterogeneity in gluten sensitivity. Gut 48: 696-701 (2001). *

• Holtmeier W, Rowell DL, Nyberg A, Kagnoff MF. Distinct delta T cell receptor repertoires in monozygotic twins concordant for coeliac disease. Clin. Exp. Immunol. 107: 148-157 (1997). *

• Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol. Med. 1: 576-582 (1995). *

• Hong SH, Wang KC, Kim SK, Cho BK, Park MH. Association of HLA-DR and -DQ genes with familial Moyamoya disease in Koreans. J. Korean Neurosurg. Soc. 46: 558-563 (2009).

• Hoover ML, Marta RT. Molecular modelling of HLA-DQ suggests a mechanism of resistance in type 1 diabetes. Scand. J. Immunol. 45: 193-202 (1997).

• Hopman EG, von Blomberg ME, Batstra MR, Morreau H, Dekker FW, Koning F, Lamers CB, Mearin ML. Gluten tolerance in adult patients with celiac disease 20 years after diagnosis? Eur. J. Gastroenterol. Hepatol. 20: 423-429 (2008).

• Horie Y, Chiba M, Iizuka M, Masamune O. Class II (HLA-DR, HLA-DP, and HLA-DQ) antigens on colonic epithelia in ulcerative colitis: a comparison between uneventful and intractable cases. Tohoku J. Exp. Med. 165: 87-97 (1991).

• Horie Y, Chiba M, Iizuka M, Masamune O. Class II (HLA-DR, -DP, and -DO) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine. Gastroenterol. Jpn. 25: 575-584 (1990).

• Horiki T, Inoko H, Moriuchi J, Ichikawa Y, Arimori S. Combinations of HLA-DPB1 and HLA-DQB1 alleles determine susceptibility to early-onset myasthenia gravis in Japan. Autoimmunity 19: 49-54 (1994).

• Horn GT, Bugawan TL, Long CM, Erlich HA. Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc. Natl. Acad. Sci. U.S.A. 85: 6012-6016 (1988). *

• Horn GT, Bugawan TL, Long CM, Manos MM, Erlich HA. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals. Hum. Immunol. 21: 249-263 (1988).

• Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC, Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S. Gene map of the extended human MHC. Nat. Rev. Genet. 5: 889-899 (2004). *

• Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group. Diabetologia 42: 608-616 (1999). *

• Hosszufalusi N, Karcagi V, Horvath R, Palik E, Varkonyi J, Rajczy K, Prohaszka Z, Szentirmai C, Karadi I, Romics L, Panczel P. A detailed investigation of maternally inherited diabetes and deafness (MIDD) including clinical characteristics, C-peptide secretion, HLA-DR and -DQ status and autoantibody pattern. Diabetes Metab. Res. Rev. 25: 127-135 (2009). *

• Houlston RS, Tomlinson IP, Ford D, Seal S, Marossy AM, Ferguson A, Holmes GK, Hosie KB, Howdle PD, Jewell DP, Godkin A, Kerr GD, Kumar P, Logan RF, Love AH, Johnston S, Marsh MN, Mitton S, O'Donoghue D, Roberts A, Walker-Smith JA, Stratton MF. Linkage analysis of candidate regions for coeliac disease genes. Hum. Mol. Genet. 6: 1335-1339 (1997). *

• Hovhannisyan Z, Weiss A, Martin A, Wiesner M, Tollefsen S, Yoshida K, Ciszewski C, Curran SA, Murray JA, David CS, Sollid LM, Koning F, Teyton L, Jabri B. The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature 456: 534-538 (2008). *

• Howell MD, Austin RK, Kelleher D, Nepom GT, Kagnoff MF. An HLA-D region restriction fragment length polymorphism associated with celiac disease. J. Exp. Med. 164: 333-338 (1986). *

• Howell MD, Smith JR, Austin RK, Kelleher D, Nepom GT, Volk B, Kagnoff MF. An extended HLA-D region haplotype associated with celiac disease. Proc. Natl. Acad. Sci. U.S.A. 85: 222-226 (1988). *

• Howell WM, Calder PC, Grimble RF. Gene polymorphisms, inflammatory diseases and cancer. Proc. Nutr. Soc. 61: 447-456 (2002). *

• Howell WM, Evans PR, Wilson PJ, Cawley MI, Smith JL. HLA class II DR, DQ, and DP restriction fragment length polymorphisms in rheumatoid arthritis. Ann. Rheum. Dis. 48: 295-301 (1989). *

• Howell WM, Leung ST, Jones DB, Nakshabendi I, Hall MA, Lanchbury JS, Ciclitira PJ, Wright DH. HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy. Hum. Immunol. 43: 29-37 (1995).

• Howson JM, Dunger DB, Nutland S, Stevens H, Wicker LS, Todd JA. A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 50: 741-746 (2007). *

• Howson JM, Walker NM, Clayton D, Todd JA; Diabetes Genetics Consortium. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes. Metab. 11 Suppl. 1: 31-45 (2009). *

• Hrycek A, Siekiera U, Cieslik P, Szkrobka W. HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus. Rheumatol. Int. 26: 1-6 (2005). *

• Hsu HY, Chang MH, Ho HN, Hsieh RP, Lee SD, Chen DS, Lee CY, Hsieh KH. Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. Vaccine 11: 1437-1440 (1993).

• Hu CY, Allen M, Chuang LM, Lin BJ, Gyllensten U. Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles. Hum. Immunol. 38: 105-114 (1993).

• Hu W, Tang L, Wang J, Wang B, Li S, Yu H, Tang W, Li H, Tan S, Shou W, Xiao C. Polymorphism of HLA-DRB1, -DQB1 and -DPB1 genes in Bai ethnic group in southwestern China. Tissue Antigens 72: 474-477 (2008). *

• Huang HS, Peng JT, She JY, Zhang LP, Chao CC, Liu KH, She JX. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population. Hum. Immunol. 44: 210-219 (1995).

• Huang W, Connor E, Rosa TD, Muir A, Schatz D, Silverstein J, Crockett S, She JX, Maclaren NK. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. J. Clin. Endocrinol. Metab. 81: 2559-2563 (1996). *

• Huang YK, Wen GS, Li HL, Hao P, Qi Q, Zhou LF. Possible association between HLA-HRB1 and DQB1 genes frequency and susceptibility or resistance to Helicobacter pylori infection in Kunming Yi ethnic group children. Zhonghua Er Ke Za Zhi 43: 137-140 (2005).

• Huang YY, Lin FJ, Fu LS, Lan JL. HLA-DR, -DQB typing of steroid-sensitive idiopathic nephrotic syndrome children in Taiwan. Nephron. Clin. Pract. 112: c57-c64 (2009).

• Huibregtse IL, Marietta EV, Rashtak S, Koning F, Rottiers P, David CS, van Deventer SJ, Murray JA. Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J. Immunol. 183: 2390-2396 (2009).

• Hunt KA, Monsuur AJ, McArdle W, Kumar PJ, Travis SP, Walters JR, Jewell DP, Strachan DP, Playford RJ, Wijmenga C, van Heel DA. Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut 55: 969-972 (2006). *

• Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, Romanos J, Dinesen LC, Ryan AW, Panesar D, Gwilliam R, Takeuchi F, McLaren WM, Holmes GK, Howdle PD, Walters JR, Sanders DS, Playford RJ, Trynka G, Mulder CJ, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat. Genet. 40: 395-402 (2008). *

• Hunt PJ, Marshall SE, Weetman AP, Bunce M, Bell JI, Wass JA, Welsh KI. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin. Endocrinol. (Oxf.) 55: 491-499 (2001). *

• Husain S, Yildirim-Toruner C, Rubio JP, Field J; The Southern MS Genetics Consortium, Schwalb M, Cook S, Devoto M, Vitale E. Variants of ST8SIA1 are associated with risk of developing multiple sclerosis. PLoS ONE 3: e2653 (2008). *

• Husain Z, Kelly MA, Eisenbarth GS, Pugliese A, Awdeh ZL, Larsen CE, Alper CA. The MHC type 1 diabetes susceptibility gene is centromeric to HLA-DQB1. J. Autoimmun. 30: 266-272 (2008).

• Hviid TV, Christiansen OB. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G - possible implications for human reproduction and autoimmune disease. Hum. Immunol. 66: 688-699 (2005).

• Iannuzzi MC. Genetics of sarcoidosis. Semin. Respir. Crit. Care Med. 28: 15-21 (2007).

• Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am. J. Respir. Crit. Care Med. 167: 1225-1231 (2003). *

• Ide A, Babu SR, Robles DT, Wang T, Erlich HA, Bugawan TL, Rewers M, Fain PR, Eisenbarth GS. "Extended" A1, B8, DR3 haplotype shows remarkable linkage disequilibrium but is similar to nonextended haplotypes in terms of diabetes risk. Diabetes 54: 1879-1883 (2005). *

• Ide A, Kawasaki E, Abiru N, Sun F, Kobayashi M, Fukushima T, Takahashi R, Kuwahara H, Kita A, Oshima K, Uotani S, Yamasaki H, Yamaguchi Y, Eguchi K. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J. Autoimmun. 22: 73-78 (2004).

• Ikaheimo I, Silvennoinen-Kassinen S, Karvonen J, Jarvinen T, Tiilikainen A. Immunogenetic profile of psoriasis vulgaris: association with haplotypes A2,B13,Cw6,DR7,DQA1*0201 and A1,B17,Cw6,DR7,DQA1*0201. Arch. Dermatol. Res. 288: 63-67 (1996). *

• Ikegami H, Awata T, Kawasaki E, Kobayashi T, Maruyama T, Nakanishi K, Shimada A, Amemiya S, Kawabata Y, Kurihara S, Tanaka S, Kanazawa Y, Mochizuki M, Ogihara T. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multi-center collaborative study in Japan. J. Clin. Endocrinol. Metab. 91: 1087-1092 (2006). *

• Ikegami H, Tahara Y, Cha T, Yamato E, Ogihara T, Noma Y, Shima K. Aspartic acid at position 57 of the HLA-DQ beta chain is not protective against insulin-dependent diabetes mellitus in Japanese people. J. Autoimmun. 3: 167-174 (1990).

• Ilonen J, Kocova M, Lipponen K, Sukarova-Angelovska E, Jovanovska A, Knip M. HLA-DR-DQ haplotypes and type 1 diabetes in Macedonia. Hum. Immunol. 70: 461-463 (2009).

• Inada H, Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Umemura T, Tanaka E, Kiyosawa K. T cell repertoire in the liver of patients with primary biliary cirrhosis. Hum. Immunol. 61: 675-683 (2000).

• Ionescu-Tirgoviste C, Guja C, Herr M, Cucca E, Welsh K, Bunce M, Marshall S, Todd JA. Low frequency of HLA DRB1*03 - DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of type I diabetes. Diabetologia 44 Suppl. 3: B60-B66 (2001).

• Ishihara M, Ishida T, Inoko H, Ando H, Naruse T, Nose Y, Ohno S. HLA serological and class II genotyping in sarcoidosis patients in Japan. Jpn. J. Ophthalmol. 40: 86-94 (1996).

• Ishihara M, Ohno S, Ishida T, Ando H, Naruse T, Nose Y, Inoko H. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 43: 238-241 (1994).

• Ishihara M, Ohno S, Mizuki N, Yamagata N, Ishida T, Naruse T, Kuwata S, Inoko H. Genetic polymorphisms of the major histocompatibility complex-encoded antigen-processing genes TAP and LMP in sarcoidosis. Hum. Immunol. 45: 105-110 (1996).

• Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, Yoshioka K, Kitagawa Y, Nakano K, Yoshikawa T, Nakamura N. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase. Immunol. Lett. 99: 180-185 (2005).

• Ivansson EL, Magnusson JJ, Magnusson PK, Erlich HA, Gyllensten UB. MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2. Genes Immun. 9: 613-623 (2008).

• Ivarsson SA, Eriksson S, Kockum I, Lernmark A, Lindgren S, Nilsson KO, Sundkvist G, Wassmuth R. HLA-DR3, DQ2 homozygosity in two patients with insulin-dependent diabetes mellitus superimposed with ulcerative colitis and primary sclerosing cholangitis. J. Intern. Med. 233: 281-286 (1993).

• Iwai LK, Juliano MA, Juliano L, Kalil J, Cunha-Neto E. T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. J. Autoimmun. 24: 111-117 (2005).

• Iwaizumi M, Yamada M, Kitagawa M, Takehira Y, Hanajima K, Murohisa G, Kawamura M, Iwaoka Y, Wada T, Morita S, Kawata K. Ulcerative colitis in monozygotic twin sisters. Intern. Med. 41: 629-632 (2002). *

• Iwama S, Ikezaki A, Kikuoka N, Kim HS, Matsuoka H, Yanagawa T, Sato H, Hoshi M, Sakamaki T, Sugihara S. Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children. Horm. Res. 63: 55-60 (2005).

• Jackson DG, Capra JD. TAP1 alleles in insulin-dependent diabetes mellitus: a newly defined centromeric boundary of disease susceptibility. Proc. Natl. Acad. Sci. U.S.A. 90: 11079-11083 (1993). *

• Jahromi MM, Eisenbarth GS. Cellular and molecular pathogenesis of type 1A diabetes. Cell. Mol. Life Sci. 64: 865-872 (2007). *

• Jalihal A, Telisinghe PU, Chong VH. Profiles of autoimmune hepatitis in Brunei Darussalam. Hepatobiliary Pancreat. Dis. Int. 8: 602-607 (2009). *

• James I, McKinnon E, Gaudieri S, Morahan G; Diabetes Genetics Consortium. Missingness in the T1DGC MHC fine-mapping SNP data: association with HLA genotype and potential influence on genetic association studies. Diabetes Obes. Metab. 11 Suppl. 1: 101-107 (2009). *

• James SP. Prototypic disorders of gastrointestinal mucosal immune function: celiac disease and Crohn's disease. J. Allergy Clin. Immunol. 115: 25-30 (2005).

• Jandus C, Bioley G, Dojcinovic D, Derre L, Baitsch L, Wieckowski S, Rufer N, Kwok WW, Tiercy JM, Luescher IF, Speiser DE, Romero P. Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts. Cancer Res. 69: 8085-8093 (2009). *

• Jarvinen TM, Harjutsalo V, Kinnunen L, Miettinen ME, Tuomilehto-Wolf E, Tuomilehto J. A population-specific diabetogenic haplotype HLA-A2,Cw1,B56,DR4,DQ8 is associated with high birthweight in Finnish diabetic families. Genes Immun. 9: 207-213 (2008). *

• Jean S, Quelvennec E, Alizadeh M, Guggenbuhl P, Birebent B, Perdriger A, Grosbois B, Pawlotsky PY, Semana G. DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjogren's syndrome genetic susceptibility. Clin. Exp. Rheumatol. 16: 725-728 (1998).

• Jee SH, Tsai TF, Tsai WL, Liaw SH, Chang CH, Hu CY. HLA-DRB1*0701 and DRB1*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population. Br. J. Dermatol. 139: 978-983 (1998).

• Jenisch S, Henseler T, Nair RP, Guo SW, Westphal E, Stuart P, Kronke M, Voorhees JJ, Christophers E, Elder JT. Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am. J. Hum. Genet. 63: 191-199 (1998). *

• Jiang C, Deshmukh US, Gaskin F, Bagavant H, Hanson J, David CS, Fu SM. Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens. J. Immunol. 184: 1085-1091 (2010).

• Jiang XH, Zong RQ, Fang XY, An F, Hu Y, Kong XT. Relationship between alleles of HLA-DRB and HLA-DQB1 and Chinese patients with primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi 12: 436 (2004).

• Jiang YG, Wang YM. Study on the polymorphisme of human leucocyte antigen-DRB1, -DQA1 and -DQB1 alleles in patients with hepatitis B. Zhonghua Liu Xing Bing Xue Za Zhi 25: 337-340 (2004).

• Jiang YG, Wang YM, Liu TH, Liu J. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J. Gastroenterol. 9: 2221-2225 (2003). *

• Jing L, McCaughey SM, Davies DH, Chong TM, Felgner PL, De Rosa SP, Wilson CB, Koelle DM. ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans. J. Immunol. Methods 347: 36-45 (2009). *

• Johansen BH, Gjertsen HA, Vartdal F, Buus S, Thorsby E, Lundin KE, Sollid LM. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. Clin. Immunol. Immunopathol. 79: 288-293 (1996).

• Johansen BH, Jensen T, Thorpe CJ, Vartdal F, Thorsby E, Sollid LM. Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential. Immunogenetics 45: 142-150 (1996).

• Johansson A, Ingman M, Mack SJ, Erlich H, Gyllensten U. Genetic origin of the Swedish Sami inferred from HLA class I and class II allele frequencies. Eur. J. Hum. Genet. 16: 1341-1349 (2008). *

• Johansson S, Lie BA, Cambon-Thomsen A, Pociot F, Nerup J, Kockum I, Thorsby E, Undlien DE. No evidence of type 1 diabetes susceptibility genes in the region centromeric of the HLA complex. Hum. Immunol. 64: 951-959 (2003).

• Johansson S, Lie BA, Pociot F, Nerup J, Cambon-Thomsen A, Kockum I, Thorsby E, Undlien DE. HLA associations in type 1 diabetes: DPB1 alleles may act as markers of other HLA-complex susceptibility genes. Tissue Antigens 61: 344-351 (2003). *

• Johansson S, Lie BA, Todd JA, Pociot F, Nerup J, Cambon-Thomsen A, Kockum I, Akselsen HE, Thorsby E, Undlien DE. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun. 4: 46-53 (2003). *

• Johnson CM, Traherne JA, Jamieson SE, Tremelling M, Bingham S, Parkes M, Blackwell JM, Trowsdale J. Analysis of the BTNL2 truncating splice site mutation in tuberculosis, leprosy and Crohn's disease. Tissue Antigens 69: 236-241 (2007). *

• Johnson ML, Keeton LG, Zhu ZB, Volanakis JE, Cooper MD, Schroeder HW Jr. Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID). Clin. Exp. Immunol. 108: 477-483 (1997). *

• Johnson TC, Diamond B, Memeo L, Negulescu H, Hovhanissyan Z, Verkarre V, Rotterdam H, Fasano A, Caillat-Zucman S, Grosdidier E, Winchester R, Cellier C, Jabri B, Green PH. Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts. Clin. Gastroenterol. Hepatol. 2: 888-894 (2004). *

• Jonsen A, Bengtsson AA, Sturfelt G, Truedsson L. Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility. Arthritis Res. Ther. 6: R557-R562 (2004). *

• Jonson CO, Hedman M, Karlsson Faresjo M, Casas R, Ilonen J, Ludvigsson J, Vaarala O; for the ABIS Study Group. The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children. Clin. Exp. Immunol. 145: 48-55 (2006). *

• Jonson CO, Lernmark A, Ludvigsson J, Rutledge EA, Hinkkanen A, Faresjo M. The importance of CTLA-4 polymorphism and human leukocyte antigen genotype for the induction of diabetes-associated cytokine response in healthy school children. Pediatr. Diabetes 8: 185-192 (2007). *

• Jores RD, Frau F, Cucca F, Clemente MG, Orru S, Rais M, De Virgiliis S, Congia M. HLA-DQB1*0201 homozygosis predisposes to severe intestinal damage in celiac disease. Scand. J. Gastroenterol. 42: 48-53 (2007). *

• Ju LY, Sun YP, Semana G, Gu XF, Krishnamoorty R, Fauchet R, Charron D. Aspartic acid at position 57 of the HLA-DQ beta chain in insulin-dependent diabetes mellitus: an association with one DRw9-DQw9 subtype in the Chinese population. Tissue Antigens 37: 218-223 (1991).

• Jurado A, Cardaba B, Jara P, Cuadrado P, Hierro L, de Andres B, del Pozo V, Cortegano MI, Gallardo S, Camarena C, Barcena R, Castaner JL, Alvarez R, Lahoz C, Palomino P. Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. J. Hepatol. 26: 983-991 (1997). *

• Jurcic Z, Brkljacic-Surkalovic L, Grubic Z, Zunec R, Vezmar V, Kastelan A. Gluten enteropathy in Croatian children is primarily associated with the HLA-DR3-DQ2 haplotype. Lijec. Vjesn. 122: 259-263 (2000).

• Juse U, Fleckenstein B, Bergseng E, Sollid LM. Soluble HLA-DQ2 expressed in S2 cells copurifies with a high affinity insect cell derived protein. Immunogenetics 61: 81-89 (2009). *

• Juse U, van de Wal Y, Koning F, Sollid LM, Fleckenstein B. Design of new high affinity peptide ligands for HLA-DQ2 using a positional scanning peptide library. Hum. Immunol. Jan 24 [Epub ahead of print] (2010).

• Kagnoff MF, Harwood JI, Bugawan TL, Erlich HA. Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype. Proc. Natl. Acad. Sci. U.S.A. 86: 6274-6278 (1989). *

• Kahles H, Kordonouri O, Ramos Lopez E, Walter M, Rosinger S, Boehm BO, Badenhoop K, Seidl C, Ziegler A; Diabetes Genetics Consortium. Mating in parents of type 1 diabetes families as a function of the HLA DR-DQ haplotype. Diabetes Obes. Metab. 11 Suppl. 1: 84-87 (2009). *

• Kaistha A, Castells S. Celiac disease in African American children with type 1 diabetes mellitus in inner city Brooklyn. Pediatr. Endocrinol. Rev. 5 Suppl. 4: 994-998 (2008).

• Kalman B, Lublin FD. The genetics of multiple sclerosis. A review. Biomed. Pharmacother. 53: 358-370 (1999).

• Kalpaklioglu AF, Turan M. Possible association between cockroach allergy and HLA class II antigens. Ann. Allergy Asthma Immunol. 89: 155-158 (2002).

• Kamata A, Chiba M, Ishii N, Kudo T, Horie Y, Iizuka M, Masamune O. Three cases of familial ulcerative colitis - in a mother and two of her sons. J. Gastroenterol. 32: 401-404 (1997).

• Kambhu S, Falldorf P, Lee JS. Endogenous retroviral long terminal repeats within the HLA-DQ locus. Proc. Natl. Acad. Sci. U.S.A. 87: 4927-4931 (1990). *

• Kane S, Kisiel J, Shih L, Hanauer S. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am. J. Gastroenterol. 99: 1523-1526 (2004). *

• Kang MY, Hahm JR, Jung TS, Lee GW, Kim DR, Park MH. A 20-year-old woman with Hashimoto's thyroiditis and Evans' syndrome. Yonsei Med. J. 47: 432-436 (2006). *

• Kanga U, Vaidyanathan B, Jaini R, Menon PS, Mehra NK. HLA haplotypes associated with type 1 diabetes mellitus in North Indian children. Hum. Immunol. 65: 47-53 (2004).

• Kapitany A, Tarr T, Gyetvai A, Szodoray P, Tumpek J, Poor G, Szegedi G, Sipka S, Kiss E. Human leukocyte antigen-DRB1 and -DQB1 genotyping in lupus patients with and without antiphospholipid syndrome. Ann. N. Y. Acad. Sci. 1173: 545-551 (2009). *

• Kapitany A, Toth L, Tumpek J, Csipo I, Sipos E, Woolley N, Partanen J, Szegedi G, Olah E, Sipka S, Korponay-Szabo IR. Diagnostic significance of HLA-DQ typing in patients with previous coeliac disease diagnosis based on histology alone. Aliment. Pharmacol. Ther. 24: 1395-1402 (2006). *

• Kapoerchan VV, Wiesner M, Hillaert U, Drijfhout JW, Overhand M, Alard P, van der Marel GA, Overkleeft HS, Koning F. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule. Mol. Immunol. Dec 2 [Epub ahead of print] (2009). *

• Kapoerchan VV, Wiesner M, Overhand M, van der Marel GA, Koning F, Overkleeft HS. Design of azidoproline containing gluten peptides to suppress CD4(+) T-cell responses associated with celiac disease. Bioorg. Med. Chem. 16: 2053-2062 (2008).

• Karell K, Holopainen P, Mustalahti K, Collin P, Maki M, Partanen J. Not all HLA DR3 DQ2 haplotypes confer equal susceptibility to coeliac disease: transmission analysis in families. Scand. J. Gastroenterol. 37: 56-61 (2002). *

• Karell K, Korponay-Szabo I, Szalai Z, Holopainen P, Mustalahti K, Collin P, Maki M, Partanen J. Genetic dissection between coeliac disease and dermatitis herpetiformis in sib pairs. Ann. Hum. Genet. 66: 387-392 (2002). *

• Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L, Ciclitira PJ, Sollid LM, Partanen J; European Genetics Cluster on Celiac Disease. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum. Immunol. 64: 469-477 (2003).

• Karinen H, Karkkainen P, Pihlajamaki J, Janatuinen E, Heikkinen M, Julkunen R, Kosma VM, Naukkarinen A, Laakso M. Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease. Scand. J. Gastroenterol. 41: 191-199 (2006). *

• Karinen H, Karkkainen P, Pihlajamaki J, Janatuinen E, Heikkinen M, Julkunen R, Kosma VM, Naukkarinen A, Laakso M. HLA genotyping is useful in the evaluation of the risk for coeliac disease in the 1st-degree relatives of patients with coeliac disease. Scand. J. Gastroenterol. 41: 1299-1304 (2006). *

• Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun. 8: 275-278 (2007). *

• Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismuller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma R, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology Nov 25 [Epub ahead of print] (2009). *

• Karni A, Kohn Y, Safirman C, Abramsky O, Barcellos L, Oksenberg JR, Kahana E, Karussis D, Chapman J, Brautbar C. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel. Mult. Scler. 5: 410-415 (1999). *

• Katahira M, Maeda H, Tosaki T, Segawa S. The human leukocyte antigen class II gene has different contributions to autoimmune type 1 diabetes with or without autoimmune thyroid disease in the Japanese population. Diabetes Res. Clin. Pract. 85: 293-297 (2009).

• Katarina K, Daniela P, Peter N, Marianna R, Pavlina C, Stepanka P, Jan L, Ludmila T, Michal A, Marie C. HLA, NFKB1 and NFKBIA gene polymorphism profile in autoimmune diabetes mellitus patients. Exp. Clin. Endocrinol. Diabetes 115: 124-129 (2007).

• Kaukinen K, Partanen J, Maki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am. J. Gastroenterol. 97: 695-699 (2002). *

• Kaukinen K, Peraaho M, Collin P, Partanen J, Woolley N, Kaartinen T, Nuutinen T, Halttunen T, Maki M, Korponay-Szabo I. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand. J. Gastroenterol. 40: 564-572 (2005). *

• Kaukinen K, Turjanmaa K, Maki M, Partanen J, Venalainen R, Reunala T, Collin P. Intolerance to cereals is not specific for coeliac disease. Scand. J. Gastroenterol. 35: 942-946 (2000). *

• Kaur G, Kumar N, Szilagyi A, Blasko B, Fust G, Rajczy K, Pozsonyi E, Hosso A, Petranyi G, Tandon N, Mehra N. Autoimmune-associated HLA-B8-DR3 haplotypes in Asian Indians are unique in C4 complement gene copy numbers and HSP-2 1267A/G. Hum. Immunol. 69: 580-587 (2008).

• Kaur G, Rapthap CC, Kumar S, Bhatnagar S, Bhan MK, Mehra NK. Polymorphism in L-selectin, E-selectin and ICAM-1 genes in Asian Indian pediatric patients with celiac disease. Hum. Immunol. 67: 634-638 (2006).

• Kaur G, Sarkar N, Bhatnagar S, Kumar S, Rapthap CC, Bhan MK, Mehra NK. Pediatric celiac disease in India is associated with multiple DR3-DQ2 haplotypes. Hum. Immunol. 63: 677-682 (2002).

• Kaushansky N, Altmann DM, Ascough S, David CS, Lassmann H, Ben-Nun A. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice. J. Immunol. 183: 3531-3541 (2009).

• Kaushansky N, Eisenstein M, Zilkha-Falb R, Ben-Nun A. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis. Autoimmun. Rev. Aug 12 [Epub ahead of print] (2009).

• Kavak A, Baykal C, Ozarmagan G, Akar U. HLA in alopecia areata. Int. J. Dermatol. 39: 589-592 (2000).

• Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J. Gastroenterol. 42 Suppl. 18: 9-14 (2007). *

• Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, Nakayama K, Tokutake Y, Katsuyama Y, Saito S, Hasebe O, Kiyosawa K. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 122: 1264-1269 (2002). *

• Kawabata Y, Ikegami H, Awata T, Imagawa A, Maruyama T, Kawasaki E, Tanaka S, Shimada A, Osawa H, Kobayashi T, Hanafusa T, Tokunaga K, Makino H; on behalf of the Committee on Type 1 Diabetes, Japan Diabetes Society. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia Oct 8 [Epub ahead of print] (2009). *

• Kawabata Y, Ikegami H, Fujisawa T, Noso S, Asano K, Hiromine Y, Ogihara T. A second component of HLA-linked susceptibility to type 1 diabetes maps to class I region. Ann. N. Y. Acad. Sci. 1079: 278-284 (2006). *

• Kawabata Y, Ikegami H, Kawaguchi Y, Fujisawa T, Hotta M, Ueda H, Shintani M, Nojima K, Ono M, Nishino M, Taniguchi H, Noso S, Yamada K, Babaya N, Ogihara T. Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus. Hum. Immunol. 61: 624-629 (2000).

• Kawahara Y, Mizuno M, Yoshino T, Yokota K, Oguma K, Okada H, Fujiki S, Shiratori Y. HLA-DQA1*0103-DQB1*0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma. Clin. Gastroenterol. Hepatol. 3: 865-868 (2005).

• Kawasaki E, Eguchi K. Genetics of fulminant type 1 diabetes. Ann. N. Y. Acad. Sci. 1079: 24-30 (2006). *

• Kchir MM, Hamdi W, Laadhar L, Kochbati S, Kaffel D, Saadellaoui K, Lahmar H, Ghannouchi MM, Azzouz D, Daoud L, Ben Hamida A, Zouari B, Zitouni M, Makni S. HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study). Rheumatol. Int. Aug 5 [Epub ahead of print] (2009). *

• Kelemen K, Gottlieb PA, Putnam AL, Davidson HW, Wegmann DR, Hutton JC. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes. J. Immunol. 172: 3955-3962 (2004). *

• Kelly P, Patchett S, McCloskey D, Alstead E, Farthing M, Fairclough P. Sclerosing cholangitis, race and sex. Gut 41: 688-689 (1997). *

• Kelsch R, Binder TM, Elsner HA, Eiermann TH, Sibrowski W. An HLA-DR11/DQ3 haplotype with a DRB1*0301 sequence motif in the third hypervariable region of the HLA-DR beta-1 chain: molecular and serological analysis of its generation in a European Caucasian family. Tissue Antigens 74: 330-335 (2009). *

• Khalil I, Berrih-Aknin S, Lepage V, Loste MN, Gajdos P, Hors J, Charron D, Degos L. Trans-encoded DQ alpha beta heterodimers confer susceptibility to myasthenia gravis disease. C. R. Acad. Sci. III. 316: 652-660 (1993).

• Khalil I, d'Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Park MS, Degos L, Galibert F, Hors J. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J. Clin. Invest. 85: 1315-1319 (1990). *

• Khalil I, Deschamps I, Lepage V, Morin L, Galibert F, Degos L, Hors J. HLA DQ alpha/beta molecule associated with the susceptibility to insulin-dependent diabetes mellitus. A model for HLA/autoimmune disease association. Nouv. Rev. Fr. Hematol. 32: 445-447 (1990).

• Khare M, Mangalam A, Rodriguez M, David CS. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice. J. Neuroimmunol. 169: 1-12 (2005).

• Khare M, Rodriguez M, David CS. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. Int. Immunol. 15: 535-546 (2003). *

• Khazaee MH, Tavakol Afshari J, Khazaee B, Daneshvar R, Akbarzadeh J, Khazaee L, Ganjali R, Raygan F. HLA-DQB1 subtypes predict diabetic retinopathy in patients with type I diabetes mellitus. Eur. J. Ophthalmol. 19: 638-645 (2009).

• Kikuoka N, Sugihara S, Yanagawa T, Ikezaki A, Kim HS, Matsuoka H, Kobayashi Y, Wataki K, Konda S, Sato H, Miyamoto S, Sasaki N, Sakamaki T, Niimi H, Murata M. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies. Clin. Endocrinol. (Oxf.) 55: 597-603 (2001). *

• Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc. Natl. Acad. Sci. U.S.A. 101: 4175-4179 (2004). *

• Kim EY, Shin CH, Yang SW. Polymorphisms of HLA class II predispose children and adolescents with type 1 diabetes mellitus to autoimmune thyroid disease. Autoimmunity 36: 177-181 (2003).

• Kim MH, Seong MC, Kwak NH, Yoo JS, Huh W, Kim TG, Han H. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am. J. Ophthalmol. 129: 173-177 (2000). *

• Kim SH, Choi JH, Lee KW, Kim SH, Shin ES, Oh HB, Suh CH, Nahm DH, Park HS. The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria. Clin. Exp. Allergy 35: 339-344 (2005). *

• Kim TG, Choi HB, Park SH, Kim HY, Han H. DQCAR 113 and DQCAR 115 in combination with HLA-DRB1 alleles are significant markers of susceptibility to rheumatoid arthritis in the Korean population. Tissue Antigens 54: 552-559 (1999). *

• King AL, Ciclitira PJ. Celiac disease: strongly heritable, oligogenic, but genetically complex. Mol. Genet. Metab. 71: 70-75 (2000). *

• Kishi A, Kawabata Y, Ugi S, Iwai T, Tanaka Y, Yoshizaki T, Uzu T, Nishio Y, Ikegami H, Kashiwagi A, Maegawa H. The onset of diabetes in three out of four sisters: a Japanese family with type 1 diabetes. A case report. Endocr. J. 56: 767-772 (2009). *

• Kiszel P, Kovacs M, Szalai C, Yang Y, Pozsonyi E, Blasko B, Laki J, Prohaszka Z, Fazakas A, Panczel P, Hosszufalusi N, Rajczy K, Wu YL, Chung EK, Zhou B, Blanchong CA, Vatay A, Yu CY, Fust G. Frequency of carriers of 8.1 ancestral haplotype and its fragments in two Caucasian populations. Immunol. Invest. 36: 307-319 (2007). *

• Klemetti P, Savilahti E, Ilonen J, Akerblom HK, Vaarala O. T-cell reactivity to wheat gluten in patients with insulin-dependent diabetes mellitus. Scand. J. Immunol. 47: 48-53 (1998). *

• Klemola T, Savilahti E, Arato A, Ormala T, Partanen J, Eland C, Koskimies S. Immunohistochemical findings in jejunal specimens from patients with IgA deficiency. Gut 37: 519-523 (1995). *

• Klinker MW, Schiller JJ, Magnuson VL, Wang T, Basken J, Veth K, Pearce KI, Kinnunen L, Harjutsalo V, Wang X, Tuomilehto J, Sarti C, Ghosh S. Single-nucleotide polymorphisms in the IL2RA gene are associated with age at diagnosis in late-onset Finnish type 1 diabetes subjects. Immunogenetics Dec 23 [Epub ahead of print] (2009). *

• Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Williams TM, Fernandez-Vina M. New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 62: 296-307 (2003). *

• Knip M, Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun. Rev. 7: 550-557 (2008).

• Koay LB, Sun CS, Tsai SL, Lin CY. Significant association of HLA-DQ5 with autoimmune hepatitis in Taiwan. J. Formos. Med. Assoc. 106: 1063-1068 (2007).

• Kobayashi K, Atoh M, Konoeda Y, Yagita A, Inoko H, Sekiguchi S. HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis. Clin. Exp. Immunol. 80: 400-403 (1990). *

• Kobayashi K, Atoh M, Yagita A, Konoeda Y, Inoko H, Ando A, Sekiguchi S. Crohn's disease in the Japanese is associated with the HLA-DRw53. Exp. Clin. Immunogenet. 7: 101-108 (1990).

• Kochi Y, Yamada R, Kobayashi K, Takahashi A, Suzuki A, Sekine A, Mabuchi A, Akiyama F, Tsunoda T, Nakamura Y, Yamamoto K. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences. Arthritis Rheum. 50: 63-71 (2004). *

• Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur. J. Immunogenet. 26: 361-372 (1999). *

• Koeleman BP, Herr MH, Zavattari P, Dudbridge F, March R, Campbell D, Barnett AH, Bain SC, Mulargia AP, Loddo M, Amos W, Cucca F, Todd JA. Conditional ETDT analysis of the human leukocyte antigen region in type 1 diabetes. Ann. Hum. Genet. 64: 215-221 (2000).

• Koeleman BP, Lie BA, Undlien DE, Dudbridge F, Thorsby E, de Vries RR, Cucca F, Roep BO, Giphart MJ, Todd JA. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun. 5: 381-388 (2004). *

• Koelle DM, Johnson ML, Ekstrom AN, Byers P, Kwok WW. Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201. Hum. Immunol. 53: 195-205 (1997).

• Kohno T, Kunitoh H, Shimada Y, Shiraishi K, Ishii Y, Goto K, Ohe Y, Nishiwaki Y, Kuchiba A, Yamamoto S, Hirose H, Oka A, Yanagitani N, Saito R, Inoko H, Yokota J. Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes. Carcinogenesis Jan 8 [Epub ahead of print] (2010). *

• Kohonen-Corish MR, Serjeantson SW, Lee HK, Zimmet P. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups. Dis. Markers 5: 153-164 (1987).

• Kokaraki G, Daniilidis M, Yiangou M, Arsenakis M, Karyotis N, Tsilipakou M, Fleva A, Gerofotis A, Karadani N, Yovos JG. Major histocompatibility complex class II (DRB1*, DQA1*, and DQB1*) and DRB1*04 subtypes' associations of Hashimoto's thyroiditis in a Greek population. Tissue Antigens 73: 199-205 (2009). *

• Kondrashova A, Mustalahti K, Kaukinen K, Viskari H, Volodicheva V, Haapala AM, Ilonen J, Knip M, Maki M, Hyoty H, Group TE. Lower economic status and inferior hygienic environment may protect against celiac disease. Ann. Med. 40: 223-231 (2008).

• Kong YC, David CS. New revelations in susceptibility to autoimmune thyroiditis by the use of H2 and HLA class II transgenic models. Int. Rev. Immunol. 19: 573-585 (2000).

• Kong YC, Flynn JC, Banga JP, David CS. Application of HLA class II transgenic mice to study autoimmune regulation. Thyroid 17: 995-1003 (2007).

• Kong YC, Flynn JC, Wan Q, David CS. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Autoimmunity 36: 397-404 (2003).

• Koning F. The molecular basis of celiac disease. J. Mol. Recognit. 16: 333-336 (2003). *

• Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 129: 1294-1301 (2005). *

• Koning F, Gilissen L, Wijmenga C. Gluten: a two-edged sword. Immunopathogenesis of celiac disease. Springer Semin. Immunopathol. 27: 217-232 (2005). *

• Koning F, Schuppan D, Cerf-Bensussan N, Sollid LM. Pathomechanisms in celiac disease. Best Pract. Res. Clin. Gastroenterol. 19: 373-387 (2005).

• Koretz K, Momburg F, Otto HF, Moller P. Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease. Am. J. Pathol. 129: 493-502 (1987). *

• Korniszewski L, Kurzyna M, Stolarski B, Torbicki A, Smerdel A, Ploski R. Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome. Eur. Respir. J. 22: 709-711 (2003). *

• Koskela RM, Karttunen TJ, Niemela SE, Lehtola JK, Ilonen J, Karttunen RA. Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis. Eur. J. Gastroenterol. Hepatol. 20: 276-282 (2008).

• Koskinen L, Romanos J, Kaukinen K, Mustalahti K, Korponay-Szabo I, Barisani D, Bardella MT, Ziberna F, Vatta S, Szeles G, Pocsai Z, Karell K, Haimila K, Adány R, Not T, Ventura A, Mäki M, Partanen J, Wijmenga C, Saavalainen P. Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics 61: 247-256 (2009). *

• Kosmopoulou A, Vlassi M, Stavrakoudis A, Sakarellos C, Sakarellos-Daitsiotis M. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex. J. Comput. Chem. 27: 1033-1044 (2006). *

• Kotalova R, Vrana M, Dobrovolna M, Nevoral J, Loudova M. HLA-DRB1/DQA1/DQB1 alleles and haplotypes in Czech children with celiac sprue. Cas. Lek. Cesk. 141: 518-522 (2002).

• Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin. Endocrinol. (Oxf.) 46: 551-554 (1997).

• Krach K, Badenhoop K, Tonjes RR. The IDDM-associated solitary retroviral promoters DQ-LTR3 and DQ-LTR13 have a distinct impact on the expression of selected DQB1 genes in different cell lines in vitro. Immunogenetics 55: 521-529 (2003). *

• Kralovicova J, Hammarstrom L, Plebani A, Webster AD, Vorechovsky I. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J. Immunol. 170: 2765-2775 (2003). *

• Kroger N, Zabelina T, Binder T, Ayuk F, Bacher U, Amtsfeld G, Lellek H, Schrum J, Erttmann R, Eiermann T, Zander A. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen. Biol. Blood Marrow Transplant. 15: 454-462 (2009).

• Krokowski M, Bodalski J, Bratek A, Boitard C, Caillat-Zucman S. HLA class II-associated predisposition to insulin-dependent diabetes mellitus in a Polish population. Hum. Immunol. 59: 451-455 (1998).

• Kruger A, Quack P, Schneider PM, Rittner C, Hohler T. Sequence analysis of the DRB1 promoter reveals limited polymorphism with no influence on gene expression. Genes Immun. 2: 211-215 (2001). *

• Kubryn I, Mlynarski W, Trippenbach-Dulska H, Szalecki M, Lisowicz L, Surdej B, Pilecki O, Heinrich A, Wyka K, Perenc M, Bodalski J. Alleles of HLA-DQB1 and familial aggregation of type 1 diabetes. Med. Wieku. Rozwoj. 7: 157-164 (2003).

• Kuhnl P, Sibrowski W, Bohm BO, Bender SW, Kalmar G, Loliger C. HLA antigen frequencies in familial Crohn's disease (CD). Beitr. Infusionsther. 26: 283-286 (1990).

• Kuloglu Z, Doganci T, Kansu A, Demirceken F, Duman M, Tutkak H, Ensari A, Girgin N. HLA types in Turkish children with celiac disease. Turk. J. Pediatr. 50: 515-520 (2008).

• Kuloglu Z, Kirsaclioglu CT, Kansu A, Ensari A, Girgin N. Celiac disease: presentation of 109 children. Yonsei Med. J. 50: 617-623 (2009). *

• Kumar R, Eastwood AL, Brown ML, Laurie GW. Human genome search in celiac disease: mutated gliadin T-cell-like epitope in two human proteins promotes T-cell activation. J. Mol. Biol. 319: 593-602 (2002). *

• Kumar R, Lumsden A, Ciclitira PJ, Ellis HJ, Laurie GW. Human genome search in celiac disease using gliadin cDNA as probe. J. Mol. Biol. 300: 1155-1167 (2000). *

• Kunstmann E, Hardt C, Treitz H, Suerbaum S, Faller G, Peitz U, Schmiegel W, Epplen JT. In the European population HLA-class II genes are not associated with Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 14: 49-53 (2002).

• Kuokkanen S, Sundvall M, Terwilliger JD, Tienari PJ, Wikstrom J, Holmdahl R, Pettersson U, Peltonen L. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat. Genet. 13: 477-480 (1996). *

• Kusaka I, Nagasaka S, Fujibayashi K, Hayashi H, Kawakami A, Nakamura T, Rokkaku K, Saito T, Higashiyama M, Honda K, Ishikawa S, Saito T. Immunologically-related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement. Endocr. J. 46: 747-754 (1999).

• Kuwana M, Inoko H, Kameda H, Nojima T, Sato S, Nakamura K, Ogasawara T, Hirakata M, Ohosone Y, Kaburaki J, Okano Y, Mimori T. Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis. Intern. Med. 38: 336-344 (1999). *

• Kuwana M, Kaburaki J, Pandey JP, Murata M, Kawakami Y, Inoko H, Ikeda Y. HLA class II alleles in Japanese patients with immune thrombocytopenic purpura. Associations with anti-platelet glycoprotein autoantibodies and responses to splenectomy. Tissue Antigens 56: 337-343 (2000).

• Kuwana M, Kimura K, Hirakata M, Kawakami Y, Ikeda Y. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases. Ann. Rheum. Dis. 61: 842-846 (2002). *

• Kuwana M, Okano Y, Kaburaki J, Inoko H. HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma). Ann. Rheum. Dis. 54: 983-987 (1995). *

• Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, Kaneshige T, Tatsumi T, Ito A, Mochizuki K, Sasaki Y, Kasahara A, Hori M. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 27: 240-244 (1998). *

• Kwok WW, Lotshaw C, Milner EC, Knitter-Jack N, Nepom GT. Mutational analysis of the HLA-DQ3.2 insulin-dependent diabetes mellitus susceptibility gene. Proc. Natl. Acad. Sci. U.S.A. 86: 1027-1030 (1989). *

• Kwon OJ, Brautbar C, Weintrob N, Sprecher E, Saphirman C, Bloch K, Pinhas-Hamiel O, Assah S, Vardi P, Israel S. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients. Hum. Immunol. 62: 85-91 (2001).

• Kwon OJ, Karni A, Israel S, Brautbar C, Amar A, Meiner Z, Abramsky O, Karussis D. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch. Neurol. 56: 555-560 (1999). *

• La Nasa G, Carcassi C, Cirillo R, Mulargia M, Leone AL, Vacca A, Pizzati A, Boero R, Arras M, Porcella R, et al. Serological and molecular studies of HLA in insulin-dependent diabetes mellitus in Sardinia. Dis. Markers 8: 333-340 (1990).

• Laadhar L, Toumi A, Kallel-Sellami M, Zitouni M, Bouraoui S, Maherzi A, Makni S, Ben Hariz M. HLA class II polymorphism in children with coeliac disease in Tunisia: is there any influence on clinical manifestation? Eur. J. Gastroenterol. Hepatol. 21: 1286-1290 (2009).

• Laaksonen M, Pastinen T, Sjoroos M, Kuokkanen S, Ruutiainen J, Sumelahti ML, Reijonen H, Salonen R, Wikstrom J, Panelius M, Partanen J, Tienari PJ, Ilonen J. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study. J. Neuroimmunol. 122: 140-145 (2002).

• Laine AP, Nejentsev S, Veijola R, Korpinen E, Sjoroos M, Simell O, Knip M, Akerblom HK, Ilonen J. A linkage study of 12 IDDM susceptibility loci in the Finnish population. Diabetes Metab. Res. Rev. 20: 144-149 (2004).

• Laivoranta-Nyman S, Mottonen T, Hermann R, Tuokko J, Luukkainen R, Hakala M, Hannonen P, Korpela M, Yli-Kerttula U, Toivanen A, Ilonen J; FIN-RACo Trial Group. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann. Rheum. Dis. 63: 1406-1412 (2004). *

• Laivoranta-Nyman S, Mottonen T, Luukkainen R, Hakala M, Yli-Kerttula U, Hannonen P, Tuokko J, Toivanen A, Ilonen J. Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis. Ann. Rheum. Dis. 59: 173-177 (2000). *

• Laki J, Kiszel P, Vatay A, Blasko B, Kovacs M, Korner A, Madacsy L, Blatniczky L, Almassy Z, Szalai C, Rajczy K, Pozsonyi E, Karadi I, Fazakas A, Hosszufalusi N, Panczel P, Arason GJ, Wu YL, Zhou B, Yang Y, Yu CY, Fust G. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation end product (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobin(A1C) levels … Mol. Immunol. 44: 648-655 (2007). *

• Laki J, Laki I, Nemeth K, Ujhelyi R, Bede O, Endreffy E, Bolbas K, Gyurkovits K, Csiszer E, Solyom E, Dobra G, Halasz A, Pozsonyi E, Rajczy K, Prohaszka Z, Fekete G, Fust G. The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis. Int. Immunol. 18: 1585-1590 (2006). *

• Lambert AP, Gillespie KM, Thomson G, Cordell HJ, Todd JA, Gale EA, Bingley PJ. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J. Clin. Endocrinol. Metab. 89: 4037-4043 (2004). *

• Lambert NC, Evans PC, Hashizumi TL, Maloney S, Gooley T, Furst DE, Nelson JL. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J. Immunol. 164: 5545-5548 (2000). *

• Lamoureux JL, Buckner JH, David CS, Bradley DS. Mice expressing HLA-DQ6ab8ab transgenes develop polychondritis spontaneously. Arthritis Res. Ther. 8: R134 (2006). *

• Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 3: 940-943 (2002). *

• Lanino E, Sacchi N, Peters C, Giardino S, Rocha V, Dini G; EBMT Paediatric, Acute Leukemia Working Parties; Eurocord. Strategies of the donor search for children with second CR ALL lacking a matched sibling donor. Bone Marrow Transplant. 41 Suppl. 2: S75-S79 (2008).

• Lapaque N, Hutchinson JL, Jones DC, Meresse S, Holden DW, Trowsdale J, Kelly AP. Salmonella regulates polyubiquitination and surface expression of MHC class II antigens. Proc. Natl. Acad. Sci. U.S.A. 106: 14052-14057 (2009). *

• Lara-Marquez ML, Yunis JJ, Layrisse Z, Ortega F, Carvallo-Gil E, Montagnani S, Makhatadze NJ, Pocino M, Granja C, Yunis E. Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population. Clin. Exp. Allergy 29: 60-71 (1999). *

• Larche M. Determining MHC restriction of T-cell responses. Methods Mol. Med. 138: 57-72 (2008). *

• Larsson K, Carlsson A, Cederwall E, Jonsson B, Neiderud J, Jonsson B, Lernmark A, Ivarsson SA; on behalf of the Skane Study Group. Annual screening detects celiac disease in children with type 1 diabetes. Pediatr. Diabetes 9: 354-359 (2008).

• Latiano A, Mora B, Bonamico M, Megiorni F, Mazzilli MC, Cucchiara S, Palmieri O, Valvano MR, Annese V. Analysis of candidate genes on chromosomes 5q and 19p in celiac disease. J. Pediatr. Gastroenterol. Nutr. 45: 180-186 (2007). *

• Lavant EH, Carlson JA. A new automated human leukocyte antigen genotyping strategy to identify DR-DQ risk alleles for celiac disease and type 1 diabetes mellitus. Clin. Chem. Lab. Med. 47: 1489-1495 (2009). *

• Lazaro AM, Xiao Y, Masaberg C, Lebeck L, Ng J, Hurley CK, Posch PE. Novel alleles at the HLA-DRB1 and -DQB1 loci. Tissue Antigens 72: 72-74 (2008). *

• Lebedeva T, Harrison K, Fresia B, Ohashi M, Yu N. DQB1 intron 3 sequences provide an insight into the evolution of DQB1 alleles and form the basis for intron-based sequencing. Tissue Antigens 74: 339-342 (2009). *

• Lecendreux M, Bassetti C, Dauvilliers Y, Mayer G, Neidhart E, Tafti M. HLA and genetic susceptibility to sleepwalking. Mol. Psychiatry 8: 114-117 (2003). *

• Lee G, Shamma FN, Diamond MP, Lee JT. HLA-DQ beta 57 in Hispanic patients with insulin-dependent diabetes mellitus. Am. J. Obstet. Gynecol. 167: 1565-1570 (1992).

• Lee HC, Ikegami H, Fujisawa T, Ogihara T, Park SW, Chung YS, Park JO, Lee EJ, Lim SK, Kim KR, Huh KB, Kim YS, Lee DS, Kim DH. Role of HLA class II alleles in Korean patients with IDDM. Diabetes Res. Clin. Pract. 31: 9-15 (1996).

• Lee HW, Hahm KB, Lee JS, Ju YS, Lee KM, Lee KW. Association of the human leukocyte antigen class II alleles with chronic atrophic gastritis and gastric carcinoma in Koreans. J. Dig. Dis. 10: 265-271 (2009). *

• Lee KW, Oh DH, Lee C, Yang SY. Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 65: 437-447 (2005). *

• Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley CK, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, Weisdorf D, Williams TM, Anasetti C. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110: 4576-4583 (2007). *

• Lee YT, Sung JJ, Poon P, Lai KN, Li PK. Association of HLA class-II genes and anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease. Scand. J. Gastroenterol. 33: 623-627 (1998). *

• Lemire M. On the association between rheumatoid arthritis and classical HLA class I and class II alleles predicted from single-nucleotide polymorphism data. BMC Proc. 3 Suppl. 7: S33 (2009). *

• Leonardi S, Spina M, Spicuzza L, Rotolo N, La Rosa M. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies? Vaccine 27: 6030-6033 (2009).

• Lerner A. New therapeutic strategies for celiac disease. Autoimmun. Rev. May 7 [Epub ahead of print] (2009).

• Leslie S, Donnelly P, McVean G. A statistical method for predicting classical HLA alleles from SNP data. Am. J. Hum. Genet. 82: 48-56 (2008). *

• Leuschner M, Dietrich CF, You T, Seidl C, Raedle J, Herrmann G, Ackermann H, Leuschner U. Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment. Gut 46: 121-126 (2000). *

• Lewis C, Book L, Black J, Sawitzke A, Cannon-Albright L, Zone J, Neuhausen S. Celiac disease and human leukocyte antigen genotype: accuracy of diagnosis in self-diagnosed individuals, dosage effect, and sibling risk. J. Pediatr. Gastroenterol. Nutr. 31: 22-27 (2000). *

• Li H, Dai Y, Huang H, Li L, Leng S, Cheng J, Niu Y, Duan H, Liu Q, Zhang X, Huang X, Xie J, Feng Z, Wang J, He J, Zheng Y. HLA-B*1301 as a biomarker for genetic susceptibility to hypersensitivity dermatitis induced by trichloroethylene among workers in China. Environ. Health Perspect. 115: 1553-1556 (2007). *

• Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM, Tang J. Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum. Genet. 126: 685-696 (2009). *

• Liao HT, Lin KC, Chang YT, Chen CH, Liang TH, Chen WS, Su KY, Tsai CY, Chou CT. Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients. J. Rheumatol. 35: 891-895 (2008). *

• Liao HT, Lin KC, Chen CH, Liang TH, Lin MW, Tsai CY, Tak Yan Yu D, Chou CT. Human leukocyte antigens in undifferentiated spondyloarthritis. Semin. Arthritis Rheum. 37: 198-201 (2007). *

• Liblau R, Gautam AM. HLA, molecular mimicry and multiple sclerosis. Rev. Immunogenet. 2: 95-104 (2000).

• Liblau RS, Caillat-Zucman S, Fischer AM, Bach JF, Boitard C. The prevalence of selective IgA deficiency in type 1 diabetes mellitus. APMIS 100: 709-712 (1992).

• Liden M, Kristjansson G, Valtysdottir S, Hallgren R. Gluten sensitivity in patients with primary Sjogren's syndrome. Scand. J. Gastroenterol. 42: 962-967 (2007). *

• Lie BA, Sollid LM, Ascher H, Ek J, Akselsen HE, Ronningen KS, Thorsby E, Undlien DE. A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens 54: 162-168 (1999). *

• Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, Joner G, Dahl-Jorgensen K, Ronningen KS, Thorsby E, Undlien DE. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am. J. Hum. Genet. 64: 793-800 (1999). *

• Lim YS, Oh HB, Choi SE, Kwon OJ, Heo YS, Lee HC, Suh DJ. Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule. J. Hepatol. 48: 133-139 (2008). *

• Lin J, Zhou ZG, Wang JP, Zhang C, Huang G. From type 1, through LADA, to type 2 diabetes: a continuous spectrum? Ann. N. Y. Acad. Sci. 1150: 99-102 (2008). *

• Lin JH, Liu ZH, Lv FJ, Fu YG, Fan XL, Li SY, Lu JM, Liu XY, Xu AL. Molecular analyses of HLA-DRB1, -DPB1, and -DQB1 in Jing ethnic minority of Southwest China. Hum. Immunol. 64: 830-834 (2003).

• Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, Tiislar M, Ferretti V, Tienari PJ, Sadovnick AD, Peltonen L, Ebers GC, Hudson TJ. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat. Genet. 37: 1108-1112 (2005). *

• Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton SM, Dyment DA, Sadovnick AD, Ebers GC. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc. Natl. Acad. Sci. U.S.A. 106: 7542-7547 (2009). *

• Lindholm E, Bakhtadze E, Cilio C, Agardh E, Groop L, Agardh CD. Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS ONE 3: e2546 (2008). *

• Lindholm E, Bakhtadze E, Sjogren M, Cilio CM, Agardh E, Groop L, Agardh CD. The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia 49: 2745-2755 (2006). *

• Lindqvist AK, Alarcon-Riquelme ME. The genetics of systemic lupus erythematosus. Scand. J. Immunol. 50: 562-571 (1999). *

• Lingappa J, Kuffner T, Tappero J, Whitworth W, Mize A, Kaiser R, McNicholl J. HLA-DQ6 and ingestion of contaminated water: possible gene-environment interaction in an outbreak of Leptospirosis. Genes Immun. 5: 197-202 (2004). *

• Lio D, Bonanno CT, D'Anna C, De Luca S, Gervasi F, Cavataio F, Iacono F, Salerno A. Gluten stimulation induces an in vitro expansion of peripheral blood T gamma delta cells from HLA-DQ2-positive subjects of families of patients with celiac disease. Exp. Clin. Immunogenet. 15: 46-55 (1998).

• Listrom C, Holt K. Inflammatory bowel disease. Emerg. Med. 36: 24-28 (2004).

• Liu C, Cheng B. Association of polymorphisms of human leucocyte antigen-DQA1 and DQB1 alleles with chronic hepatitis B virus infection, liver cirrhosis and hepatocellular carcinoma in Chinese. Int. J. Immunogenet. 34: 373-378 (2007). *

• Liu CP, Bach FH, Wu SK. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes. J. Immunol. 140: 3631-3639 (1988).

• Liu E, Li M, Bao F, Miao D, Rewers MJ, Eisenbarth GS, Hoffenberg EJ. Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children. J. Pediatr. 146: 494-499 (2005). *

• Liu E, Rewers M, Eisenbarth GS. Genetic testing: who should do the testing and what is the role of genetic testing in the setting of celiac disease? Gastroenterology 128: S33-S37 (2005). *

• Liu H, Wang B, Liu D, Cheng Y, Yu W, Liang X, An W. Molecular genetic studies on relationships among longevity, diseases, and HLA-DRB1/DQB1 allelic polymorphism. Exp. Aging Res. 33: 123-125 (2007).

• Liu J, Juo SH, Holopainen P, Terwilliger J, Tong X, Grunn A, Brito M, Green P, Mustalahti K, Maki M, Gilliam TC, Partanen J. Genomewide linkage analysis of celiac disease in Finnish families. Am. J. Hum. Genet. 70: 51-59 (2002). *

• Liu Q, Bu DF, Li D, Zhu XJ. Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus. Br. J. Dermatol. 158: 587-591 (2008). *

• Liu W, Li WM, Sun NL. Relationship between HLA-DQA1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy. Chin. Med. J. (Engl.) 117: 1449-1452 (2004).

• Liu W, Li WM, Sun NL. Association of HLA-DQ with idiopathic dilated cardiomyopathy in a Northern Chinese Han population. Cell. Mol. Immunol. 1: 311-314 (2004). *

• Liu W, Li WM, Sun NL. HLA-DQA1, -DQB1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy in Hans of northern China. Ann. Hum. Genet. 69: 382-388 (2005).

• Lobnig BM, Chantelau E, Vidgren G, Van Landeghem AA, Kinnunen L, Tuomilehto-Wolf E. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases. Diabetes Metab. 28: 217-221 (2002).

• Loewenthal R, Slomov Y, Gonzalez-Escribano MF, Goldberg I, Korostishevsky M, Brenner S, Nunez-Roldan A, Conejo-Mir JS, Gazit E. Common ancestral origin of pemphigus vulgaris in Jews and Spaniards: a study using microsatellite markers. Tissue Antigens 63: 326-334 (2004). *

• Lohmann T, Halder T, Engler J, Morgenthaler NG, Khoo-Morgenthaler UY, Schroder S, Seissler J, Scherbaum WA, Kalbacher H. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes. Exp. Clin. Endocrinol. Diabetes 107: 166-171 (2005).

• Loiseau P, Lepage V, Djelal F, Busson M, Tamouza R, Raffoux C, Menkes CJ, Meyer O, Charron D, Goldberg D. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome. Hum. Immunol. 62: 725-731 (2001).

• Loisel DA, Rockman MV, Wray GA, Altmann J, Alberts SC. Ancient polymorphism and functional variation in the primate MHC-DQA1 5' cis-regulatory region. Proc. Natl. Acad. Sci. U.S.A. 103: 16331-16336 (2006). *

• Lombard Z, Brune AE, Hoal EG, Babb C, Van Helden PD, Epplen JT, Bornman L. HLA class II disease associations in Southern Africa. Tissue Antigens 67: 97-110 (2006). *

• Lombard Z, Dalton DL, Venter PA, Williams RC, Bornman L. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum. Immunol. 67: 643-654 (2006).

• Lombardi ML, Pirozzi G, Luongo V, Mercuro O, Pace E, Blanco Del Vecchio G, Cozzolino A, Errico S, Fusco C, Castiglione F. Crohn disease: susceptibility and disease heterogeneity revealed by HLA genotyping. Hum. Immunol. 62: 701-704 (2001).

• Lombardi ML, Terrazzano G, Cosentini E, Gargiulo L, Risitano A, Camerlingo R, Sica M, Aufiero D, Poggi A, Pirozzi G, Luzzatto L, Rotoli B, Notaro R, Alfinito F, Ruggiero G. Paroxysmal nocturnal hemoglobinuria: significant association with specific HLA-A, -B, -C, and -DR alleles in an Italian population. Hum. Immunol. 69: 202-206 (2008).

• Londei M, Ciacci C, Ricciardelli I, Vacca L, Quaratino S, Maiuri L. Gliadin as a stimulator of innate responses in celiac disease. Mol. Immunol. 42: 913-918 (2005). *

• Longstreth WT Jr, Ton TG, Koepsell T, Gersuk VH, Hendrickson A, Velde S. Prevalence of narcolepsy in King County, Washington, USA. Sleep Med. 10: 422-426 (2009).

• Lopez-Escamez JA, Vilchez JR, Soto-Varela A, Santos-Perez S, Perez-Garrigues H, Aran I, Lopez-Nevot MA. HLA-DRB1*1101 allele may be associated with bilateral Meniere's disease in Southern European population. Otol. Neurotol. 28: 891-895 (2007).

• Lopez-Tello A, Rodriguez-Carreon AA, Jurado F, Yamamoto-Furusho JK, Castillo-Vazquez M, Chavez-Munoz C, Salgado N, Arellano-Campos O, Vargas-Alarcon G, Granados J. Association of HLA-DRB1*16 with chronic discoid lupus erythematosus in Mexican mestizo patients. Clin. Exp. Dermatol. 32: 435-438 (2007). *

• Lopez-Vazquez A, Fuentes D, Rodrigo L, Gonzalez S, Moreno M, Fernandez E, Martinez-Borra J, Lopez-Larrea C. MHC class I region plays a role in the development of diverse clinical forms of celiac disease in a Saharawi population. Am. J. Gastroenterol. 99: 662-667 (2004). *

• Lopez-Vazquez A, Rodrigo L, Fuentes D, Riestra S, Bousono C, Garcia-Fernandez S, Martinez-Borra J, Gonzalez S, Lopez-Larrea C. MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201. Gut 50: 336-340 (2002). *

• Lopez-Vazquez A, Rodrigo L, Fuentes D, Riestra S, Bousono C, Garcia-Fernandez S, Martinez-Borra J, Gonzalez S, Lopez-Larrea C. MICA-A5.1 allele is associated with atypical forms of celiac disease in HLA-DQ2-negative patients. Immunogenetics 53: 989-991 (2002). *

• Lorentzen AR, Celius EG, Ekstrom PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. J. Neuroimmunol. 166: 197-201 (2005).

• Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. Ann. Neurol. 65: 658-666 (2009).

• Louka AS, Lie BA, Talseth B, Ascher H, Ek J, Gudjonsdottir AH, Sollid LM. Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics 55: 339-343 (2003). *

• Louka AS, Moodie SJ, Karell K, Bolognesi E, Ascher H, Greco L, Momigliano-Richiardi P, Partanen J, Ciclitira PJ, Sollid LM; European Genetics Cluster on Celiac Disease. A collaborative European search for non-DQA1*05-DQB1*02 celiac disease loci on HLA-DR3 haplotypes: analysis of transmission from homozygous parents. Hum. Immunol. 64: 350-358 (2003).

• Louka AS, Nilsson S, Olsson M, Talseth B, Lie BA, Ek J, Gudjonsdottir AH, Ascher H, Sollid LM. HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 60: 147-154 (2002). *

• Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 61: 105-117 (2003). *

• Lu LY, Ding WZ, Fici D, Deulofeut R, Cheng HH, Cheu CC, Sung PK, Schur PH, Fraser PA. Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum. 40: 1138-1145 (1997).

• Lu MC, Yang KL, Huang KY, Tung CH, Liu SQ, Lai NS. HLA haplotype A33-B58-Cw10 may modulate radiographic development of bamboo spine in Taiwanese patients with primary ankylosing spondylitis. Dis. Markers 26: 93-96 (2009).

• Ludajic K, Balavarca Y, Bickeboller H, Pohlreich D, Kouba M, Dobrovolna M, Vrana M, Rosenmayr A, Fischer GF, Fae I, Kalhs P, Greinix HT. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. Br. J. Haematol. 142: 436-443 (2008). *

• Ludvigsson JF, Eylert M, Ilonen J, Ludvigson J, Vaarala O. Effect of HLA DQ2, dietary exposure and coeliac disease on the development of antibody response to gliadin in children. Scand. J. Gastroenterol. 41: 919-928 (2006). *

• Ludvigsson JF, Ludvigsson J, Ekbom A, Montgomery SM. Celiac disease and risk of subsequent type 1 diabetes: a general population cohort study of children and adolescents. Diabetes Care 29: 2483-2488 (2006). *

• Lulli P, Mangano VD, Onori A, Batini C, Luoni G, Sirima BS, Nebie I, Chessa L, Petrarca V, Modiano D. HLA-DRB1 and -DQB1 loci in three West-African ethnic groups: genetic relationship with Sub-Saharan African populations and Europeans. Hum. Immunol. 70: 903-909 (2009).

• Lundin KE, Rřnningen KS, Aono S, Spurkland A, Gaudernack G, Isshiki G, Thorsby E. HLA-DQ antigens and DQ beta amino acid 57 of Japanese patients with insulin-dependent diabetes mellitus: detection of a DRw8DQw8 haplotype. Tissue Antigens 34: 233-241 (1989).

• Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178: 187-196 (1993). *

• Luopajarvi K, Skarsvik S, Ilonen J, Akerblom HK, Vaarala O. Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetes. Immunology 121: 189-196 (2007). *

• Lynch KF, Lernmark B, Merlo J, Cilio CM, Ivarsson SA, Lernmark A. Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype. J. Perinatol. 28: 211-217 (2008).

• Maalej A, Hadj Kacem H, Bellassoued M, Abid M, Makni H, Ayadi H. Polymorphisms of HLA DQB1 CAR1/CAR2 and TNFalpha IR2/IR4 microsatellite markers in patients affected with Graves disease. Clin. Immunol. 96: 91-93 (2000). *

• Macchini F, Selicorni A, Luzzani S, Milani D, Roggero P, Valade A. Coeliac disease and Cornelia de Lange syndrome: lack of association. Acta Paediatr. 96: 1518-1520 (2007). *

• MacDonald MJ, Famuyiwa OO, Nwabuebo IA, Bella AF, Junaid TA, Marrari M, Duquesnoy RJ. HLA-DR associations in black type I diabetics in Nigeria. Further support for models of inheritance. Diabetes 35: 583-589 (1986).

• MacFarlane AJ, Burghardt KM, Kelly J, Simell T, Simell O, Altosaar I, Scott FW. A type 1 diabetes-related protein from wheat (Triticum aestivum). cDNA clone of a wheat storage globulin, Glb1, linked to islet damage. J. Biol. Chem. 278: 54-63 (2003). *

• MacHulla HK, Schonermarck U, Schaaf A, Muller LP, Kloss C, Kruger J, Kunze G, Schonermarck G, Langner J. HLA-A, B, Cw and DRB1, DRB3/4/5, DQB1, DPB1 frequencies in German immunoglobulin A-deficient individuals. Scand. J. Immunol. 52: 207-211 (2000). *

• Mack R, Chowdary D, Samaan P, Podolak I, Dermody J. Prevalence of CTLA-4 polymorphism A49G in Ashkenazi Jews. Genet. Test. 5: 269-271 (2001).

• Madrigal A, Shaw BE. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation. Blood Cells Mol. Dis. 40: 40-43 (2008).

• Maggiore G, Sciveres M. Autoimmune hepatitis: a childhood disease. Current Pediatric Reviews 1: 73-90 (2005). *

• Magnusson PK, Enroth H, Eriksson I, Held M, Nyren O, Engstrand L, Hansson LE, Gyllensten UB. Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res. 61: 2684-2689 (2001). *

• Mahdi N, Al-Ola K, Al-Subaie AM, Ali ME, Al-Irhayim Z, Al-Irhayim AQ, Almawi WY. Distinct HLA class II associations with vaso-occlusion in children with sickle cell disease. Clin. Vaccine Immunol. 15: 729-731 (2008). *

• Mahran MZ, Ross DG, Sadeghi-Nejad A, Rabson AR. Use of the polymerase chain reaction mismatch technique to identify the HLA-DQw8 allele in patients with insulin-dependent diabetes mellitus. Am. J. Clin. Pathol. 97: 29-33 (1992).

• Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum. Immunol. 68: 779-788 (2007).

• Majumder P, Gomez JA, Boss JM. The human major histocompatibility complex class II HLA-DRB1 and HLA-DQA1 genes are separated by a CTCF binding enhancer-blocking element. J. Biol. Chem. 281: 18435-18443 (2006). *

• Makhatadze NJ, Franco MT, Layrisse Z. HLA class I and class II allele and haplotype distribution in the Venezuelan population. Hum. Immunol. 55: 53-58 (1997).

• Maki M. The humoral immune system in coeliac disease. Baillieres Clin. Gastroenterol. 9: 231-249 (1995).

• Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, Hopfl P, Knip M. Prevalence of celiac disease among children in Finland. N. Engl. J. Med. 348: 2517-2524 (2003). *

• Makino S, Hamada S, Iwata M, Fujiwara M. A case of abrupt onset autoimmune type 1 diabetes mimicking fulminant type 1 diabetes. Endocr. J. 56: 1113-1117 (2009).

• Maksymowych WP, Gabriel CA, Luyrink L, Melin-Aldana H, Elma M, Giannini EH, Lovell DJ, Van Kerckhove C, Leiden J, Choi E, et al. Polymorphism in a T-cell receptor variable gene is associated with susceptibility to a juvenile rheumatoid arthritis subset. Immunogenetics 35: 257-262 (1992).

• Malamut G, Cellier C. Celiac disease. Rev. Prat. 58: 1199-1205 (2008).

• Malamut G, Meresse B, Cellier C, Cerf-Bensussan N. Celiac disease in 2009: a future without gluten-free diet? Gastroenterol. Clin. Biol. 33: 635-647 (2009).

• Malanga D, Barba P, Harris PE, Maffei A, Del Pozzo G. The active translation of MHCII mRNA during dendritic cells maturation supplies new molecules to the cell surface pool. Cell. Immunol. 246: 75-80 (2007). *

• Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen FT. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359: 727-732 (2002). *

• Mamyrova G, O'hanlon TP, Monroe JB, Carrick DM, Malley JD, Adams S, Reed AM, Shamim EA, James-Newton L, Miller FW, Rider LG. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. Arthritis Rheum. 54: 3979-3987 (2006). *

• Mangalam A, Luckey D, Basal E, Behrens M, Rodriguez M, David C. HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma. J. Immunol. 180: 7747-7756 (2008). *

• Mangalam A, Luckey D, Basal E, Jackson M, Smart M, Rodriguez M, David C. HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice. J. Immunol. 182: 5131-5139 (2009).

• Mangalam A, Rodriguez M, David C. Role of MHC class II expressing CD4(+) T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice. Eur. J. Immunol. 36: 3356-3370 (2006). *

• Mangalam AK, Khare M, Krco C, Rodriguez M, David C. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice. Eur. J. Immunol. 34: 280-290 (2004). *

• Mangalam AK, Rajagopalan G, Taneja V, David CS. HLA class II transgenic mice mimic human inflammatory diseases. Adv. Immunol. 97C: 65-147 (2008).

• Mannion A, Stevens FM, McCarthy CF, Grimes-O'Cearbhaill H, Killeen AA. Extended major histocompatibility complex haplotypes in celiac patients in the west of Ireland. Am. J. Med. Genet. 45: 373-377 (1993).

• Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, Moutsopoulos HM. Sjogren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren's syndrome. Arthritis Rheum. 50: 882-891 (2004). *

• Mantovani V, Corazza GR, Angelini G, Delfino L, Frisoni M, Mirri P, Valentini RA, Barboni P, Gasbarrini G, Ferrara GB. Molecular analysis of HLA-DQ A alleles in coeliac disease lack of a unique disease-associated sequence. Clin. Exp. Immunol. 83: 74-78 (1991). *

• Mantovani V, Corazza GR, Bragliani M, Frisoni M, Zaniboni MG, Gasbarrini G. Asp57-negative HLA DQ beta chain and DQA1*0501 allele are essential for the onset of DQw2-positive and DQw2-negative coeliac disease. Clin. Exp. Immunol. 91: 153-156 (1993). *

• Mantovani V, Corazza GR, Frisoni M, Zaniboni MG, Bragliani M, Valentini RA, Barboni P, Lambertini A, Gasbarrini G. HLA-DP polymorphism in northern Italian celiac patients. Tissue Antigens 40: 182-186 (1992).

• Margaritte-Jeannin P, Babron MC, Bourgey M, Louka AS, Clot F, Percopo S, Coto I, Hugot JP, Ascher H, Sollid LM, Greco L, Clerget-Darpoux F. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens 63: 562-567 (2004). *

• Mariani SM. Genes and autoimmune diseases - a complex inheritance. MedGenMed. 6: 18 (2004). *

• Marietta E, Black K, Camilleri M, Krause P, Rogers RS 3rd, David C, Pittelkow MR, Murray JA. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J. Clin. Invest. 114: 1090-1097 (2004). *

• Marinovic B, Lipozencic J. Reminiscence on the Post IID 2008 Satellite International Meeting on Autoimmune Bullous Diseases Otsu Prince Hotel, Japan, May 17-19, 2008. Acta Dermatovenerol. Croat. 16: 170-171 (2008).

• Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum. Mol. Genet. 7: 1235-1237 (1998). *

• Marrosu MG, Murru R, Costa G, Melis MC, Rolesu M, Schirru L, Solla E, Cuccu S, Secci MA, Whalen MB, Cocco E, Pugliatti M, Sotgiu S, Rosati G, Cucca F. Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population. BMC Genet. 8: 25 (2007). *

• Marrosu MG, Murru R, Murru MR, Costa G, Zavattari P, Whalen M, Cocco E, Mancosu C, Schirru L, Solla E, Fadda E, Melis C, Porru I, Rolesu M, Cucca F. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum. Mol. Genet. 10: 2907-2916 (2001). *

• Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2002. Tissue Antigens 60: 407-464 (2002). *

• Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2002. Hum. Immunol. 63: 1213-1268 (2002).

• Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2000. Hum. Immunol. 62: 419-468 (2001).

• Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2000. Tissue Antigens 57: 236-283 (2001). *

• Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, MacH B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2000. Eur. J. Immunogenet. 28: 377-424 (2001).

• Martin TM, Zhang G, Luo J, Jin L, Doyle TM, Rajska BM, Coffman JE, Smith JR, Becker MD, Mackensen F, Khan MA, Levinson RD, Schumacher HR, Wade NK, Rosenbaum JT, Reveille JD. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum. 52: 269-274 (2005). *

• Martinetti M, Biagi F, Badulli C, Feurle GE, Muller C, Moos V, Schneider T, Marth T, Marchese A, Trotta L, Sachetto S, Pasi A, De Silvestri A, Salvaneschi L, Corazza GR. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease. Gastroenterology 136: 2289-2294 (2009). *

• Martinez A, Salido M, Bonilla G, Pascual-Salcedo D, Fernandez-Arquero M, De Miguel S, Balsa A, De La Concha EG, Fernandez-Gutierrez B. Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients. Arthritis Rheum. 50: 1077-1082 (2004). *

• Martinez-Laso J, Gazit E, Gomez-Casado E, Morales P, Martinez-Quiles N, Alvarez M, Martin-Villa JM, Fernandez V, Arnaiz-Villena A. HLA DR and DQ polymorphism in Ashkenazi and non-Ashkenazi Jews: comparison with other Mediterraneans. Tissue Antigens 47: 63-71 (1996).

• Martinka E, Shawkatova I, Strakova J, Buc M, Mokan M. Latent autoimmune (type I) diabetes mellitus in adults. Part. II. Association of HLA antigens, status of cellular immunity and occurrence of other autoimmune diseases. Vnitr. Lek. 45: 103-109 (1999).

• Martins EB, Chapman RW. Sclerosing cholangitis. Curr. Opin. Gastroenterol. 16: 444-449 (2000).

• Marttila J, Huttunen S, Vaarala O, Suzuki K, Elliott JF, Narvanen A, Knip M, Simell O, Ilonen J. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies. J. Autoimmun. 31: 142-148 (2008).

• Maruya E, Saji H, Yokoyama S. PCR-LIS-SSCP (low ionic strength single-stranded conformation polymorphism) - a simple method for high-resolution allele typing of HLA-DRB1, -DQB1, and -DPB1. Genome Res. 6: 51-57 (1996). *

• Maruyama T. Analysis of HLA-DR, -DQA1, -DQB1 genes in Japanese IDDM patients. Nippon Rinsho 52: 2751-2757 (1994).

• Maruyama T, Oak S, Hall TR, Banga JP, Ortqvist E, Ettinger RA, Endl J, Hampe CS. Autoantibody epitopes to the smaller isoform of glutamate decarboxylase do not differ in Swedish and Japanese type 1 diabetes patients and may be associated with high-risk human leucocyte antigen class II alleles. Clin. Exp. Immunol. 150: 416-421 (2007). *

• Matake H, Naito S, Ogawara S, Iida M, Matsui T, Okabe N, Yamamoto T, Fujita K, Okada M, Yao T. HLA study in 108 Japanese patients with Crohn's disease. Nippon Shokakibyo Gakkai Zasshi 86: 1448-1454 (1989).

• Matoba K, Tojo K, Nemoto M, Tajima N. Familial Graves' disease associated with type 1 diabetes. Intern. Med. 48: 701-704 (2009). *

• Matri S, Boubaker J, Hamzaoui S, Bardi R, Ayed K, Filali A. The role of major histocompatibility complex genes in the pathogenesis of chronic inflammatory bowel diseases. Tunis. Med. 81: 289-294 (2003).

• Matsuzaka Y, Makino S, Nakajima K, Tomizawa M, Oka A, Kimura M, Bahram S, Tamiya G, Inoko H. New polymorphic microsatellite markers in the human MHC class II region. Tissue Antigens 56: 492-500 (2000). *

• Matusiewicz K, Iwanczak B, Matusiewicz M, Iwanczak F. Diagnostic validity of anti-tissue transglutaminase and anti-endomysium antibodies in children with celiac disease. Pol. Merkuriusz. Lek. 20: 17-21 (2006).

• Maurino E, Niveloni S, Chernavsky AC, Sugai E, Vazquez H, Pedreira S, Periolo N, Mazure R, Smecuol E, Moreno ML, Litwin N, Nachman F, Kogan Z, Bai JC. Clinical characteristics and long-term outcome of patients with refractory sprue diagnosed at a single institution. Acta Gastroenterol. Latinoam. 36: 10-22 (2006).

• Mayer A, Fabien N, Gutowski MC, Dubois V, Gebuhrer L, Bienvenu J, Orgiazzi J, Madec AM. Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adults. Eur. J. Endocrinol. 157: 53-61 (2007).

• Mazzarella G, Maglio M, Paparo F, Nardone G, Stefanile R, Greco L, van de Wal Y, Kooy Y, Koning F, Auricchio S, Troncone R. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 52: 57-62 (2003). *

• Mbanya JC, Sobngwi E, Mbanya DN. HLA-DRB1, -DQA1, -DQB1 and DPB1 susceptibility alleles in Cameroonian type 1 diabetes patients and controls. Eur. J. Immunogenet. 28: 459-462 (2001). *

• McDaniel DO, Barger BO, Acton RT, Koopman WJ, Alarcon GS. Molecular analysis of HLA-D region genes in seropositive rheumatoid arthritis. Tissue Antigens 34: 299-308 (1989).

• McDermott AB, Cohen SB, Zuckerman JN, Madrigal JA. Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine. Vaccine 17: 330-339 (1999).

• McDermott AB, Zuckerman JN, Sabin CA, Marsh SG, Madrigal JA. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 50: 8-14 (1997).

• McDonagh AJ, Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin. Exp. Dermatol. 27: 405-409 (2002). *

• McGinnis R, McLaren W, Ranganath V, Whittaker P, Hunt S, Deloukas P; Diabetes Genetics Consortium. Haplotype-based search for SNPs associated with differential type 1 diabetes risk among chromosomes carrying a specific HLA DRB1-DQA1-DQB1 haplotype. Diabetes Obes. Metab. 11 Suppl. 1: 8-16 (2009). *

• McGough N, Cummings JH. Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye. Proc. Nutr. Soc. 64: 434-450 (2005). *

• McGuigan C, Dunne C, Crowley J, Hagan R, Rooney G, Lawlor E, Hutchinson M. Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland. J. Neurol. 252: 1245-1248 (2005).

• McHugh NJ, Owen P, Cox B, Dunphy J, Welsh K. MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus. Ann. Rheum. Dis. 65: 488-494 (2006). *

• McHugh NJ, Whyte J, Artlett C, Briggs DC, Stephens CO, Olsen NJ, Gusseva NG, Maddison PJ, Black CM, Welsh K. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study. Clin. Exp. Immunol. 96: 267-274 (1994). *

• McKinnon E, Morahan G, Nolan D, James I; Diabetes Genetics Consortium. Association of MHC SNP genotype with susceptibility to type 1 diabetes: a modified survival approach. Diabetes Obes. Metab. 11 Suppl. 1: 92-100 (2009). *

• McManus DP, Ross AG, Williams GM, Sleigh AC, Wiest P, Erlich H, Trachtenberg E, Guanling W, McGarvey ST, Li YS, Waine GJ. HLA class II antigens positively and negatively associated with hepatosplenic schistosomiasis in a Chinese population. Int. J. Parasitol. 31: 674-680 (2001). *

• McManus R, Moloney M, Borton M, Finch A, Chuan YT, Lawlor E, Weir DG, Kelleher D. Association of celiac disease with microsatellite polymorphisms close to the tumor necrosis factor genes. Hum. Immunol. 45: 24-31 (1996).

• McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur. J. Immunol. 26: 2113-2118 (1996).

• McNearney TA, Hunnicutt SE, Fischbach M, Friedman AW, Aguilar M, Ahn CW, Reveille JD, Lisse JR, Baethge BA, Goel N, Mayes MD. Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine. J. Rheumatol. 36: 2724-2732 (2009).

• McTernan CL, Stewart LC, Mijovic CH, Barnett AH. Assessment of the non-HLA-DR-DQ contribution to IDDM1 in British Caucasian families: analysis of LMP7 polymorphisms. Diabet. Med. 17: 661-666 (2000). *

• Mearin ML, Ivarsson A, Dickey W. Coeliac disease: is it time for mass screening? Best Pract. Res. Clin. Gastroenterol. 19: 441-452 (2005).

• Megiorni F, Mora B, Bonamico M, Barbato M, Montuori M, Viola F, Trabace S, Mazzilli MC. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am. J. Gastroenterol. 103: 997-1003 (2008). *

• Megiorni F, Mora B, Bonamico M, Barbato M, Nenna R, Maiella G, Lulli P, Mazzilli MC. HLA-DQ and risk gradient for celiac disease. Hum. Immunol. 70: 55-59 (2009).

• Megiorni F, Mora B, Bonamico M, Nenna R, Di Pierro M, Catassi C, Drago S, Mazzilli MC. A rapid and sensitive method to detect specific human lymphocyte antigen (HLA) class II alleles associated with celiac disease. Clin. Chem. Lab. Med. 46: 193-196 (2008). *

• Melo FM, Cavalcanti MS, Santos SB, Lopes AK, Oliveira FA. Association between serum markers for celiac and thyroid autoimmune diseases. Arq. Bras. Endocrinol. Metabol. 49: 542-547 (2005).

• Melo N, Morais A, Alves H, Lima B, Tafulo S, Goncalves R. HLA - A, -C, -B, -DRB1 e -DQB polymorphisms in extrinsic allergic alveolitis (EAA). Rev. Port. Pneumol. 11: S29 (2005).

• Menardo G, Brizzolara R, Bonassi S, Marchetti A, Dante GL, Pistone C, Marenco D, Rabellino V, Buscaglia S, Scarso R, Murialdo M, Venturino E, Marino CE, Descalzi D, Minetti F, Bagnasco M, Pesce G. Population screening for coeliac disease in a low prevalence area in Italy. Scand. J. Gastroenterol. 41: 1414-1420 (2006). *

• Mendez-Sanchez N, King-Martínez AC, Ramos MH, Pichardo-Bahena R, Uribe M. The Amerindian's genes in the Mexican population are associated with development of gallstone disease. Am. J. Gastroenterol. 99: 2166-2170 (2004). *

• Meresse B, Ripoche J, Heyman M, Cerf-Bensussan N. Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol. 2: 8-23 (2009). *

• Merryman P, Silver J, Gregersen PK, Solomon G, Winchester R. A novel association of DQ alpha and DQ beta genes in the DRw10 haplotype. Determination of a DQw1 specificity by the DQ beta-chain. J. Immunol. 143: 2068-2073 (1989).

• Michalski JP, McCombs CC. Celiac disease: clinical features and pathogenesis. Am. J. Med. Sci. 307: 204-211 (1994).

• Michalski JP, McCombs CC, Arai T, Elston RC, Cao T, McCarthy CF, Stevens FM. HLA-DR, DQ genotypes of celiac disease patients and healthy subjects from the West of Ireland. Tissue Antigens 47: 127-133 (1996).

• Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20: 1012-1020 (1997).

• Mignot E, Kimura A, Abbal M, Thorsby E, Lin X, Voros A, Macaubas C, Bouissou F, Sollid LM, Cambon-Thomsen A, et al. DQCAR microsatellite polymorphisms in three selected HLA class II-associated diseases. Tissue Antigens 46: 299-304 (1995).

• Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, Okun M, Hohjoh H, Miki T, Hsu S, Leffell M, Grumet F, Fernandez-Vina M, Honda M, Risch N. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am. J. Hum. Genet. 68: 686-699 (2001). *

• Milicic A, Lee D, Brown MA, Darke C, Wordsworth BP. HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians. J. Rheumatol. 29: 1821-1826 (2002). *

• Miller EN, Jamieson SE, Joberty C, Fakiola M, Hudson D, Peacock CS, Cordell HJ, Shaw MA, Lins-Lainson Z, Shaw JJ, Ramos F, Silveira F, Blackwell JM. Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians. Genes Immun. 5: 63-67 (2004). *

• Mimbacas A, García L, Zorrilla P, Acosta M, Airaudo C, Ferrero R, Pena A, Simonelli B, Soto E, Vitarella G, Fernandez J, Javiel G. Genotype and phenotype correlations in diabetic patients in Uruguay. Genet. Mol. Res. 8: 1352-1358 (2009).

• Mimbacas A, Perez-Bravo F, Santos JL, Pisciottano C, Grignola R, Javiel G, Jorge AM, Cardoso H. The association between HLA DQ genetic polymorphism and type 1 diabetes in a case-parent study conducted in an admixed population. Eur. J. Epidemiol. 19: 931-934 (2004).

• Min HY, Niu NF, Liu Y, Zhang MF, Zhu XL, Zhao JL. Single nucleotide polymorphisms of promoter of human leukocyte antigen-DQB1 alleles in Chinese Han patients with Vogt-Koyanagi-Harada syndrome. Zhonghua Yan Ke Za Zhi 44: 870-875 (2008).

• Mirel DB, Barcellos LF, Wang J, Hauser SL, Oksenberg JR, Erlich HA. Analysis of IL4R haplotypes in predisposition to multiple sclerosis. Genes Immun. 5: 138-141 (2004). *

• Mitea C, Kooy-Winkelaar Y, van Veelen P, de Ru A, Drijfhout JW, Koning F, Dekking L. Fine specificity of monoclonal antibodies against celiac disease-inducing peptides in the gluteome. Am. J. Clin. Nutr. 88: 1057-1066 (2008). *

• Miyagawa S, Amagai M, Niizeki H, Yamashina Y, Kaneshige T, Nishikawa T, Shirai T, Inoko H. HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus. Tissue Antigens 54: 333-340 (1999).

• Miyagawa S, Shinohara K, Kidoguchi K, Fujita T, Fukumoto T, Hashimoto K, Yoshioka A, Shirai T. Neonatal lupus erythematosus: studies on HLA class II genes and autoantibody profiles in Japanese mothers. Autoimmunity 26: 95-101 (1997).

• Miyagawa S, Shinohara K, Nakajima M, Kidoguchi K, Fujita T, Fukumoto T, Yoshioka A, Dohi K, Shirai T. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. Arthritis Rheum. 41: 927-934 (1998). *

• Miyagawa T, Honda M, Kawashima M, Shimada M, Tanaka S, Honda Y, Tokunaga K. Polymorphism located in TCRA locus confers susceptibility to essential hypersomnia with HLA-DRB1*1501-DQB1*0602 haplotype. J. Hum. Genet. Nov 20 [Epub ahead of print] (2009).

• Miyagawa T, Kawashima M, Nishida N, Ohashi J, Kimura R, Fujimoto A, Shimada M, Morishita S, Shigeta T, Lin L, Hong SC, Faraco J, Shin YK, Jeong JH, Okazaki Y, Tsuji S, Honda M, Honda Y, Mignot E, Tokunaga K. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat. Genet. 40: 1324-1328 (2008). *

• Mizuki N, Inoko H, Mizuki N, Tanaka H, Kera J, Tsuiji K, Ohno S. Human leukocyte antigen serologic and DNA typing of Behcet's disease and its primary association with B51. Invest. Ophthalmol. Vis. Sci. 33: 3332-3340 (1992). *

• Mizuki N, Ohno S, Tanaka H, Sugimura K, Seki T, Mizuki N, Kera J, Inaba G, Tsuji K, Inoko H. Association of HLA-B51 and lack of association of class II alleles with Behcet's disease. Tissue Antigens 40: 22-30 (1992).

• Mohammadi J, Pourpak Z, Jarefors S, Saghafi S, Zendehdel K, Pourfathollah AA, Amirzargar AA, Aghamohammadi A, Moin M, Hammarstrom L. Human leukocyte antigens (HLA) associated with selective IgA deficiency in Iran and Sweden. Iran J. Allergy Asthma Immunol. 7: 209-214 (2008).

• Mohammadi J, Ramanujam R, Jarefors S, Rezaei N, Aghamohammadi A, Gregersen PK, Hammarstrom L. IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J. Clin. Immunol. Oct 16 [Epub ahead of print] (2009). *

• Mojibian M, Chakir H, Lefebvre DE, Crookshank JA, Sonier B, Keely E, Scott FW. A diabetes-specific HLA-DR restricted pro-inflammatory T cell response to wheat polypeptides in tissue transglutaminase antibody negative patients with type 1 diabetes. Diabetes 58: 1789-1796 (2009).

• Molberg O, Kett K, Scott H, Thorsby E, Sollid LM, Lundin KE. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand. J. Immunol. 46: 103-109 (1997).

• Molberg O, Lundin KE, Nilsen EM, Scott H, Kett K, Brandtzaeg P, Thorsby E, Sollid LM. HLA restriction patterns of gliadin- and astrovirus-specific CD4+ T cells isolated in parallel from the small intestine of celiac disease patients. Tissue Antigens 52: 407-415 (1998).

• Molberg O, McAdam S, Lundin KE, Kristiansen C, Arentz-Hansen H, Kett K, Sollid LM. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur. J. Immunol. 31: 1317-1323 (2001).

• Molberg O, Mcadam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KE, Sjostrom H, Sollid LM. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4: 713-717 (1998).

• Molberg O, Solheim Flaete N, Jensen T, Lundin KE, Arentz-Hansen H, Anderson OD, Kjersti Uhlen A, Sollid LM. Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology 125: 337-344 (2003). *

• Molberg O, Uhlen AK, Jensen T, Flaete NS, Fleckenstein B, Arentz-Hansen H, Raki M, Lundin KE, Sollid LM. Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease. Gastroenterology 128: 393-401 (2005). *

• Molenaar ET, Voskuyl AE, van der Horst-Bruinsma IE, Schreuder GM, Zanelli E, Dijkmans BA. Influence of HLA polymorphism on persistent remission in rheumatoid arthritis. Ann. Rheum. Dis. 61: 351-353 (2002). *

• Moloney MM, Thomson LJ, Strettell MJ, Williams R, Donaldson PT. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology 28: 660-662 (1998). *

• Momburg F, Koretz K, Von Herbay A, Moller P. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain - an immunohistological study on normal and chronically inflamed small intestine. Clin. Exp. Immunol. 72: 367-372 (1988). *

• Monos DS, Spielman RS, Gogolin KJ, Radka SF, Baker L, Zmijewski CM, Kamoun M. HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation. Immunogenetics 26: 299-303 (1987).

• Monsuur AJ, de Bakker PI, Zhernakova A, Pinto D, Verduijn W, Romanos J, Auricchio R, Lopez A, van Heel DA, Crusius JB, Wijmenga C. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS ONE 3: e2270 (2008). *

• Monsuur AJ, Wijmenga C. Understanding the molecular basis of celiac disease: what genetic studies reveal. Ann. Med. 38: 578-591 (2006).

• Montano-Loza AJ, Sultan A, Falanga D, Loss G, Mason AL. Immunogenetic susceptibility to diabetes mellitus in patients with liver disease. Liver Int. 29: 1543-1551 (2009). *

• Moodie S, Ciclitira P. Recent developments in celiac disease. Curr. Opin. Gastroenterol. 18: 182-186 (2002).

• Morais A, Alves H, Lima B, Delgado L, Goncalves R, Tafulo S. HLA class I and II and TNF-alpha gene polymorphisms in sarcoidosis patients. Rev. Port. Pneumol. 14: 727-746 (2008).

• Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee JH, El-Awar N, Alberu J. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 86: 1111-1115 (2008).

• Moreau C, Drui D, Arnault-Ouary G, Charbonnel B, Chaillous L, Cariou B. Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab. 34: 529-532 (2008).

• Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc. Natl. Acad. Sci. U.S.A. 85: 8111-8115 (1988). *

• Morgan ME, Witteveen HJ, Sutmuller RP, de Vries RR, Toes RE. CD25(+) regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis. Hum. Immunol. 65: 1319-1327 (2004).

• Morling N, Andersen V, Fugger L, Georgsen J, Halberg P, Oxholm P, Odum N, Svejgaard A. Immunogenetics of rheumatoid arthritis and primary Sjogren's syndrome: DNA polymorphism of HLA class II genes. Dis. Markers 9: 289-296 (1991).

• Morling N, Dalhoff K, Fugger L, Georgsen J, Jakobsen B, Ranek L, Odum N, Svejgaard A. DNA polymorphism of HLA class II genes in primary biliary cirrhosis. Immunogenetics 35: 112-116 (1992).

• Morling N, Frentz G, Fugger L, Georgsen J, Jakobsen B, Odum N, Svejgaard A. DNA polymorphism of HLA class II genes in alopecia areata. Dis. Markers 9: 35-42 (1991).

• Morse JH, Barst RJ, Fotino M, Zhang Y, Flaster E, Fritzler MJ. Primary pulmonary hypertension: immunogenetic response to high-mobility group (HMG) proteins and histone. Clin. Exp. Immunol. 106: 389-395 (1996). *

• Motala AA, Busson M, Al-Harbi EM, Khuzam MA, Al-Omari EM, Arekat MR, Almawi WY. Susceptible and protective human leukocyte antigen class II alleles and haplotypes in Bahraini type 2 (non-insulin-dependent) diabetes mellitus patients. Clin. Diagn. Lab. Immunol. 12: 213-217 (2005).

• Moustakas AK, Papadopoulos GK. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells. Am. J. Med. Genet. 115: 37-47 (2002).

• Moustakas AK, van de Wal Y, Routsias J, Kooy YM, van Veelen P, Drijfhout JW, Koning F, Papadopoulos GK. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Int. Immunol. 12: 1157-1166 (2000). *

• Movahedi M, Moin M, Gharagozlou M, Aghamohammadi A, Dianat S, Moradi B, Nicknam MH, Nikbin B, Amirzargar A. Association of HLA class II alleles with childhood asthma and total IgE levels. Iran J. Allergy Asthma Immunol. 7: 215-220 (2008).

• Mullarkey ME, Stevens AM, McDonnell WM, Loubiere LS, Brackensick JA, Pang JM, Porter AJ, Galloway DA, Nelson JL. Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. Tissue Antigens 65: 199-205 (2005). *

• Munthe-Kaas MC, Carlsen KL, Carlsen KH, Egeland T, Haland G, Devulapalli CS, Akselsen H, Undlien D. HLA DR-DQ haplotypes and the TNFA-308 polymorphism: associations with asthma and allergy. Allergy 62: 991-998 (2007).

• Muratori P, Czaja AJ, Muratori L, Pappas G, Maccariello S, Cassani F, Granito A, Ferrari R, Mantovani V, Lenzi M, Bianchi FB. Genetic distinctions between autoimmune hepatitis in Italy and North America. World J. Gastroenterol. 11: 1862-1866 (2005). *

• Murdock AM, Johnston SD. Diagnostic criteria for coeliac disease: time for change? Eur. J. Gastroenterol. Hepatol. 17: 41-43 (2005).

• Muro Y, Ogawa Y, Sugiura K, Tomita Y. HLA-associated production of anti-DFS70/LEDGF autoantibodies and systemic autoimmune disease. J. Autoimmun. 26: 252-257 (2006).

• Murray JA, Moore SB, Van Dyke CT, Lahr BD, Dierkhising RA, Zinsmeister AR, Melton LJ 3rd, Kroning CM, El-Yousseff M, Czaja AJ. HLA DQ gene dosage and risk and severity of celiac disease. Clin. Gastroenterol. Hepatol. 5: 1406-1412 (2007).

• Mustafa AS, Al-Attiyah R, Hanif SN, Shaban FA. Efficient testing of large pools of Mycobacterium tuberculosis RD1 peptides and identification of major antigens and immunodominant peptides recognized by human Th1 cells. Clin. Vaccine Immunol. 15: 916-924 (2008). *

• Myhre AG, Undlien DE, Lovas K, Uhlving S, Nedrebo BG, Fougner KJ, Trovik T, Sorheim JI, Husebye ES. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. J. Clin. Endocrinol. Metab. 87: 618-623 (2002). *

• Nabozny GH, Baisch JM, Cheng S, Cosgrove D, Griffiths MM, Luthra HS, David CS. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183: 27-37 (1996). *

• Nahon S, Serre NP, Lejeune O, Huchet FX, Lahmek P, Lesgourgues B, Traissac L, Bodiguel V, Adotti F, Tuszynski T, Delas N. Duodenal intraepithelial lymphocytosis during Helicobacter pylori infection is reduced by antibiotic treatment. Histopathology 48: 417-423 (2006).

• Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol. Pharmacol. 63: 732-741 (2003). *

• Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 109: 1462-1467 (1995). *

• Nakanishi K, Komatsu Y, Kogawa N, Matsushita H. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein. Biochem. Biophys. Res. Commun. 329: 356-361 (2005). *

• Nakanishi K, Shima Y. Capture of type 1 diabetes-susceptible HLA DR-DQ haplotypes in Japanese subjects using a tag single nucleotide polymorphism. Diabetes Care Oct 16 [Epub ahead of print] (2009).

• Nakanishi K, Watanabe C. Rate of beta-cell destruction in type 1 diabetes influences the development of diabetic retinopathy: protective effect of residual beta-cell function for more than 10 years. J. Clin. Endocrinol. Metab. 93: 4759-4766 (2008). *

• Nalini R, Gaur LK, Maldonado M, Hampe CS, Rodriguez L, Garza G, Lernmark A, Balasubramanyam A. HLA class II alleles specify phenotypes of ketosis-prone diabetes (KPD). Diabetes Care 31: 1195-1200 (2008). *

• Nanto-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, Hekkala A, Korhonen S, Erkkola R, Sipila JI, Haavisto L, Siltala M, Tuominen J, Hakalax J, Hyoty H, Ilonen J, Veijola R, Simell T, Knip M, Simell O. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 372: 1746-1755 (2008). *

• Natividad JM, Huang X, Slack E, Jury J, Sanz Y, David C, Denou E, Yang P, Murray J, McCoy KD, Verdu EF. Host responses to intestinal microbial antigens in gluten-sensitive mice. PLoS One 4: e6472 (2009). *

• Nejentsev S, Gombos Z, Laine AP, Veijola R, Knip M, Simell O, Vaarala O, Akerblom HK, Ilonen J. Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 49: 2217-2221 (2000). *

• Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, Reynolds P, Hardy M, King E, Masters J, Hulme J, Maier LM, Smyth D, Bailey R, Cooper JD, Ribas G, Campbell RD, Clayton DG, Todd JA; The Wellcome Trust Case Control Consortium. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450: 887-892 (2007). *

• Nejentsev S, Laaksonen M, Tienari PJ, Fernandez O, Cordell H, Ruutiainen J, Wikstrom J, Pastinen T, Kuokkanen S, Hillert J, Ilonen J. Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis. Hum. Immunol. 64: 345-349 (2003).

• Nejentsev S, Laine AP, Simell O, Ilonen J. Intercellular adhesion molecule-1 (ICAM-1) K469E polymorphism: no association with type 1 diabetes among Finns. Tissue Antigens 55: 568-570 (2000). *

• Nejentsev S, Reijonen H, Adojaan B, Kovalchuk L, Sochnevs A, Schwartz EI, Akerblom HK, Ilonen J. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 46: 1888-1892 (1997).

• Nelson JL, Gillespie KM, Lambert NC, Stevens AM, Loubiere LS, Rutledge JC, Leisenring WM, Erickson TD, Yan Z, Mullarkey ME, Boespflug ND, Bingley PJ, Gale EA. Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc. Natl. Acad. Sci. U.S.A. 104: 1637-1642 (2007). *

• Nenna R, Mora B, Megiorni F, Mazzilli MC, Magliocca FM, Tiberti C, Bonamico M. HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease. J. Pediatr. Gastroenterol. Nutr. 47: 288-292 (2008). *

• Nepom BS, Nepom GT, Coleman M, Kwok WW. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. U.S.A. 93: 7202-7206 (1996). *

• Nepom GT. Determinants of genetic susceptibility in HLA-associated autoimmune disease. Clin. Immunol. Immunopathol. 53: S53-S62 (1989).

• Nepom GT, Hansen JA, Nepom BS. The molecular basis for HLA class II associations with rheumatoid arthritis. J. Clin. Immunol. 7: 1-7 (1987).

• Nepom GT, Kwok WW. Molecular basis for HLA-DQ associations with IDDM. Diabetes 47: 1177-1184 (1998). *

• Nepom GT, Seyfried CA, Nepom BS. Immunogenetics of disease susceptibility: new perspectives in HLA. Pathol. Immunopathol. Res. 5: 37-46 (1986).

• Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, Podda M, Zuin M, Colombo M, Floreani A, Rosina F, Bianchi Porro G, Strazzabosco M, Okolicsanyi L. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig. Liver Dis. 35: 571-576 (2003).

• Nevalainen J, Kenward MG, Virtanen SM. Missing values in longitudinal dietary data: a multiple imputation approach based on a fully conditional specification. Stat. Med. 28: 3657-3669 (2009). *

• Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST. No allelic variation in genes with high gliadin homology in patients with celiac disease and type 1 diabetes. Immunogenetics 56: 375-378 (2004). *

• Nielsen C, Husby S, Lillevang ST. Molecular mechanisms behind the immunological reaction against gluten in patients with celiac disease. Ugeskr. Laeger. 165: 917-920 (2003).

• Nieto A, Blanco Quiros A, Arranz E, Alonso Franch M, Garrote JA, Calvo C. Study of HLA-DQA1 alleles in celiac children. J. Investig. Allergol. Clin. Immunol. 5: 209-215 (1995).

• Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37: 766-776 (1995). *

• Nishi H, Koga Y, Koyanagi T, Harada H, Imaizumi T, Toshima H, Sasazuki T, Kimura A. DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy. J. Mol. Cell. Cardiol. 27: 2385-2392 (1995). *

• Nishimaki K, Kawamura T, Inada H, Yagawa K, Nose Y, Nabeya N, Isshiki G, Tatsumi N, Niihira S. HLA DPB1*0201 gene confers disease susceptibility in Japanese with childhood onset type I diabetes, independent of HLA-DR and DQ genotypes. Diabetes Res. Clin. Pract. 47: 49-55 (2000).

• Nishimoto H, Yamada G, Mizuno M, Tsuji T. Immunoelectron microscopic localization of MHC class 1 and 2 antigens on bile duct epithelial cells in patients with primary biliary cirrhosis. Acta Med. Okayama 48: 317-322 (1994).

• Nishimura Y. Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases. Nippon Rinsho 55: 1384-1396 (1997).

• Nishimura Y, Kanai T, Oiso M, Tabata H, Ito H, Kira J, Chen YZ, Matsushita S. Molecular analyses of HLA class II-associated susceptibility to subtypes of autoimmune diseases unique to Asians. Int. J. Cardiol. 66 Suppl. 1: S93-104 (1998).

• Nishio A, Keeffe EB, Gershwin ME. Immunopathogenesis of primary biliary cirrhosis. Semin. Liver Dis. 22: 291-302 (2002). *

• Nistico L, Fagnani C, Coto I, Percopo S, Cotichini R, Limongelli MG, Paparo F, D'Alfonso S, Giordano M, Sferlazzas C, Magazzu G, Momigliano-Richiardi P, Greco L, Stazi MA. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 55: 803-808 (2006). *

• Niveloni S, Dezi R, Pedreira S, Podesta A, Cabanne A, Vazquez H, Sugai E, Smecuol E, Doldan I, Valero J, Kogan Z, Boerr L, Maurino E, Terg R, Bai JC. Gluten sensitivity in patients with primary biliary cirrhosis. Am. J. Gastroenterol. 93: 404-408 (1998). *

• Niveloni S, Pedreira S, Sugai E, Vazquez H, Smecuol E, Fiorini A, Cabanne A, Dezi R, Valero J, Kogan Z, Maurino E, Bai JC. The natural history of gluten sensitivity: report of two new celiac disease patients resulting from a long-term follow-up of nonatrophic, first-degree relatives. Am. J. Gastroenterol. 95: 463-468 (2000). *

• No authors listed. Summaries for patients. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann. Intern. Med. 147: I34 (2007). *

• Nobili V, Marcellini M, Devito R, Comparcola D, Vento S. Co-occurrence of chronic hepatitis B virus infection and autoimmune hepatitis in a young Senegalese girl. Eur. J. Gastroenterol. Hepatol. 18: 927-929 (2006).

• Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A, Lorini R, Pozzilli P, Buzzetti R, Erlich HA. Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Hum. Immunol. 69: 291-300 (2008). *

• Noble JA, Valdes AM, Bugawan TL, Apple RJ, Thomson G, Erlich HA. The HLA class I A locus affects susceptibility to type 1 diabetes. Hum. Immunol. 63: 657-664 (2002).

• Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet. 59: 1134-1148 (1996). *

• Noble JA, Valdes AM, Lane JA, Green AE, Erlich HA. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum. Immunol. 67: 999-1004 (2006).

• Nocera A. Desensitization protocols in immunized living donor kidney transplant recipients. G. Ital. Nefrol. 26: 499-515 (2009).

• Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am. J. Gastroenterol. 98: 2289-2292 (2003). *

• Nolte W, Polzien F, Sattler B, Ramadori G, Hartmann H. Recurrent episodes of acute hepatitis associated with LKM-1 (cytochrome P450 2D6) antibodies in identical twin brothers. J. Hepatol. 23: 734-739 (1995). *

• Nooh MM, El-Gengehi N, Kansal R, David CS, Kotb M. HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J. Immunol. 178: 3076-3083 (2007). *

• Novota P, Cejkova P, Cerna M, Andel M. Genetic risk factors in autoimmune diabetes mellitus, their significance and function. Cas. Lek. Cesk. 143: 159-163 (2004).

• Nowak J, Mika-Witkowska R, Polak M, Zajko M, Rogatko-Koros M, Graczyk-Pol E, Lange A. Allele and extended haplotype polymorphism of HLA-A, -C, -B, -DRB1 and -DQB1 loci in Polish population and genetic affinities to other populations. Tissue Antigens 71: 193-205 (2008). *

• Nunez C, Alecsandru D, Varade J, Polanco I, Maluenda C, Fernandez-Arquero M, G de la Concha E, Urcelay E, Martinez A. Interleukin-10 haplotypes in celiac disease in the Spanish population. BMC Med. Genet. 7: 32 (2006). *

• Nunez C, Marquez A, Varade J, Martinez A, Polanco I, Maluenda C, Fernandez-Arquero M, de la Concha EG, Urcelay E. No evidence of association of the MYO9B polymorphisms with celiac disease in the Spanish population. Tissue Antigens 68: 489-492 (2006). *

• Nunez C, Rueda B, Martinez A, Maluenda C, Polanco I, Lopez-Nevot MA, Ortega E, Sierra E, Gomez de la Concha E, Urcelay E, Martin J. A functional variant in the CD209 promoter is associated with DQ2-negative celiac disease in the Spanish population. World J. Gastroenterol. 12: 4397-4400 (2006). *

• O'Connor G, Neufeld DS, Greenberg DA, Concepcion ES, Roman SH, Davies TF. Lack of disease associated HLA-DQ restriction fragment length polymorphisms in families with autoimmune thyroid disease. Autoimmunity 14: 237-241 (1993).

• O'Donnell BF, O'Neill CM, Francis DM, Niimi N, Barr RM, Barlow RJ, Kobza Black A, Welsh KI, Greaves MW. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br. J. Dermatol. 140: 853-858 (1999). *

• O'Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSween RN, Mills PR. Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 47: 717-720 (2000). *

• O'Hanlon TP, Carrick DM, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Dreyfuss J, Shamim EA, Rider LG, Chanock SJ, Foster CB, Bunch T, Plotz PH, Love LA, Miller FW. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in Caucasians. Medicine (Baltimore) 84: 338-349 (2005).

• O'Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Rider LG, Chanock SJ, Foster CB, Bunch T, Blackshear PJ, Plotz PH, Love LA, Miller FW. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 85: 111-127 (2006).

• O'Hanlon TP, Rider LG, Mamyrova G, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Chanock SJ, Foster CB, Bunch T, Reed AM, Love LA, Miller FW. HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum. 54: 3670-3681 (2006). *

• Obermayer-Straub P, Manns MP. Hepatitis C and D, retroviruses and autoimmune manifestations. J. Autoimmun. 16: 275-285 (2001). *

• Odermarsky M, Lernmark AK, Truedsson L, Liuba P. Cutaneous microvascular dysfunction is associated with HLA-DQ in youths with type 1 diabetes. Pediatr. Res. 63: 420-422 (2008). *

• Odermarsky M, Nilson A, Sjoblad S, Liuba P. Atherogenic vascular and lipid phenotypes in young type 1 diabetics are associated with diabetes high risk HLA. Am. J. Physiol. Heart Circ. Physiol. 293: H3175-H3179 (2007). *

• Okada S, Kamb ML, Pandey JP, Philen RM, Love LA, Miller FW. Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms. Arthritis Rheum. 61: 1305-1311 (2009). *

• Okazaki A, Miyagawa S, Yamashina Y, Kitamura W, Shirai T. Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid. J. Dermatol. 27: 149-156 (2000).

• Oksanen AM, Haimila KE, Rautelin HI, Partanen JA. Immunogenetic characteristics of patients with autoimmune gastritis. World J. Gastroenterol. 16: 354-358 (2010). *

• Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am. J. Hum. Genet. 74: 160-167 (2004). *

• Olerup O, Olsson R, Hultcrantz R, Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 108: 870-878 (1995). *

• Olerup O, Smith CI, Bjorkander J, Hammarstrom L. Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc. Natl. Acad. Sci. U.S.A. 89: 10653-10657 (1992). *

• Olerup O, Smith CI, Hammarstrom L. Different amino acids at position 57 of the HLA-DQ beta chain associated with susceptibility and resistance to IgA deficiency. Nature 347: 289-290 (1990). *

• Olerup O, Wallin J, Carlsson B, Marcusson J, Emtestam L, Bjornelius E, Moller E. Genomic HLA-typing by RFLP-analysis using DR beta and DQ beta cDNA probes reveals normal DR-DQ linkages in patients with psoriasis vulgaris. Tissue Antigens 30: 139-142 (1987).

• Ollikka P, Raussi HM, Laitala V, Jaakkola L, Hovinen J, Hemmila I, Ylikoski A. Genotyping of celiac disease-related-risk haplotypes using a closed-tube polymerase chain reaction analysis of dried blood and saliva disk samples. Anal. Biochem. 386: 20-29 (2009). *

• Olsson PG, Hammarstrom L, Cox DW, Smith CI. Involvement of both HLA and Ig heavy chain haplotypes in human IgA deficiency. Immunogenetics 36: 389-395 (1992).

• Ongagna JC, Sapin R, Pinget M, Belcourt A. Markers for risk of type 1 diabetes in relatives of Alsacian patients with type 1 diabetes. Int. J. Exp. Diabetes Res. 3: 1-9 (2002). *

• Onishi S, Sakamaki T, Maeda T, Iwamura S, Tomita A, Saibara T, Yamamoto Y. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J. Hepatol. 21: 1053-1060 (1994).

• Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 118: 274-278 (2000). *

• Orilieri E, Cappellano G, Clementi R, Cometa A, Ferretti M, Cerutti E, Cadario F, Martinetti M, Larizza D, Calcaterra V, D'Annunzio G, Lorini R, Cerutti F, Bruno G, Chiocchetti A, Dianzani U. Variations of the perforin gene in patients with type 1 diabetes. Diabetes 57: 1078-1083 (2008). *

• Orozco G, Eerligh P, Sanchez E, Zhernakova S, Roep BO, Gonzalez-Gay MA, Lopez-Nevot MA, Callejas JL, Hidalgo C, Pascual-Salcedo D, Balsa A, Gonzalez-Escribano MF, Koeleman BP, Martin J. Analysis of a functional BTNL2 polymorphism in type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. Hum. Immunol. 66: 1235-1241 (2005).

• Osame K, Takahashi Y, Takasawa H, Watanabe S, Kishimoto M, Yasuda K, Kaburagi Y, Nakanishi K, Kajio H, Noda M. Rapid-onset type 1 diabetes associated with cytomegalovirus infection and islet autoantibody synthesis. Intern. Med. 46: 873-877 (2007). *

• Oshima M, Deitiker P, Atassi M. Targeting the antigen-binding site of HLA-restricting alleles in treatment of autoimmune disease. Crit. Rev. Immunol. 27: 271-288 (2007).

• Oshima M, Ohtani M, Deitiker PR, Glenn Smith R, Mosier DR, Zouhair Atassi M. Suppression by mAbs against DQB1 peptides of in vitro proliferation of AChR-specific T cells from myasthenia gravis patients. Autoimmunity 38: 161-169 (2005).

• Ostrowski M, Izdebska M, Grzanka A, Zuryn A, Grzanka D. The involvement of transglutaminase 2 in autoimmunological diseases. Postepy. Hig. Med. Dosw. (Online) 59: 334-339 (2005).

• Oswald-Richter K, Sato H, Hajizadeh R, Shepherd BE, Sidney J, Sette A, Newman LS, Drake WP. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101. J. Clin. Immunol. Jun 18 [Epub ahead of print] (2009). *

• Ota M, Katsuyama Y, Hamano H, Umemura T, Kimura A, Yoshizawa K, Kiyosawa K, Fukushima H, Bahram S, Inoko H, Kawa S. Two critical genes (HLA-DRB1 and ABCF1) in the HLA region are associated with the susceptibility to autoimmune pancreatitis. Immunogenetics 59: 45-52 (2007). *

• Otley CC, Wenstrup RJ, Hall RP. DNA sequence analysis and restriction fragment length polymorphism (RFLP) typing of the HLA-DQw2 alleles associated with dermatitis herpetiformis. J. Invest. Dermatol. 97: 318-322 (1991).

• Ouedraogo DD, Palazzo E, Nlome-Nze M, Somogyi-Demerjian N, Meyer O. Ankylosing spondylitis and systemic sclerosis: a rare combination. Joint Bone Spine. 76: 290-292 (2009). *

• Overeem S, Black JL 3rd, Lammers GJ. Narcolepsy: immunological aspects. Sleep Med. Rev. 12: 95-107 (2008).

• Ovsyannikova IG, Jacobson RM, Vierkant RA, O'Byrne MM, Poland GA. Replication of Rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine 27: 6926-6931 (2009). *

• Ovsyannikova IG, Jacobson RM, Vierkant RA, Shane Pankratz V, Jacobsen SJ, Poland GA. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. Vaccine 22: 1914-1920 (2004). *

• Owerbach D, Gunn S, Ty G, Wible L, Gabbay KH. Oligonucleotide probes for HLA-DQA and DQB genes define susceptibility to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 31: 751-757 (1988).

• Ozgur BC, Gonenc F, Yazicioglu AH. HLA class I and II antigens expression in patients with renal cell carcinoma. Saudi J. Kidney Dis. Transpl. 20: 97-101 (2009).

• Palacio LG, Rivera D, Builes JJ, Jimenez ME, Salgar M, Anaya JM, Jimenez I, Camargo M, Arcos-Burgos M, Sanchez JL. Multiple sclerosis in the tropics: genetic association to STR's loci spanning the HLA and TNF. Mult. Scler. 8: 249-255 (2002). *

• Pallone F, Fais S, Capobianchi MR. HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clin. Exp. Immunol. 74: 75-79 (1988). *

• Pando M, Larriba J, Fernandez GC, Fainboim H, Ciocca M, Ramonet M, Badia I, Daruich J, Findor J, Tanno H, Canero-Velasco C, Fainboim L. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 30: 1374-1380 (1999). *

• Pani MA, Regulla K, Segni M, Krause M, Hofmann S, Hufner M, Herwig J, Pasquino AM, Usadel KH, Badenhoop K. Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus. Eur. J. Endocrinol. 146: 777-781 (2002). *

• Pani MA, Seidl C, Bieda K, Seissler J, Krause M, Seifried E, Usadel KH, Badenhoop K. Preliminary evidence that an endogenous retroviral long-terminal repeat (LTR13) at the HLA-DQB1 gene locus confers susceptibility to Addison's disease. Clin. Endocrinol. (Oxf.) 56: 773-777 (2002). *

• Pani MA, Van Autreve J, Van der Auwera BJ, Gorus FK, Badenhoop K. Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 45: 1340-1343 (2002). *

• Pani MA, Wood JP, Bieda K, Toenjes RR, Usadel KH, Badenhoop K. The variable endogenous retroviral insertion in the human complement C4 gene: a transmission study in type I diabetes mellitus. Hum. Immunol. 63: 481-484 (2002).

• Papadopoulou A, Lynch KF, Shaat N, Nilsson A, Lernmark B, Berntorp K, Ivarsson SA, Agardh CD, Lernmark A; on behalf of the DiPiS Study Group. The type 1 diabetes protective HLA DQB1*0602 allele is less frequent in gestational diabetes mellitus. Diabetologia 52: 1339-1342 (2009). *

• Papassavas EC, Spyropoulou-Vlachou M, Papassavas AC, Schipper RF, Doxiadis IN, Stavropoulos-Giokas C. MHC class I and class II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data. Hum. Immunol. 61: 615-623 (2000).

• Papiha SS, Murty GE, Ad'Hia A, Mains BT, Venning M. Association of Wegener's granulomatosis with HLA antigens and other genetic markers. Ann. Rheum. Dis. 51: 246-248 (1992). *

• Park DH, Kim MH, Oh HB, Kwon OJ, Choi YJ, Lee SS, Lee TY, Seo DW, Lee SK. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 134: 440-446 (2008). *

• Park MH, Oh MD, Song YW, Pai HJ, Takeuchi F, Tokunaga K, Hong GH, Park KS. Association of complement alleles C4AQ0 and C4B5 with rheumatoid arthritis in Koreans. Ann. Rheum. Dis. 55: 776-778 (1996). *

• Park MH, Park YJ, Song EY, Park H, Kim TY, Park DJ, Park KS, Cho BY. Association of HLA-DR and -DQ genes with Graves disease in Koreans. Hum. Immunol. 66: 741-747 (2005).

• Park Y. Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes. Diabetes Res. Clin. Pract. 77 Suppl. 1: S110-S115 (2007).

• Park Y. Why is type 1 diabetes uncommon in Asia? Ann. N. Y. Acad. Sci. 1079: 31-40 (2006). *

• Park Y. Prediction of the risk of type 1 diabetes from polymorphisms in candidate genes. Diabetes Res. Clin. Pract. 66: S19-S25 (2004).

• Park Y, Choi H, Park H, Park S, Yoo EK, Kim D, Sanjeevi CB. Predominance of the group A killer Ig-like receptor haplotypes in Korean patients With T1D. Ann. N. Y. Acad. Sci. 1079: 240-350 (2006). *

• Park Y, Eisenbarth GS. Genetic susceptibility factors of type 1 diabetes in Asians. Diabetes Metab. Res. Rev. 17: 2-11 (2001).

• Park Y, Lee H, Sanjeevi CB, Eisenbarth GS. MICA polymorphism is associated with type 1 diabetes in the Korean population. Diabetes Care 24: 33-38 (2001). *

• Park Y, Tait BD, Kawasaki E, Rowley M, Mackay IR. Closer association of IA-2 humoral autoreactivity with HLA DR3/4 than DQB1*0201/*0302 in Korean T1D patients. Ann. N. Y. Acad. Sci. 1037: 104-109 (2004). *

• Park YS, Kim TW, Kim WB, Cho BY. Increased prevalence of autoimmune thyroid disease in patients with type 1 diabetes. Korean J. Intern. Med. 15: 202-210 (2000).

• Park YS, Sanjeevi CB, Robles D, Yu L, Rewers M, Gottlieb PA, Fain P, Eisenbarth GS. Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease. Tissue Antigens 60: 155-163 (2002). *

• Park YS, Wang CY, Ko KW, Yang SW, Park M, Yang MC, She JX. Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans. Hum. Immunol. 59: 794-801 (1998).

• Parkes AB, Darke C, Othman S, Thomas M, Young N, Richards CJ, Hall R, Lazarus JH. Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditis. Eur. J. Endocrinol. 134: 449-453 (1996).

• Parmar S, de Lima M, Zou Y, Patah P, Liu P, Cano P, Rondon G, Pesoa S, de Padua Silva L, Qazilbash MH, Hosing C, Popat U, Kebriaei P, Shpall EJ, Giralt S, Champlin RE, Stastny P, Fernandez-Vina M. Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. Blood 114: 2884-2887 (2009). *

• Parrot I, Huang PC, Khosla C. Circular dichroism and nuclear magnetic resonance spectroscopic analysis of immunogenic gluten peptides and their analogs. J. Biol. Chem. 277: 45572-45578 (2002). *

• Parry CS, Brooks BR. A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes. Biol. Direct 3: 42 (2008). *

• Partanen J, Peterson P, Westman P, Aranko S, Krohn K. Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility. Hum. Immunol. 41: 135-140 (1994).

• Parveen S, Morshed SA, Arima K, Nishioka M, Czaja AJ, Chow WC, Ng HS. Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association. Dig. Dis. Sci. 43: 1322-1331 (1998). *

• Pascual M, Martin J, Nieto A, Giphart MJ, van der Slik AR, de Vries RR, Zanelli E. Distribution of HERV-LTR elements in the 5'-flanking region of HLA-DQB1 and association with autoimmunity. Immunogenetics 53: 114-118 (2001).

• Pascual M, Mataran L, Jones G, Shing D, van der Slik AR, Giphart MJ, Schreuder GM, de Vries RR, Breedveld FC, Roovers E, Zanelli E, Martin J. HLA haplotypes and susceptibility to rheumatoid arthritis. More than class II genes. Scand. J. Rheumatol. 31: 275-278 (2002). *

• Pascual M, Nieto A, Lopez-Nevot MA, Ramal L, Mataran L, Caballero A, Alonso A, Martin J, Zanelli E. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition. Arthritis Rheum. 44: 307-314 (2001). *

• Pastorino R, Menni C, Barca M, Foco L, Saddi V, Gazzaniga G, Ferrai R, Mascaretti L, Dudbridge F, Berzuini C, Murgia SB, Piras ML, Ticca A, Bitti PP, Bernardinelli L. Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia. PLoS One 4: e6526 (2009). *

• Patarroyo JC, Stuve O, Piskurich JF, Hauser SL, Oksenberg JR, Zamvil SS. Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA). Genes Immun. 3: 34-37 (2002). *

• Paulsen G, Lundin KE, Gjertsen HA, Hansen T, Sollid LM, Thorsby E. HLA-DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of amino acid substitutions in the membrane distal domain of DQ beta 1*0201. Hum. Immunol. 42: 145-153 (1995).

• Pedrazzoli M, Pontes JC, Peirano P, Tufik S. HLA-DQB1 genotyping in a family with narcolepsy-cataplexy. Brain Res. 1165: 1-4 (2007).

• Peltola M, Kaukinen K, Dastidar P, Haimila K, Partanen J, Haapala AM, Maki M, Keranen T, Peltola J. Hippocampal sclerosis in refractory temporal lobe epilepsy is associated with gluten sensitivity. J. Neurol. Neurosurg. Psychiatry 80: 626-630 (2009).

• Pena AS, Garrote JA, Crusius JB. Advances in the immunogenetics of coeliac disease. Clues for understanding the pathogenesis and disease heterogeneity. Scand. J. Gastroenterol. Suppl. 225: 56-58 (1998). *

• Pena-Quintana L, Torres-Galvan MJ, Deniz-Naranjo MC, Ortigosa-Castillo L, Ramos-Varela JC, Calvo-Hernandez F, Fiuza-Perez MD, Rodriguez-Gallego JC, Sanchez-Garcia F. Assessment of the DQ heterodimer test in the diagnosis of celiac disease in the Canary Islands (Spain). J. Pediatr. Gastroenterol. Nutr. 37: 604-608 (2003). *

• Pender MP, Greer AJ. Immunology of multiple sclerosis. Curr. Allergy Asthma Rep. 7: 285-292 (2007).

• Peng B, Chen Q, Zhang L, Zou H, Liu S. Association of genetic polymorphisms in human leukocyte antigen-DQA1 with intrahepatic cholestasis of pregnancy in Chengdu district. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 555-557 (2006).

• Penglis PS, Bond C, Humphreys I, McCluskey J, Cleland LG. Genetic susceptibility and the link between cat exposure and rheumatoid arthritis. Semin. Arthritis Rheum. 30: 111-120 (2000). *

• Penna-Martinez M, Ramos-Lopez E, Robbers I, Kahles H, Hahner S, Willenberg H, Reisch N, Seidl C, Segni M, Badenhoop K. The rs1990760 polymorphism within the IFIH1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease. BMC Med. Genet. 10: 126 (2009). *

• Perdriger A. Do the HLA-DQ and DP genes play a role in rheumatoid arthritis? Joint Bone Spine 68: 12-18 (2001).

• Perdriger A, Chales G, Semana G, Guggenbuhl P, Meyer O, Quillivic F, Pawlotsky Y. Role of HLA-DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis. J. Rheumatol. 24: 1272-1276 (1997).

• Perez F, Gutierrez-Lopez MD, Calvillan M, Martinez MT, Carrasco E, Lopez G, Serrano-Rios M. HLA and insulin-dependent diabetes mellitus. Rev. Med. Chil. 122: 1413-1420 (1994).

• Perri F, Annese V, Piepoli A, Napolitano G, Lombardi G, Ciavarella G, Di Giorgio G, Andriulli A. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital. J. Gastroenterol. Hepatol. 30: 56-61 (1998).

• Petersdorf EW, Hansen JA. New advances in hematopoietic cell transplantation. Curr. Opin. Hematol. 15: 549-554 (2008).

• Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med. 4: e8 (2007). *

• Petrone A, Battelino T, Krzisnik C, Bugawan T, Erlich H, Di Mario U, Pozzilli P, Buzzetti R. Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens 60: 244-253 (2002). *

• Petrone A, Bugawan TL, Mesturino CA, Nistico L, Galgani A, Giorgi G, Cascino I, Erlich HA, Di Mario U, Buzzetti R. The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region). Tissue Antigens 58: 385-394 (2001). *

• Petrone A, Giorgi G, Galgani A, Alemanno I, Corsello SM, Signore A, Mario UD, Nistico L, Cascino I, Buzzetti R. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid 15: 232-238 (2005).

• Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Di Mario U, Buzzetti R. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 11: 171-175 (2001).

• Picchioni D, Hope CR, Harsh JR. A case-control study of the environmental risk factors for narcolepsy. Neuroepidemiology 29: 185-192 (2007).

• Piersma SJ, Welters MJ, van der Hulst JM, Kloth JN, Kwappenberg KM, Trimbos BJ, Melief CJ, Hellebrekers BW, Fleuren GJ, Kenter GG, Offringa R, van der Burg SH. Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element. Int. J. Cancer 122: 486-494 (2008). *

• Pietzak MM, Schofield TC, McGinniss TJ, Nakamura RM. Stratifying risk for celiac disease in a large at-risk US population using HLA alleles. Clin. Gastroenterol. Hepatol. 7: 966-971 (2009).

• Pimtanothai N, Hurley CK, Leke R, Klitz W, Johnson AH. HLA-DR and -DQ polymorphism in Cameroon. Tissue Antigens 58: 1-8 (2001). *

• Pinier M, Verdu EF, Nasser-Eddine M, David CS, Vezina A, Rivard N, Leroux JC. Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology 136: 288-298 (2009). *

• Piper JL, Gray GM, Khosla C. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue. Biochemistry 41: 386-393 (2002). *

• Pirri A, Contieri FC, Benvenutti R, Bicalho MD. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors. Transpl. Immunol. 20: 143-149 (2009).

• Plensa I, Pavia C, Ercilla MG. Susceptibility to chronic HLA-system-associated lymphocytic thyroiditis. Its relationship with insulin-dependent diabetes mellitus. Med. Clin. (Barc.) 93: 761-764 (1989).

• Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 110: 1053-1060 (1996). *

• Plot L, Amital H. Infectious associations of celiac disease. Autoimmun. Rev. 8: 316-319 (2009).

• Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun. 3: 235-249 (2002). *

• Pociot F, Molvig J, Wogensen L, Worsaae H, Dalboge H, Baek L, Nerup J. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand. J. Immunol. 33: 37-49 (1991).

• Pociot F, Wilson AG, Nerup J, Duff GW. No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus. Eur. J. Immunol. 23: 3050-3053 (1993).

• Polvi A, Maki M, Partanen J. Celiac patients predominantly inherit HLA-DPB1*0101 positive haplotype from HLA-DQ2 homozygous parent. Hum. Immunol. 53: 156-158 (1997).

• Ponsioen CY, Stokkers PC, vd Horst AR, Tytgat GN, van Deventer SJ. A patient with hereditary hemochromatosis, ulcerative colitis, and primary sclerosing cholangitis: genetic aspects. Eur. J. Intern. Med. 12: 518-521 (2001). *

• Popat S, Hearle N, Wixey J, Hogberg L, Bevan S, Lim W, Stenhammar L, Houlston RS. Analysis of the CTLA4 gene in Swedish coeliac disease patients. Scand. J. Gastroenterol. 37: 28-31 (2002). *

• Popat S, Hogberg L, McGuire S, Green H, Bevan S, Stenhammar L, Houlston RS. Germline mutations in TGM2 do not contribute to coeliac disease susceptibility in the Swedish population. Eur. J. Gastroenterol. Hepatol. 13: 1477-1479 (2001).

• Pope JE, Stevens A, Howson W, Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J. Rheumatol. 25: 1687-1693 (1998).

• Portig I, Sandmoeller A, Kreilinger S, Maisch B. HLA-DQB1* polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis. Autoimmunity 42: 33-40 (2009).

• Poulain C, Johanet C, Delcroix C, Levy-Marchal C, Tubiana-Rufi N. Prevalence and clinical features of celiac disease in 950 children with type 1 diabetes in France. Diabetes Metab. 33: 453-458 (2007). *

• Powis SH, Rosenberg WM, Hall M, Mockridge I, Tonks S, Ivinson A, Ciclitira PJ, Jewell DP, Lanchbury JS, Bell JI, et al. TAP1 and TAP2 polymorphism in coeliac disease. Immunogenetics 38: 345-350 (1993).

• Powis SH, Tonks S, Mockridge I, Kelly AP, Bodmer JG, Trowsdale J. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics 37: 373-380 (1993).

• Pozsonyi E, Gyorgy B, Berki T, Banlaki Z, Buzas E, Rajczy K, Hosso A, Prohaszka Z, Szilagyi A, Cervenak L, Fust G. HLA-association of serum levels of natural antibodies. Mol. Immunol. 46: 1416-1423 (2009). *

• Prat E, Tomaru U, Sabater L, Park DM, Granger R, Kruse N, Ohayon JM, Bettinotti MP, Martin R. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. J. Neuroimmunol. 167: 108-119 (2005).

• Pratsidou-Gertsi P, Kanakoudi-Tsakalidou F, Spyropoulou M, Germenis A, Adam K, Taparkou A, Siamopoulou A, Drakou C, Konstantinidis T, Prieur AM, Stavropoulos-Giokas C. Nationwide collaborative study of HLA class II associations with distinct types of juvenile chronic arthritis (JCA) in Greece. Eur. J. Immunogenet. 26: 299-310 (1999). *

• Price P, Cheong KY, Boodhoo A, Witt CS, McCann V, Christiansen FT, Allcock RJ. Can MHC class II genes mediate resistance to type 1 diabetes? Immunol. Cell Biol. 79: 602-606 (2001). *

• Price P, Santoso L, Mastaglia F, Garlepp M, Kok CC, Allcock R, Laing N. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. Tissue Antigens 64: 575-580 (2004). *

• Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167: 257-274 (1999).

• Price VH, Colombe BW. Heritable factors distinguish two types of alopecia areata. Dermatol. Clin. 14: 679-689 (1996).

• Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. N. Engl. J. Med. 322: 1842-1844 (1990).

• Proust B, Kennel A, Ladriere M, Kessler M, Perrier P. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant. Transpl. Immunol. 21: 166-168 (2009).

• Przemioslo RT, Lundin KE, Sollid LM, Nelufer J, Ciclitira PJ. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut 36: 874-879 (1995). *

• Puglisi F, Capuano P, Simone M, Verzillo F, Laurentaci C, Catalano G. Immunogenetics of inflammatory bowel disease. Minerva Gastroenterol. Dietol. 45: 5-9 (1999).

• Qiao SW, Bergseng E, Molberg O, Jung G, Fleckenstein B, Sollid LM. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. J. Immunol. 175: 254-261 (2005). *

• Qiao SW, Bergseng E, Molberg O, Xia J, Fleckenstein B, Khosla C, Sollid LM. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. J. Immunol. 173: 1757-1762 (2004). *

• Qiao SW, Piper J, Haraldsen G, Oynebraten I, Fleckenstein B, Molberg O, Khosla C, Sollid LM. Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease. J. Immunol. 174: 1657-1663 (2005). *

• Qiao SW, Sollid LM, Blumberg RS. Antigen presentation in celiac disease. Curr. Opin. Immunol. 21: 111-117 (2009).

• Qu HQ, Marchand L, Szymborski A, Grabs R, Polychronakos C. The association between type 1 diabetes and the ITPR3 gene polymorphism due to linkage disequilibrium with HLA class II. Genes Immun. 9: 264-266 (2008). *

• Qu HQ, Polychronakos C. The effect of the MHC locus on autoantibodies in type 1 diabetes. J. Med. Genet. 46: 469-471 (2009).

• Quarsten H, McAdam SN, Jensen T, Arentz-Hansen H, Molberg O, Lundin KE, Sollid LM. Staining of celiac disease-relevant T cells by peptide-DQ2 multimers. J. Immunol. 167: 4861-4868 (2001). *

• Quarsten H, Molberg O, Fugger L, McAdam SN, Sollid LM. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur. J. Immunol. 29: 2506-2514 (1999). *

• Quarsten H, Paulsen G, Johansen BH, Thorpe CJ, Holm A, Buus S, Sollid LM. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules. Int. Immunol. 10: 1229-1236 (1998). *

• Quelvennec E, Bera O, Cabre P, Alizadeh M, Smadja D, Jugde F, Edan G, Semana G. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome. Tissue Antigens 61: 166-171 (2003). *

• Rajagopalan G, Iijima K, Singh M, Kita H, Patel R, David CS. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect. Immun. 74: 1284-1296 (2006). *

• Rajagopalan G, Mangalam AK, Sen MM, Cheng S, Kudva YC, David CS. Autoimmunity in HLA-DQ8 transgenic mice expressing granulocyte/macrophage-colony stimulating factor in the beta cells of islets of Langerhans. Autoimmunity 40: 169-179 (2007).

• Rajagopalan G, Mangalam AK, Sen MM, Kudva YC, David CS. Distinct local immunogenic stimuli dictate differential requirements for CD4(+) and CD8(+) T cell subsets in the pathogenesis of spontaneous autoimmune diabetes. Autoimmunity 40: 489-496 (2007).

• Rajagopalan G, Polich G, Sen MM, Singh M, Epstein BE, Lytle AK, Rouse MS, Patel R, David CS. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice. Tissue Antigens 71: 135-145 (2008). *

• Raju R, Zhan WZ, Karachunski P, Conti-Fine B, Sieck GC, David C. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis. J. Immunol. 160: 4169-4174 (1998). *

• Rak JM, Maestroni L, Balandraud N, Guis S, Boudinet H, Guzian MC, Yan Z, Azzouz D, Auger I, Roudier C, Martin M, Didelot R, Roudier J, Lambert NC. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum. 60: 73-80 (2009). *

• Raki M, Fallang LE, Brottveit M, Bergseng E, Quarsten H, Lundin KE, Sollid LM. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc. Natl. Acad. Sci. U.S.A. 104: 2831-2836 (2007). *

• Raki M, Schjetne KW, Stamnaes J, Molberg O, Jahnsen FL, Issekutz TB, Bogen B, Sollid LM. Surface expression of transglutaminase 2 by dendritic cells and its potential role for uptake and presentation of gluten peptides to T cells. Scand. J. Immunol. 65: 213-220 (2007). *

• Raki M, Tollefsen S, Molberg O, Lundin KE, Sollid LM, Jahnsen FL. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 131: 428-438 (2006). *

• Ramagopalan SV, Dyment DA, Herrera BM, Deluca GC, Lincoln MR, Orton SM, Handunnetthi L, Chao MJ, Dessa Sadovnick A, Ebers GC. Parental non-inherited HLA resistance alleles do not confer protection against multiple sclerosis. J. Neuroimmunol. 196: 170-172 (2008).

• Ramagopalan SV, Dyment DA, Morrison KM, Herrera BM, Deluca GC, Lincoln MR, Orton SM, Handunnetthi L, Chao MJ, Sadovnick AD, Ebers GC. Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis. BMC Med. Genet. 9: 63 (2008). *

• Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, Harbo HF, Padyukov L, Alfredsson L, Olsson T, Sadovnick AD, Hillert J, Ebers GC. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 73: 2107-2111 (2009).

• Ramagopalan SV, Morris AP, Dyment DA, Herrera BM, Deluca GC, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet. 3: e150 (2007). *

• Ramos-Arroyo MA, Feijoo E, Sanchez-Valverde F, Aranburu E, Irisarri N, Olivera JE, Valiente A. Heat-shock protein 70-1 and HLA class II gene polymorphisms associated with celiac disease susceptibility in Navarra (Spain). Hum. Immunol. 62: 821-825 (2001).

• Ramos-Lopez E, Fernandez-Balsells M, Kahles H, Seidl C, Ferrer J, Badenhoop K. HLA-DQ haplotypes in Spanish and German families with Graves' disease: contribution to DQA1*0501-DQB1*0301 mediated genetic susceptibility from fathers. Thyroid 17: 1131-1135 (2007).

• Rani R, Sood A, Goswami R. Molecular basis of predisposition to develop type 1 diabetes mellitus in North Indians. Tissue Antigens 64: 145-155 (2004). *

• Rani R, Sood A, Lazaro AM, Stastny P. Associations of MHC class II alleles with insulin-dependent diabetes mellitus (IDDM) in patients from North India. Hum. Immunol. 60: 524-531 (1999).

• Rashtak S, Marietta EV, Cheng S, Camilleri MJ, Pittelkow MR, David CS, Grande JP, Murray JA. Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background. Lupus Feb 8 [Epub ahead of print] (2010).

• Rassi DM, Junta CM, Fachin AL, Sandrin-Garcia P, Mello SS, Fernandes AP, Deghaide NN, Foss-Freitas MC, Foss MC, Sakamoto-Hojo ET, Passos GA, Donadi EA. Is HLA class II profile relevant for the study of large-scale differentially expressed genes in type 1 diabetes mellitus patients? Ann. N. Y. Acad. Sci. 1079: 305-309 (2006). *

• Rassi DM, Wastowski IJ, Simoes RT, Rodrigues S, Deghaide NN, Mendes-Junior CT, Simoes AL, Soares CP, Passos GA, Donadi EA. TNFa-e microsatellite, HLA-DRB1 and -DQB1 alleles and haplotypes in Brazilian patients presenting recently diagnosed type 1 diabetes mellitus. Ann. N. Y. Acad. Sci. 1079: 300-304 (2006). *

• Ratanachaiyavong S, Lloyd L, Darke C, McGregor AM. MHC-extended haplotypes in families of patients with Graves' disease. Hum. Immunol. 36: 99-111 (1993).

• Rau H, Donner H, Usadel KH, Badenhoop K. Polymorphisms of tumor necrosis factor receptor 2 are not associated with insulin-dependent diabetes mellitus or Graves' disease. Tissue Antigens 49: 535-536 (1997).

• Rau H, Nicolay A, Donner H, Usadel KH, Badenhoop K. Polymorphisms of TAP1 and TAP2 genes in German patients with type 1 diabetes mellitus. Eur. J. Immunogenet. 24: 229-236 (1997).

• Rau H, Nicolay A, Usadel KH, Finke R, Donner H, Walfish PG, Badenhoop K. Polymorphisms of TAP1 and TAP2 genes in Graves' disease. Tissue Antigens 49: 16-22 (1997).

• Ravelli A, Bolognini S, Gambarotti M, Villanacci V. Variability of histologic lesions in relation to biopsy site in gluten-sensitive enteropathy. Am. J. Gastroenterol. 100: 177-185 (2005). *

• Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S, Chang J, Palmieri A, Haugen E, Kaul R, Olson MV. Ancient haplotypes of the HLA class II region. Genome Res. 15: 1250-1257 (2005). *

• Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. Recent Prog. Horm. Res. 56: 69-89 (2001). *

• Rees LE, Jones P, Pinkerton K, Cogan T, Ayling SM, Belafsky P, Birchall MA. Exposure to environmental pollutants is related to sore throats and increased expression of HLA-DQ in the upper airway mucosa of man. Clin. Otolaryngol. 33: 642 (2008).

• Reil A, Bein G, Machulla HK, Sternberg B, Seyfarth M. High-resolution DNA typing in immunoglobulin A deficiency confirms a positive association with DRB1*0301, DQB1*02 haplotypes. Tissue Antigens 50: 501-506 (1997).

• Reinke Y, Zimmer KP, Naim HY. Toxic peptides in Frazer's fraction interact with the actin cytoskeleton and affect the targeting and function of intestinal proteins. Exp. Cell Res. 315: 3442-3452 (2009).

• Reinshagen M, Loeliger C, Kuehnl P, Weiss U, Manfras BJ, Adler G, Boehm BO. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany. Gut 38: 538-542 (1996). *

• Reinton N, Helgheim A, Shegarfi H, Moghaddam A. A one-step real-time PCR assay for detection of DQA1*05, DQB1*02 and DQB1*0302 to aid diagnosis of celiac disease. J. Immunol. Methods 316: 125-132 (2006).

• Reis EA, Athanazio DA, McBride AJ, Azevedo TM, Magalhaes-Santos IF, Harn D, Reis MG. Influence of the HLA-DQB1*0201 allele on the immune response in a Schistosoma mansoni infection. Acta Trop. 108: 131-134 (2008).

• Rekha PL, Valluri V, Rakh SS, Pantula V, Ishaq M. Association of HLA DQ B1* and HLA DR B1* alleles with goitrous juvenile autoimmune hypothyroidism - a case control study. J. Clin. Immunol. 27: 486-489 (2007). *

• Renne C, Ramos Lopez E, Steimle-Grauer SA, Ziolkowski P, Pani MA, Luther C, Holzer K, Encke A, Wahl RA, Bechstein WO, Usadel KH, Hansmann ML, Badenhoop K. Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. J. Clin. Endocrinol. Metab. 89: 5810-5814 (2004). *

• Resic-Lindehammer S, Larsson K, Ortqvist E, Carlsson A, Cederwall E, Cilio CM, Ivarsson SA, Jonsson BA, Larsson HE, Lynch K, Neiderud J, Nilsson A, Sjoblad S, Lernmark A; and the Swedish Childhood Diabetes Study Group. Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk. Acta Diabetol. 45: 231-235 (2008).

• Reunala T. Dermatitis herpetiformis: coeliac disease of the skin. Ann. Med. 30: 416-418 (1998).

• Reveille JD. The genetic basis of autoantibody production. Autoimmun. Rev. 5: 389-398 (2006).

• Reveille JD, Alarcon GS, Fowler SE, Pillemer SR, Neuner R, Clegg DO, Mikhail IS, Trentham DE, Leisen JC, Bluhm G, Cooper SM, Duncan H, Tuttleman M, Heyse SP, Sharp JT, Tilley B. HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum. 39: 1802-1807 (1996).

• Reynier F, Cazalis MA, Lecoq A, Paye M, Rosa A, Durand A, Jhumka U, Mougin B, Miossec P, Bendelac N, Nicolino M, Thivolet C. Lack of association of IL-10 promoter gene variants with type 1 diabetes in a French population. Hum. Immunol. 67: 311-317 (2006).

• Rezaieyazdi Z, Tavakkol-Afshari J, Esmaili E, Orouji E, Pezeshkpour F, Khodadoost M, Mazhani M, Sandooghi M. Association of HLA-DQB1 allelic sequence variation with susceptibility to systemic lupus erythematosus. Iran. J. Allergy Asthma Immunol. 7: 91-95 (2008).

• Rider LG. The heterogeneity of juvenile myositis. Autoimmun. Rev. 6: 241-247 (2007).

• Riemersma SA, Jordanova ES, Haasnoot GW, Drabbels J, Schuuring E, Schreuder GM, Kluin PM. The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients. Hum. Immunol. 67: 303-310 (2006).

• Rihs HP, Chen Z, Rueff F, Cremer R, Raulf-Heimsoth M, Baur X, Moneret-Vautrin DA, Bruning T. HLA-DQ8 and the HLA-DQ8-DR4 haplotype are positively associated with the hevein-specific IgE immune response in health care workers with latex allergy. J. Allergy Clin. Immunol. 110: 507-514 (2002). *

• Ringquist S, Styche A, Rudert WA, Trucco M. Pyrosequencing(R)-based strategies for improved allele typing of human leukocyte antigen loci. Methods Mol. Biol. 373: 115-134 (2006).

• Rioux JD, Karinen H, Kocher K, McMahon SG, Karkkainen P, Janatuinen E, Heikkinen M, Julkunen R, Pihlajamaki J, Naukkarinen A, Kosma VM, Daly MJ, Lander ES, Laakso M. Genomewide search and association studies in a Finnish celiac disease population: identification of a novel locus and replication of the HLA and CTLA4 loci. Am. J. Med. Genet. 130A: 345-350 (2004). *

• Roach JC, Deutsch K, Li S, Siegel AF, Bekris LM, Einhaus DC, Sheridan CM, Glusman G, Hood L, Lernmark A, Janer M; Swedish Childhood Diabetes Study Group and the Diabetes Incidence in Sweden Study Group. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. Am. J. Hum. Genet. 79: 614-627 (2006). *

• Robinson DM, Holbeck S, Palmer J, Nepom GT. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM. Genet. Epidemiol. 6: 149-154 (1989).

• Robles DT, Fain PR, Gottlieb PA, Eisenbarth GS. The genetics of autoimmune polyendocrine syndrome type II. Endocrinol. Metab. Clin. North Am. 31: 353-368, vi-vii (2002).

• Rodrigo L. Celiac disease. World J. Gastroenterol. 12: 6585-6593 (2006). *

• Rodrigo L. Investigational therapies for celiac disease. Expert Opin. Investig. Drugs 18: 1865-1873 (2009).

• Rodrigo L, Fuentes D, Riestra S, Nino P, Alvarez N, Lopez-Vazquez A, Lopez-Larrea C. Increased prevalence of celiac disease in first and second-grade relatives. A report of a family with 19 studied members. Rev. Esp. Enferm. Dig. 99: 149-155 (2007). *

• Rodriguez T, Mendez R, Del Campo A, Aptsiauri N, Martin J, Orozco G, Pawelec G, Schadendorf D, Ruiz-Cabello F, Garrido F. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines. Immunogenetics 59: 123-133 (2007). *

• Rodriguez-Perez JM, Fragoso JM, Alvarez-Leon E, Martinez-Rodriguez N, Gallardo GJ, Ines-Real S, Granados J, Reyes PA, Vargas-Alarcon G. MHC class II genes in Mexican patients with idiopathic dilated cardiomyopathy. Exp. Mol. Pathol. 82: 49-52 (2007). *

• Roe DL, Lewis RE, Cruse JM. Association of HLA-DQ and -DR alleles with protection from or infection with HIV-1. Exp. Mol. Pathol. 68: 21-28 (2000). *

• Roep BO, Bontrop RE, Pena AS, van Eggermond MC, van Rood JJ, Giphart MJ. An HLA-DQ alpha allele identified at DNA and protein level is strongly associated with celiac disease. Hum. Immunol. 23: 271-279 (1988).

• Rojas OL, Rojas-Villarraga A, Cruz-Tapias P, Sanchez JL, Suarez-Escudero JC, Patarroyo MA, Anaya JM. HLA class II polymorphism in Latin American patients with multiple sclerosis. Autoimmun. Rev. Nov 4 [Epub ahead of print] (2009).

• Roka V, Potamianos SP, Kapsoritakis AN, Yiannaki EE, Koukoulis GN, Stefanidis I, Koukoulis GK, Germenis AE. Prevalence of coeliac disease in the adult population of central Greece. Eur. J. Gastroenterol. Hepatol. 19: 982-987 (2007).

• Romanos J, van Diemen CC, Nolte IM, Trynka G, Zhernakova A, Fu J, Bardella MT, Barisani D, McManus R, van Heel DA, Wijmenga C. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology 137: 834-840.e3 (2009). *

• Romero V, Azocar J, Zuniga J, Clavijo OP, Terreros D, Gu X, Husain Z, Chung RT, Amos C, Yunis EJ. Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in hepatitis C virus infection outcome. Mol. Immunol. 45: 2429-2436 (2008). *

• Romphruk AV, Naruse TK, Romphruk A, Kawata H, Puapairoj C, Kulski JK, Leelayuwat C, Inoko H. Diversity of MICA (PERB11.1) and HLA haplotypes in Northeastern Thais. Tissue Antigens 58: 83-89 (2001). *

• Ronningen KS, Gjertsen HA, Iwe T, Spurkland A, Hansen T, Thorsby E. Particular HLA-DQ alpha beta heterodimer associated with IDDM susceptibility in both DR4-DQw4 Japanese and DR4-DQw8/DRw8-DQw4 whites. Diabetes 40: 759-763 (1991).

• Ronningen KS, Iwe T, Halstensen TS, Spurkland A, Thorsby E. The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. Hum. Immunol. 26: 215-225 (1989).

• Roschmann E, Wienker TF, Gerok W, Volk BA. T-cell receptor variable genes and genetic susceptibility to celiac disease: an association and linkage study. Gastroenterology 105: 1790-1796 (1993).

• Roschmann E, Wienker TF, Volk BA. Role of T cell receptor delta gene in susceptibility to celiac disease. J. Mol. Med. 74: 93-98 (1996).

• Rossi M, Maurano F, Luongo D. Immunomodulatory strategies for celiac disease. Int. Rev. Immunol. 24: 479-499 (2005).

• Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, Pandey JP, Newman LS, Magira E, Beznik-Cizman B, Monos D; ACCESS Group. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet. 73: 720-735 (2003). *

• Roth MP, Nogueira L, Coppin H, Clanet M, Clayton J, Cambon-Thomsen A. Tumor necrosis factor polymorphism in multiple sclerosis: no additional association independent of HLA. J. Neuroimmunol. 51: 93-99 (1994).

• Roudier J. Association of MHC and rheumatoid arthritis. Association of RA with HLA-DR4: the role of repertoire selection. Arthritis Res. 2: 217-220 (2000). *

• Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, Jewell DP. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 112: 1845-1853 (1997). *

• Routsias J, Papadopoulos GK. Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM. Diabetologia 38: 1251-1261 (1995).

• Rubio JP, Bahlo M, Butzkueven H, van Der Mei IA, Sale MM, Dickinson JL, Groom P, Johnson LJ, Simmons RD, Tait B, Varney M, Taylor B, Dwyer T, Williamson R, Gough NM, Kilpatrick TJ, Speed TP, Foote SJ. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am. J. Hum. Genet. 70: 1125-1137 (2002). *

• Rubio JP, Bahlo M, Stankovich J, Burfoot RK, Johnson LJ, Huxtable S, Butzkueven H, Lin L, Taylor BV, Speed TP, Kilpatrick TJ, Mignot E, Foote SJ. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients. Immunogenetics 59: 177-186 (2007). *

• Rubio JP, Bahlo M, Tubridy N, Stankovich J, Burfoot R, Butzkueven H, Chapman C, Johnson L, Marriott M, Mraz G, Tait B, Wilkinson C, Taylor B, Speed TP, Foote SJ, Kilpatrick TJ. Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis. Hum. Genet. 114: 573-580 (2004). *

• Rubio-Tapia A, Abdulkarim AS, Wiesner RH, Moore SB, Krause PK, Murray JA. Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int. 28: 467-476 (2008). *

• Rubio-Tapia A, Van Dyke CT, Lahr BD, Zinsmeister AR, El-Youssef M, Moore SB, Bowman M, Burgart LJ, Melton LJ 3rd, Murray JA. Predictors of family risk for celiac disease: a population-based study. Clin. Gastroenterol. Hepatol. 6: 983-987 (2008).

• Ruiz del Prado MY, Olivares Lopez JL, Lazaro Almarza A, Lasierra Diaz MP. Two loci HLA haplotypes in celiac children. Linkage imbalance and haplotype frequencies. Comparative study with a control population. An. Esp. Pediatr. 54: 7-12 (2001).

• Ruiz MY, Olivares JL. Three-loci HLA haplotypes in Spanish celiac children and healthy subjects: estimation of linkage disequilibrium and haplotype frequencies. Am. J. Gastroenterol. 96: 1455-1459 (2001). *

• Rutherford RM, Brutsche MH, Kearns M, Bourke M, Stevens F, Gilmartin JJ. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc. Diffuse Lung Dis. 21: 191-198 (2004).

• Rutherford RM, Brutsche MH, Kearns M, Bourke M, Stevens F, Gilmartin JJ. Prevalence of coeliac disease in patients with sarcoidosis. Eur. J. Gastroenterol. Hepatol. 16: 911-915 (2004).

• Ryan AW, Thornton JM, Brophy K, Daly JS, McLoughlin RM, O'Morain C, Abuzakouk M, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R. Chromosome 5q candidate genes in coeliac disease: genetic variation at IL4, IL5, IL9, IL13, IL17B and NR3C1. Tissue Antigens 65: 150-155 (2005). *

• Ryan AW, Thornton JM, Brophy K, Daly JS, O'Morain C, McLoughlin RM, Kennedy NP, Abuzakouk M, Stevens FM, Feighery C, Kelleher D, McManus R. Haplotype variation at the IBD5/SLC22A4 locus (5q31) in coeliac disease in the Irish population. Tissue Antigens 64: 195-198 (2004). *

• Sacks SH, Bushell A, Rust NA, Karagiannis JA, Jewell DP, Ledingham JG, Wood KJ, McMichael AJ. Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathy. Hum. Immunol. 20: 175-187 (1987).

• Sadanaga Y, Uno M, Kitao Y, Ishikawa T. Investigation of the genetic regulation in allergic rhinitis. Auris. Nasus. Larynx. 17: 23-32 (1990).

• Saeki H, Kuwata S, Nakagawa H, Asahina A, Tamaki K, Shibata Y, Juji T. Analysis of HLA class II and TAP alleles in Japanese patients with psoriasis vulgaris. Hum. Immunol. 59: 503-511 (1998).

• Saeki H, Kuwata S, Nakagawa H, Etoh T, Yanagisawa M, Miyamoto M, Tokunaga K, Juji T, Shibata Y. Analysis of disease-associated amino acid epitopes on HLA class II molecules in atopic dermatitis. J. Allergy Clin. Immunol. 96: 1061-1068 (1995).

• Saila H, Pitkaniemi J, Tuomilehto J, Savolainen A, Alakulppi N, Tuomilehto-Wolf E, Leirisalo-Repo M, Aho K. HLA and susceptibility to juvenile idiopathic arthritis: a study of affected sibpairs in an isolated Finnish population. J. Rheumatol. 31: 2281-2285 (2004). *

• Sakkas LI, Loqueman N, Bird H, Vaughan RW, Welsh KI, Panayi GS. HLA class II and T cell receptor gene polymorphisms in psoriatic arthritis and psoriasis. J. Rheumatol. 17: 1487-1490 (1990).

• Samaroo D, Dickerson F, Kasarda DD, Green PH, Briani C, Yolken RH, Alaedini A. Novel immune response to gluten in individuals with schizophrenia. Schizophr. Res. Sep 10 [Epub ahead of print] (2009).

• Sanchez-Velasco P, Anton E, Munoz D, Martinez-Quesada J, Ruiz de Alegria C, Lopez-Hoyos M, Garcia-Martin A, Jimenez I, Alonso ST, Duque S, Suarez A, Jerez J, Leyva-Cobian F. Sensitivity to bee venom antigen phospholipase A2: association with specific HLA class I and class II alleles and haplotypes in beekeepers and allergic patients. Hum. Immunol. 66: 818-825 (2005).

• Sanchez-Velasco P, Karadsheh NS, Garcia-Martin A, Ruiz de Alegria C, Leyva-Cobian F. Molecular analysis of HLA allelic frequencies and haplotypes in Jordanians and comparison with other related populations. Hum. Immunol. 62: 901-909 (2001).

• Sanchez-Velasco P, Leyva-Cobian F. The HLA class I and class II allele frequencies studied at the DNA level in the Svanetian population (Upper Caucasus) and their relationships to Western European populations. Tissue Antigens 58: 223-233 (2001). *

• Sand T, Schrader H. Narcolepsy and other hypersomnias. Tidsskr. Nor. Laegeforen. 129: 2007-2010 (2009).

• Sanjeevi CB. Genes influencing innate and acquired immunity in type 1 diabetes and latent autoimmune diabetes in adults. Ann. N. Y. Acad. Sci. 1079: 67-80 (2006). *

• Sanjeevi CB, Kanungo A, Samal KC. Immunogenetic studies on malnutrition-modulated diabetes mellitus. Ann. N. Y. Acad. Sci. 958: 144-147 (2002). *

• Sanjeevi CB, Landin-Olsson M, Kockum I, Dahlquist G, Lernmark A. Effects of the second HLA-DQ haplotype on the association with childhood insulin-dependent diabetes mellitus. Tissue Antigens 45: 148-152 (1995).

• Sanjeevi CB, Lybrand TP, DeWeese C, Landin-Olsson M, Kockum I, Dahlquist G, Sundkvist G, Stenger D, Lernmark A. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study. Diabetes 44: 125-131 (1995).

• Sanjeevi CB, Lybrand TP, Landin-Olsson M, Kockum I, Dahlquist G, Hagopian WA, Palmer JP, Lernmark A. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus. Tissue Antigens 44: 110-119 (1994).

• Sanjeevi CB, Miller EN, Dabadghao P, Rumba I, Shtauvere A, Denisova A, Clayton D, Blackwell JM. Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. Arthritis Rheum. 43: 1397-1404 (2000). *

• Sanjeevi CB, Sedimbi SK, Landin-Olsson M, Kockum I, Lernmark A; Swedish Childhood Diabetes and the Diabetes Incidence in Sweden Study Groups. Risk conferred by HLA-DR and DQ for type 1 diabetes in 0-35-year age group in Sweden. Ann. N. Y. Acad. Sci. 1150: 106-111 (2008). *

• Sansom DM, Amin SN, Bidwell JL, Klouda PT, Bradley BA, Evison G, Goulding NJ, Hall ND, Maddison PJ. HLA-DO-related restriction fragment length polymorphisms in rheumatoid arthritis: evidence for a link with disease expression. Br. J. Rheumatol. 28: 374-378 (1989).

• Santamaria P, Barbosa JJ, Lindstrom AL, Lemke TA, Goetz FC, Rich SS. HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type I diabetic patients. J. Clin. Endocrinol. Metab. 78: 878-883 (1994). *

• Santaolalla R, Fernandez-Banares F, Rodriguez R, Alsina M, Rosinach M, Marine M, Farre C, Salas A, Forne M, Loras C, Espinos J, Viver JM, Esteve M. Diagnostic value of duodenal anti-tissue transglutaminase antibodies in gluten-sensitive enteropathy. Aliment. Pharmacol. Ther. 27: 820-829 (2008). *

• Santiago JL, Li W, Lee A, Martinez A, Chandrasekaran A, Fernandez-Arquero M, Khalili H, de la Concha EG, Urcelay E, Gregersen PK. Localization of type 1 diabetes susceptibility in the ancestral haplotype 18.2 by high density SNP mapping. Genomics 94: 228-232 (2009). *

• Santin I, Castellanos-Rubio A, Aransay AM, Gutierrez G, Gaztambide S, Rica I, Vicario JL, Noble JA, Castano L, Bilbao JR. Exploring the diabetogenicity of the HLA-B18-DR3 CEH: independent association with T1D genetic risk close to HLA-DOA. Genes Immun. 10: 596-600 (2009).

• Saruhan-Direskeneli G, Kilic A, Parman Y, Serdaroglu P, Deymeer F. HLA-DQ polymorphism in Turkish patients with myasthenia gravis. Hum. Immunol. 67: 352-358 (2006).

• Saruhan-Direskeneli G, Uyar FA, Bas F, Gunoz H, Bundak R, Saka N, Darendeliler F. HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey. Hum. Immunol. 61: 296-302 (2000).

• Sasai T, Inoue Y, Komada Y, Sugiura T, Matsushima E. Comparison of clinical characteristics among narcolepsy with and without cataplexy and idiopathic hypersomnia without long sleep time, focusing on HLA-DRB1( *)1501/DQB1( *)0602 finding. Sleep Med. 10: 961-966 (2009).

• Sasaki M, Yuzawa M, Saito T, Ikoma A, Tamemoto H, Kawakami M, Ishikawa SE. New HLA DRB1 and DQB1 haplotypes in a pedigree of familial Graves' disease in Japan. Endocr. J. 54: 721-725 (2007). *

• Sato H, Grutters JC, Pantelidis P, Mizzon AN, Ahmad T, Van Houte AJ, Lammers JW, Van Den Bosch JM, Welsh KI, Du Bois RM. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am. J. Respir. Cell Mol. Biol. 27: 406-412 (2002). *

• Sato H, Spagnolo P, Silveira L, Welsh KI, du Bois RM, Newman LS, Maier LA. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals. Tissue Antigens 70: 480-486 (2007). *

• Satsangi J, Landers CJ, Welsh KI, Koss K, Targan S, Jewell DP. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Inflamm. Bowel Dis. 4: 18-26 (1998). *

• Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, Jewell DP. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347: 1212-1217 (1996).

• Savage DA, Middleton D, Trainor F, Taylor A, Carson M, Stevens FM, McCarthy CF. HLA class II frequencies in celiac disease patients in the west of Ireland. Hum. Immunol. 34: 47-52 (1992).

• Savilahti EM, Ilonen J, Kiviniemi M, Saarinen KM, Vaarala O, Savilahti E. Human leukocyte antigen (DR1)-DQB1*0501 and (DR15)-DQB1*0602 haplotypes are associated with humoral responses to early food allergens in children. Int. Arch. Allergy Immunol. 152: 169-177 (2009).

• Scharf SJ, Freidmann A, Steinman L, Brautbar C, Erlich HA. Specific HLA-DQB and HLA-DRB1 alleles confer susceptibility to pemphigus vulgaris. Proc. Natl. Acad. Sci. U.S.A. 86: 6215-6219 (1989). *

• Scharf SJ, Friedmann A, Brautbar C, Szafer F, Steinman L, Horn G, Gyllensten U, Erlich HA. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc. Natl. Acad. Sci. U.S.A. 85: 3504-3508 (1988). *

• Schmidt H, Williamson D, Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am. J. Epidemiol. 165: 1097-1109 (2007). *

• Schmitz J, Garnier-Lengline H. Celiac disease diagnosis in 2008. Arch. Pediatr. 15: 456-461 (2008).

• Schreuder GM, Hurley CK, Marsh SG, Lau M, Fernandez-Vina M, Noreen HJ, Setterholm M, Maiers M. The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Int. J. Immunogenet. 32: 19-69 (2005). *

• Schreuder GM, Hurley CK, Marsh SG, Lau M, Fernandez-Vina M, Noreen HJ, Setterholm M, Maiers M. The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens 65: 1-55 (2005). *

• Schreuder GM, Hurley CK, Marsh SG, Lau M, Fernandez-Vina MA, Noreen HJ, Setterholm M, Maiers M. HLA dictionary 2004: summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Hum. Immunol. 66: 170-210 (2005).

• Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen H. The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Hum. Immunol. 60: 1157-1181 (1999).

• Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen H. The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens 54: 409-437 (1999).

• Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen HJ. The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Hum. Immunol. 62: 826-849 (2001).

• Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen HJ. The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Eur. J. Immunogenet. 28: 565-596 (2001). *

• Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen HJ. The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens 58: 109-140 (2001). *

• Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 119: 234-242 (2000). *

• Schuppan D. Progress of knowledge of immunopathogenesis in celiac disease. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 59-60. September 12 - 13 (2003). *

• Schuppan D. Current concepts in celiac disease. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 55 (2005). *

• Schuppan D, Dennis MD, Kelly CP. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutr. Clin. Care 8: 54-69 (2005).

• Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 137: 1912-1933 (2009). *

• Scola L, Lio D, Candore G, Forte GI, Crivello A, Colonna-Romano G, Pes MG, Carru C, Ferrucci L, Deiana L, Baggio G, Franceschi C, Caruso C. Analysis of HLA-DRB1,DQA1,DQB1 haplotypes in Sardinian centenarians. Exp. Gerontol. 43: 114-118 (2008).

• Scolari F, Amoroso A, Savoldi S, Mazzola G, Prati E, Valzorio B, Viola BF, Nicola B, Movilli E, Sandrini M, Campanini M, Maiorca R. Familial clustering of IgA nephropathy: further evidence in an Italian population. Am. J. Kidney Dis. 33: 857-865 (1999).

• Scully M, Brown J, Patel R, McDonald V, Brown CJ, Machin S. HLA association in idiopathic thrombotic thrombocytopenic purpura - evidence for an immunogenetic link. J. Thromb. Haemost. Nov 17 [Epub ahead of print] (2009).

• Sebastiani GD, Morozzi G, Bellisai F, Fineschi I, Bacarelli MR, Simpatico A, Font J, Cervera R, Houssiau F, Fernandez-Nebro A, De Ramon Garrido E, De Pita O, Smolen J, Galeazzi M. Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations. Immunol. Invest. 37: 375-385 (2008).

• Seegers D, Borm ME, van Belzen MJ, Mulder CJ, Bailing J, Crusius JB, Meijer JW, Wijmenga C, Pena AS, Bouma G. IL12B and IRF1 gene polymorphisms and susceptibility to celiac disease. Eur. J. Immunogenet. 30: 421-425 (2003). *

• Segni M, Pani MA, Pasquino AM, Badenhoop K. Familial clustering of juvenile thyroid autoimmunity: higher risk is conferred by human leukocyte antigen DR3-DQ2 and thyroid peroxidase antibody status in fathers. J. Clin. Endocrinol. Metab. 87: 3779-3782 (2002). *

• Seguín-Estevez Q, De Palma R, Krawczyk M, Leimgruber E, Villard J, Picard C, Tagliamacco A, Abbate G, Gorski J, Nocera A, Reith W. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation. J. Immunol. 183: 2545-2553 (2009).

• Seidl C, Donner H, Petershofen E, Usadel KH, Seifried E, Kaltwasser JP, Badenhoop K. An endogenous retroviral long terminal repeat at the HLA-DQB1 gene locus confers susceptibility to rheumatoid arthritis. Hum. Immunol. 60: 63-68 (1999).

• Seidl C, Kasser UR, Fischer B, Koch U, Meier L, Fischer P, Wisseler HM, Faust-Tinnefeldt G, Bach G, Maas D, Bolten WW, Badenhoop K, Seifried E, Kaltwasser JP. HLA-DR/DQ interaction in patients with erosive rheumatoid arthritis presenting articular and extraarticular disease manifestations. Eur. J. Immunogenet. 26: 19-27 (1999). *

• Seidl C, Koch U, Brunnler G, Buhleier T, Frank R, Moller B, Markert E, Koller-Wagner G, Seifried E, Kaltwasser JP. HLA-DR/DQ/DP interactions in rheumatoid arthritis. Eur. J. Immunogenet. 24: 365-376 (1997).

• Seidl C, Korbitzer J, Badenhoop K, Seifried E, Hoelzer D, Zanelli E, Kaltwasser JP. Protection against severe disease is conferred by DERAA-bearing HLA-DRB1 alleles among HLA-DQ3 and HLA-DQ5 positive rheumatoid arthritis patients. Hum. Immunol. 62: 523-529 (2001).

• Seki T, Kiyosawa K, Inoko H, Ota M. Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients. Hepatology 12: 1300-1304 (1990).

• Seki T, Kiyosawa K, Ota M, Inoko H. Molecular biological analysis of HLA class II gene in autoimmune hepatitis among Japanese. Nippon Rinsho 51: 458-465 (1993).

• Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K, Mizuki N, Ando A, Tsuji K, Inoko H, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 103: 1041-1047 (1992).

• Sekiguchi Y, Hara Y, Takahashi M, Hirata Y. Reverse 'see-saw' relationship between Graves' disease and myasthenia gravis; clinical and immunological studies. J. Med. Dent. Sci. 52: 43-50 (2005).

• Selva-O'Callaghan A, Casellas F, de Torres I, Palou E, Grau-Junyent JM, Vilardell-Tarres M. Celiac disease and antibodies associated with celiac disease in patients with inflammatory myopathy. Muscle Nerve 35: 49-54 (2007).

• Selvaraj P, Raghavan S, Swaminathan S, Alagarasu K, Narendran G, Narayanan PR. HLA-DQB1 and -DPB1 allele profile in HIV infected patients with and without pulmonary tuberculosis of south India. Infect. Genet. Evol. 8: 664-671 (2008).

• Semana G. Genetic susceptibility of insulin-dependent diabetes. Ann. Endocrinol. (Paris) 53: 73-77 (1992).

• Semana G, Allanic H, Quillivic F, Vallejo MT, Simon JP, Genetet B, Fauchet R. Implication of the HLA-DRB3 gene in Graves' disease: predominance of allele Dw24. Hum. Immunol. 29: 143-149 (1990).

• Senger S, Maurano F, Mazzeo MF, Gaita M, Fierro O, David CS, Troncone R, Auricchio S, Siciliano RA, Rossi M. Identification of immunodominant epitopes of alpha-gliadin in HLA-DQ8 transgenic mice following oral immunization. J. Immunol. 175: 8087-8095 (2005). *

• Serjeantson SW, Easteal S. Cross-ethnic group comparisons of HLA class II alleles and insulin dependent diabetes mellitus. Baillieres Clin. Endocrinol. Metab. 5: 299-320 (1991).

• Serjeantson SW, Gao X, Hawkins BR, Higgins DA, Yu YL. Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur. J. Immunogenet. 19: 11-19 (1992).

• Setien Baranda F, Coto E, Menendez Diaz J, Martinez-Naves E, Alvarez Martinez V, Lopez-Larrea C. HLA class II and susceptibility and resistance to insulin-dependent diabetes mellitus in a population from the northwest of Spain. Eur. J. Immunogenet. 21: 219-229 (1994).

• Setterfield J, Theron J, Vaughan RW, Welsh KI, Mallon E, Wojnarowska F, Challacombe SJ, Black MM. Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br. J. Dermatol. 145: 406-414 (2001). *

• Setty M, Hormaza L, Guandalini S. Celiac disease: risk assessment, diagnosis, and monitoring. Mol. Diagn. Ther. 12: 289-298 (2008).

• Shamaly H, Hartman C, Pollack S, Hujerat M, Katz R, Gideoni O, Shamir R. Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome. J. Pediatr. Gastroenterol. Nutr. 44: 583-586 (2007). *

• Shams S, Amirzargar AA, Yousefi M, Rezaei N, Solgi G, Khosravi F, Ansaripour B, Moradi B, Nikbin B. HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris. J. Clin. Immunol. 29: 175-179 (2009).

• Shankarkumar U, Pawar A, Prabu G, Ghosh K. Role of HLA class I (HLA-A, B) and HLA class II (HLA-DRB, DQB) in HIV-1 patients with and without pulmonary tuberculosis. J. Acquir. Immune Defic. Syndr. 51: 640-641 (2009).

• Sharma SK, Balamurugan A, Pandey RM, Saha PK, Mehra NK. Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am. J. Respir. Cell. Mol. Biol. 29: 225-231 (2003). *

• Shaw BE. The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation. Int. J. Immunogenet. 35: 367-374 (2008). *

• Shaw BE, Gooley TA, Malkki M, Madrigal JA, Begovich AB, Horowitz MM, Gratwohl A, Ringden O, Marsh SG, Petersdorf EW. The importance of HLA-DPB1 in unrelated donor haematopoietic cell transplantation. Blood 110: 4560-4566 (2007). *

• Shaw BE, Mayor NP, Russell NH, Apperley JF, Clark RE, Cornish J, Darbyshire P, Ethell ME, Goldman JM, Little AM, Mackinnon S, Marks DI, Pagliuca A, Thomson K, Marsh SG, Madrigal JA. Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia Nov 19 [Epub ahead of print] (2009).

• Shaw MA, Donaldson IJ, Collins A, Peacock CS, Lins-Lainson Z, Shaw JJ, Ramos F, Silveira F, Blackwell JM. Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun. 2: 196-204 (2001). *

• Shawkatova I, Michalkova D, Barak L, Fazekasova H, Kuba D, Buc M. HLA class II allele frequencies in type 1A diabetes mellitus Slovak patients. Bratisl. Lek. Listy. 107: 76-79 (2006).

• Shibasaki T, Shimada T, Morita T, Sakai O. Immunogenetical penetrance in patients with primary biliary cirrhosis. Jpn. J. Med. 29: 533-536 (1990).

• Shimomura-Kuroki J, Yamashita K, Shimooka S. Tannerella forsythia and the HLA-DQB1 allele are associated with susceptibility to periodontal disease in Japanese adolescents. Odontology 97: 32-37 (2009).

• Shin HD, Yang SW, Kim DH, Park Y. Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility. Ann. N. Y. Acad. Sci. 1150: 76-85 (2008). *

• Shin JH, Janer M, McNeney B, Blay S, Deutsch K, Sanjeevi CB, Kockum I, Lernmark A, Graham J. IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5. Genes Immun. 8: 503-512 (2007). *

• Shin YK, Yoon IY, Han EK, No YM, Hong MC, Yun YD, Jung BK, Chung SH, Choi JB, Cyn JG, Lee YJ, Hong SC. Prevalence of narcolepsy-cataplexy in Korean adolescents. Acta Neurol. Scand. 117: 273-278 (2008).

• Shtauvere-Brameus A, Ghaderi M, Rumba I, Sanjeevi CB. Microsatellite allele 5 of MHC class I chain-related gene A increases the risk for insulin-dependent diabetes mellitus in Latvians. Ann. N. Y. Acad. Sci. 958: 349-352 (2002). *

• Sidhu M, Griffiths MM, Bradley DS. Vaccination with collagen-pulsed dendritic cells prevents the onset and reduces the disease severity in the mouse model of spontaneous polychondritis. Clin. Exp. Immunol. 157: 350-358 (2009). *

• Siegel M, Xia J, Khosla C. Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2. Bioorg. Med. Chem. 15: 6253-6261 (2007). *

• Siegmund B, Zeitz M. Transglutaminases: new target molecules for inflammatory bowel disease? Gut 54: 443-444 (2005). *

• Siegmund T, Usadel KH, Donner H, Braun J, Walfish PG, Badenhoop K. Interferon-gamma gene microsatellite polymorphisms in patients with Graves' disease. Thyroid 8: 1013-1017 (1998).

• Silano M, Vincentini O, De Vincenzi M. Toxic, immunostimulatory and antagonist gluten peptides in celiac disease. Curr. Med. Chem. 16: 1489-1498 (2009).

• Silva EM, Fernandes MI, Galvao LC, Sawamura R, Donadi EA. Human leukocyte antigen class II alleles in white Brazilian patients with celiac disease. J. Pediatr. Gastroenterol. Nutr. 31: 391-394 (2000). *

• Silva ME, Mory D, Davini E. Genetic and humoral autoimmunity markers of type 1 diabetes: from theory to practice. Arq. Bras. Endocrinol. Metabol. 52: 166-180 (2008). *

• Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, Annese V, Achkar JP, Goyette P, Scott R, Xu W, Barmada MM, Klei L, Daly MJ, Abraham C, Bayless TM, Bossa F, Griffiths AM, Ippoliti AF, Lahaie RG, Latiano A, Pare P, Proctor DD, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat. Genet. 41: 216-220 (2009). *

• Silverberg MS, Mirea L, Bull SB, Murphy JE, Steinhart AH, Greenberg GR, McLeod RS, Cohen Z, Wade JA, Siminovitch KA. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease. Inflamm. Bowel Dis. 9: 1-9 (2003). *

• Simeon CP, Fonollosa V, Tolosa C, Palou E, Selva A, Solans R, Armadans L, Moreno E, Marsal S, Vilardell M. Association of HLA class II genes with systemic sclerosis in Spanish patients. J. Rheumatol. 36: 2733-2736 (2009).

• Simmonds MJ, Heward JM, Barrett JC, Franklyn JA, Gough SC. Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74. Clin. Endocrinol. (Oxf.) 65: 429-432 (2006). *

• Simmonds MJ, Howson JM, Heward JM, Carr-Smith J, Franklyn JA, Todd JA, Gough SC. A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Hum. Mol. Genet. 16: 2149-2153 (2007). *

• Singal DP, Green D, Reid B, Gladman DD, Buchanan WW. HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann. Rheum. Dis. 51: 23-28 (1992). *

• Sinha S, Prasad KN, Jain D, Nyati KK, Pradhan S, Agrawal S. Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barre syndrome. Acta Neurol. Scand. Jan 25 [Epub ahead of print] (2010).

• Sipak-Szmigiel O, Ronin-Walknowska E, Miklaszewicz A, Dolubeczko A, Zejmo M, Giedrys-Kalemba S. Association between HLA-DQA1, HLA-DQB1 alleles and risk of early pregnancy loss. Ginekol. Pol. 78: 792-795 (2007).

• Sjostrom H, Lundin KE, Molberg O, Korner R, McAdam SN, Anthonsen D, Quarsten H, Noren O, Roepstorff P, Thorsby E, Sollid LM. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand. J. Immunol. 48: 111-115 (1998). *

• Skarlas T, Panou-Pomonis E, Kluczyk A, Szewczuk Z, Zimecki M, Kosmopoulou A, Sakarellos-Daitsiotis M, Sakarellos C. HLA-DQ7 beta(1) and beta(2) derived peptides as immunomodulators. J. Pept. Sci. 15: 296-304 (2009). *

• Skarsvag S, Hansen KE, Holst A, Moen T. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes? Tissue Antigens 40: 128-133 (1992).

• Skovbjerg H, Noren O, Anthonsen D, Moller J, Sjostrom H. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease. Scand. J. Gastroenterol. 37: 812-817 (2002). *

• Smerdel A, Lie BA, Finholt C, Ploski R, Forre O, Undlien DE, Thorsby E. An additional susceptibility gene for juvenile idiopathic arthritis in the HLA class I region on several DR-DQ haplotypes. Tissue Antigens 61: 80-84 (2003). *

• Smerud HK, Fellstrom B, Hallgren R, Osagie S, Venge P, Kristjansson G. Gluten sensitivity in patients with IgA nephropathy. Nephrol. Dial. Transplant. 24: 2476-2481 (2009).

• Smestad C, Brynedal B, Jonasdottir G, Lorentzen AR, Masterman T, Akesson E, Spurkland A, Lie BA, Palmgren J, Celius EG, Hillert J, Harbo HF. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Eur. J. Neurol. 14: 835-840 (2007).

• Smyth CM, McKiernan SM, Hagan R, Pilkington R, O'Regan M, Lawlor E, Kelleher D. Chronic hepatitis C infection and sicca syndrome: a clear association with HLA DQB1*02. Eur. J. Gastroenterol. Hepatol. 19: 493-498 (2007).

• Snijders A, Elferink DG, Geluk A, van Der Zanden AL, Vos K, Schreuder GM, Breedveld FC, de Vries RR, Zanelli EH. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs. J. Immunol. 166: 4987-4993 (2001). *

• So AK, Fielder AH, Warner CA, Isenberg DA, Batchelor JR, Walport MJ. DNA polymorphism of major histocompatibility complex class II and class III genes in systemic lupus erythematosus. Tissue Antigens 35: 144-147 (1990).

• Solberg OD, Mack SJ, Lancaster AK, Single RM, Tsai Y, Sanchez-Mazas A, Thomson G. Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Hum. Immunol. 69: 443-464 (2008).

• Sollid LM. Molecular basis of celiac disease. Annu. Rev. Immunol. 18: 53-81 (2000). *

• Sollid LM, Khosla C. Future therapeutic options for celiac disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 140-147 (2005). *

• Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin. Gastroenterol. Hepatol. 3: 843-851 (2005).

• Sollid LM, Lundin KE. Diagnosis and treatment of celiac disease. Mucosal Immunol. 2: 3-7 (2009).

• Sollid LM, McAdam SN, Molberg O, Quarsten H, Arentz-Hansen H, Louka AS, Lundin KE. Genes and environment in celiac disease. Acta Odontol. Scand. 59: 183-186 (2001).

• Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105: 910-922 (1993).

• Song EY, Park MH, Kang SJ, Park HJ, Kim BC, Tokunaga K, Akaza T, Juji T. HLA class II allele and haplotype frequencies in Koreans based on 107 families. Tissue Antigens 59: 475-486 (2002). *

• Soria J, Garagorri JM, Rodriguez M, Rodriguez G, Larrad L, Elizalde M. Epidemiology and genetic risk of type 1 diabetes among children in Aragon community, Spain. Diabetes Res. Clin. Pract. 79: 112-116 (2008).

• Sorrentino R, De Grazia U, Buzzetti R, Nistico L, Iannicola C, Costanzi S, Tosi R. An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes 41: 904-908 (1992).

• Sospedra M, Muraro PA, Stefanova I, Zhao Y, Chung K, Li Y, Giulianotti M, Simon R, Mariuzza R, Pinilla C, Martin R. Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype. J. Immunol. 176: 1951-1961 (2006). *

• Spaapen RM, Lokhorst HM, van den Oudenalder K, Otterud BE, Dolstra H, Leppert MF, Minnema MC, Bloem AC, Mutis T. Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis. J. Exp. Med. 205: 2863-2872 (2008). *

• Spaenij-Dekking EH, Kooy-Winkelaar EM, Nieuwenhuizen WF, Drijfhout JW, Koning F. A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin. Gut 53: 1267-1273 (2004). *

• Spagnolo P, du Bois RM. Genetics of sarcoidosis. Clin. Dermatol. 25: 242-249 (2007).

• Spatz M, Eibl N, Hink S, Wolf HM, Fischer GF, Mayr WR, Schernthaner G, Eibl MM. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell. Immunol. 221: 5-26 (2003). *

• Spengler U, Pape GR, Hoffmann RM, Johnson JP, Eisenburg J, Paumgartner G, Riethmuller G. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology 8: 459-462 (1988).

• Spoletini M, Petrone A, Zampetti S, Capizzi M, Zavarella S, Osborn J, Foffi C, Tuccinardi D, Pozzilli P, Buzzetti R; on behalf of the IMDIAB Group. Low-risk HLA genotype in type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis. Diabet. Med. 24: 1487-1490 (2007). *

• Spriewald BM, Lefter C, Huber I, Lauer B, Wenkel H. A suggestive association of Fuchs heterochromic cyclitis with cytotoxic T cell antigen 4 gene polymorphism. Ophthalmic Res. 39: 116-120 (2007).

• Spriewald BM, Witzke O, Wassmuth R, Wenzel RR, Arnold ML, Philipp T, Kalden JR. Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis. Ann. Rheum. Dis. 64: 457-461 (2005). *

• Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53: 459-469 (1999). *

• Spurkland A, Sollid LM, Ronningen KS, Bosnes V, Ek J, Vartdal F, Thorsby E. Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles. Hum. Immunol. 29: 157-165 (1990).

• Srivastava A, Yachha SK, Mathias A, Parveen F, Poddar U, Agrawal S. Prevalence, human leukocyte antigen typing and strategy for screening among Asian first-degree relatives of children with celiac disease. J. Gastroenterol. Hepatol. Nov 19 [Epub ahead of print] (2009). *

• Stanevicha V, Eglite J, Sochnevs A, Gardovska D, Zavadska D, Shantere R. HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res. Ther. 5: R340-R346 (2003). *

• Stayoussef M, Benmansour J, Al-Irhayim AQ, Said HB, Rayana CB, Mahjoub T, Almawi WY. Autoimmune type 1 diabetes genetic susceptibility encoded by HLA-DRB1 and -DQB1 genes in Tunisia. Clin. Vaccine Immunol. 16: 1146-1150 (2009). *

• Stayoussef M, Jatta J, Al-Jenaidi FA, Nemr R, Ali ME, Mahjoub T, Almawi WY. Common and specific HLA-DRB1/DQB1 haplotypes influence the genetic susceptibility to type 1 diabetes in three distinct Arab populations. Clin. Vaccine Immunol. 16: 136-138 (2009). *

• Stazi AV. Coeliac disease and reproduction: possible in vivo models. Ann. Ist Super Sanita. 41: 523-531 (2005).

• Steck AK, Baschal EE, Jasinski JM, Boehm BO, Bottini N, Concannon P, Julier C, Morahan G, Noble JA, Polychronakos C, She JX, Eisenbarth GS. rs2476601 T allele (R620W) defines high-risk PTPN22 type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype. Genes Immun. 10: S21-S26 (2009).

• Steck AK, Zhang W, Bugawan TL, Barriga KJ, Blair A, Erlich HA, Eisenbarth GS, Norris JM, Rewers MJ. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes? Diabetes 58: 1028-1033 (2009). *

• Stenberg P, Roth EB, Sjoberg K. Transglutaminase and the pathogenesis of coeliac disease. Eur. J. Intern. Med. 19: 83-91 (2008).

• Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L, Taki I, Norris JM, Erlich HA, Eisenbarth GS, Rewers M. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am. J. Gastroenterol. 101: 2333-2340 (2006). *

• Stene LC, Thorsby PM, Berg JP, Ronningen KS, Joner G; the Norwegian Childhood Diabetes Study Group. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism, cod liver oil and risk of type 1 diabetes. Pediatr. Diabetes 9: 40-45 (2008). *

• Stepniak D, Koning F. Celiac disease - sandwiched between innate and adaptive immunity. Hum. Immunol. 67: 460-468 (2006).

• Stepniak D, Vader LW, Kooy Y, van Veelen PA, Moustakas A, Papandreou NA, Eliopoulos E, Drijfhout JW, Papadopoulos GK, Koning F. T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics 57: 8-15 (2005). *

• Stepniak D, Wiesner M, de Ru AH, Moustakas AK, Drijfhout JW, Papadopoulos GK, van Veelen PA, Koning F. Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2. J. Immunol. 180: 3268-3278 (2008). *

• Sterkers G, Zeliszewski D, Chaussee AM, Deschamps I, Font MP, Freidel C, Hors J, Betuel H, Dausset J, Levy JP. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. Proc. Natl. Acad. Sci. U.S.A. 85: 6473-6477 (1988). *

• Stevens AM, Tsao BP, Hahn BH, Guthrie K, Lambert NC, Porter AJ, Tylee TS, Nelson JL. Maternal HLA class II compatibility in men with systemic lupus erythematosus. Arthritis Rheum. 52: 2768-2773 (2005). *

• Stickler M, Valdes AM, Gebel W, Razo OJ, Faravashi N, Chin R, Rochanayon N, Harding FA. The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4(+) T-cell epitope in human interferon-beta. Genes Immun. 5: 1-7 (2004). *

• Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 45: 395-401 (1999). *

• Stone J, Wade JA, Cauch-Dudek K, Ng C, Lindor KD, Heathcote EJ. Human leukocyte antigen class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis. J. Hepatol. 36: 8-13 (2002). *

• Straumfors A, Johansen BH, Vartdal F, Sollid LM, Thorsby E, Buus S. A peptide-binding assay for the disease-associated HLA-DQ8 molecule. Scand. J. Immunol. 47: 561-567 (1998). *

• Strettell MD, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, Williams R. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 112: 2028-2035 (1997). *

• Stuck BJ, Pani MA, Besrour F, Segni M, Krause M, Usadel KH, Badenhoop K. No association of two Fas gene polymorphisms with Hashimoto's thyroiditis and Graves' disease. Eur. J. Endocrinol. 149: 393-396 (2003). *

• Sturgess R, Day P, Ellis HJ, Lundin KE, Gjertsen HA, Kontakou M, Ciclitira PJ. Wheat peptide challenge in coeliac disease. Lancet 343: 758-761 (1994).

• Su H, Wang BL, Zhang XJ, Hao JH, Xiao Q, Ye DQ. Disequilibrium linkage between the polymorphism in exons 2, 3 and 4 of the MICA gene and HLA-B antigen of patient with ankylosing spondylitis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 446-448 (2006).

• Su X, Bi L, Hai R, Qimuge S, Ying M, Bahring S, Gong M. HLA-DPB1, -DRB1, and -DQB1 polymorphism defined in Ewenki ethnic minority of China Inner Mongolia Autonomous Region. Int. J. Immunogenet. 34: 435-440 (2007). *

• Sulcebe G, Sanchez-Mazas A, Tiercy JM, Shyti E, Mone I, Ylli Z, Kardhashi V. HLA allele and haplotype frequencies in the Albanian population and their relationship with the other European populations. Int. J. Immunogenet. 36: 337-343 (2009).

• Sumnik Z, Cinek O, Bratanic N, Kordonouri O, Kulich M, Roszai B, Arato A, Lebl J, Soltesz G, Danne T, Battelino T, Schober E. Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB1*02-DQA1*05 andTNF -308A. Diabetes Care 29: 858-863 (2006). *

• Sumnik Z, Drevinek P, Snajderova M, Kolouskova S, Sedlakova P, Pechova M, Vavrinec J, Cinek O. HLA-DQ polymorphisms modify the risk of thyroid autoimmunity in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 16: 851-858 (2003).

• Suzuki H, Isaka M, Suzuki S. Type 1 diabetes mellitus associated with Graves' disease and Vogt-Koyanagi-Harada syndrome. Intern. Med. 47: 1241-1244 (2008). *

• Suzuki S, Kuwana M, Yasuoka H, Tanaka K, Fukuuchi Y, Kawakami Y. Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis. J. Neurol. Sci. 189: 59-64 (2001).

• Suzuki S, Shimoda M, Kawamura M, Sato H, Nogawa S, Tanaka K, Suzuki N, Kuwana M. Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects. Eur. J. Neurol. 12: 566-570 (2005).

• Szanto S, Bardos T, Szabo Z, David CS, Buzas EI, Mikecz K, Glant TT. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background. Arthritis Rheum. 50: 1984-1995 (2004). *

• Taccari E, Spadaro A, Sorgi ML, Riccieri V, Mora B. Role for familial and genetic features in the therapeutic response of psoriatic arthritis. Reumatismo 56: 162-168 (2004).

• Tait BD. Genetic susceptibility to type I diabetes: a review. J. Autoimmun. 3 Suppl. 1: 3-11 (1990).

• Tait BD. Solid phase assays for HLA antibody detection in clinical transplantation. Curr. Opin. Immunol. 21: 573-577 (2009).

• Tait BD, Drummond BP, Varney MD, Harrison LC. HLA-DRB1*0401 is associated with susceptibility to insulin-dependent diabetes mellitus independently of the DQB1 locus. Eur. J. Immunogenet. 22: 289-297 (1995).

• Tait BD, Hudson F, Cantwell L, Brewin G, Holdsworth R, Bennett G, Jose M. Review article: luminex technology for HLA antibody detection in organ transplantation. Nephrology (Carlton) 14: 247-254 (2009). *

• Takahashi H, Katagiri M. DNA sequence analysis of HLA-DQB genes associated with insulin-dependent diabetes mellitus in Japanese. Hokkaido Igaku Zasshi 65: 412-418 (1990).

• Takahashi K, Satoh J, Kojima Y, Negoro K, Hirai M, Hinokio Y, Kinouchi Y, Suzuki S, Matsuura N, Shimosegawa T, Oka Y. Promoter polymorphism of SLC11A1 (formerly NRAMP1) confers susceptibility to autoimmune type 1 diabetes mellitus in Japanese. Tissue Antigens 63: 231-236 (2004). *

• Takeuchi F, Nakano K, Yamada H, Hong GH, Nabeta H, Yoshida A, Matsuta K, Bannai M, Tokunaga K, Ito K. Association of HLA-DR with progressive systemic sclerosis in Japanese. J. Rheumatol. 21: 857-863 (1994).

• Taleb N, Bou Khalil P, Zantout MS, Zalloua P, Azar ST. Prevalence of asthmatic symptoms in Lebanese patients with type 1 diabetes and their unaffected siblings compared to age-matched controls. Acta Diabetol. Mar 25 [Epub ahead of print] (2009).

• Tamai H, Kimura A, Dong RP, Matsubayashi S, Kuma K, Nagataki S, Sasazuki T. Resistance to autoimmune thyroid disease is associated with HLA-DQ. J. Clin. Endocrinol. Metab. 78: 94-97 (1994). *

• Tamai H, Matsubayashi S, Kimura A. The linkage of the major histocompatibility complex to autoimmune thyroid diseases. Nippon Rinsho 57: 1710-1715 (1999).

• Tanaka A, Igarashi M, Kakinuma M, Oh-i T, Koga M, Okuda T. The occurrence of various collagen diseases in one family: a sister with ISSc, PBC, APS, and SS and a brother with systemic lupus erythematosus. J. Dermatol. 28: 547-653 (2001).

• Tanaka M, Abe J, Ito J, Horikawa R, Miki Y, Nakayama M, Kohsaka T, Tanae A, Hibi I. HLA class II (DR, DQ) in Japanese patients with type 1 diabetes mellitus. Acta Paediatr. Jpn. 32: 645-650 (1990).

• Tanaka S, Honda Y, Honda M. MX2 gene expression tends to be downregulated in subjects with HLA-DQB1*0602. Sleep 31: 749-751 (2008). *

• Tanaka S, Honda Y, Honda M. Identification of differentially expressed genes in blood cells of narcolepsy patients. Sleep 30: 974-979 (2007). *

• Taneja V, Behrens M, Basal E, Sparks J, Griffiths MM, Luthra H, David CS. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J. Immunol. 181: 2869-2877 (2008). *

• Taneja V, David CS. Autoimmunity versus tolerance: analysis using transgenic mice. Hum. Immunol. 61: 1383-1389 (2000).

• Taneja V, David CS. HLA class II transgenic mice as models of human diseases. Immunol. Rev. 169: 67-79 (1999).

• Taneja V, David CS. Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice. J. Autoimmun. 33: 260-269 (2009).

• Taneja V, Giphart MJ, Verduijn W, Naipal A, Malaviya AN, Mehra NK. Polymorphism of HLA-DRB, -DQA1, and -DQB1 in rheumatoid arthritis in Asian Indians: association with DRB1*0405 and DRB1*1001. Hum. Immunol. 46: 35-41 (1996).

• Taneja V, Griffiths MM, Luthra H, David CS. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism. Int. Immunol. 10: 1449-1457 (1998).

• Taneja V, Krco CJ, Behrens MD, Luthra HS, Griffiths MM, David CS. B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice. Mol. Immunol. 44: 2988-2996 (2007). *

• Taneja V, Taneja N, Behrens M, Griffiths MM, Luthra HS, David CS. Requirement for CD28 may not be absolute for collagen-induced arthritis: study with HLA-DQ8 transgenic mice. J. Immunol. 174: 1118-1125 (2005). *

• Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, David CS. CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J. Immunol. 168: 5867-5875 (2002). *

• Tanwandee T, Wanichapol S, Vejbaesya S, Chainuvati S, Chotiyaputta W. Association between HLA class II alleles and autoimmune hepatitis type 1 in Thai patients. J. Med. Assoc. Thai. 89 Suppl. 5: S73-S78 (2007).

• Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'hanlon TP, Miller FW, Rider LG. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 54: 3682-3689 (2006). *

• Tay GK, Hui J, Gaudieri S, Schmitt-Egenolf M, Martinez OP, Leelayuwat C, Williamson JF, Eiermann TH, Dawkins RL. PERB11 (MIC): a polymorphic MHC gene is expressed in skin and single nucleotide polymorphisms are associated with psoriasis. Clin. Exp. Immunol. 119: 553-558 (2000). *

• Taylor GM, Hussain A, Lightfoot TJ, Birch JM, Eden TO, Greaves MF. HLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypes. Br. J. Cancer 98: 1125-1131 (2008). *

• Taylor M, Hussain A, Urayama K, Chokkalingam A, Thompson P, Trachtenberg E, Buffler P. The human major histocompatibility complex and childhood leukemia: an etiological hypothesis based on molecular mimicry. Blood Cells Mol. Dis. 42: 129-135 (2009).

• TEDDY Study Group. The environmental determinants of diabetes in the young (TEDDY) study. Ann. N. Y. Acad. Sci. 1150: 1-13 (2008). *

• Teller K, Budhai L, Zhang M, Haramati N, Keiser HD, Davidson A. HLA-DRB1 and DQB typing of Hispanic American patients with rheumatoid arthritis: the "shared epitope" hypothesis may not apply. J. Rheumatol. 23: 1363-1368 (1996).

• Temajo NO, Howard N. The co-operative specificity theory: phenotypic protection from T1D by certain HLA class II DRB1 and DQ alleles identifies the absence of co-operation between the respective DR and DQ molecules eventuating in no T1D-predisposition. Autoimmun. Rev. 8: 364-368 (2009).

• Teufel A, Worns M, Weinmann A, Centner C, Piendl A, Lohse AW, Galle PR, Kanzler S. Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients. World J. Gastroenterol. 12: 5513-5516 (2006). *

• Teutsch SM, Bennetts BH, Buhler MM, Heard RN, Stewart GJ. The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients. Hum. Immunol. 60: 715-722 (1999).

• Thakur S, Ranjan P, Ghoshal UC, Muller-Myhsok B, Khan F, Talwar S, Agarwal S. Association of human leucocyte DR and DQ antigens in Crohn's disease in Asian Indians: a family study. Trop. Gastroenterol. 24: 185-188 (2003).

• Thibaudin D, Thibaudin L, Berthoux P, Mariat C, Filippis JP, Laurent B, Alamartine E, Berthoux F. TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset/occurrence of idiopathic membranous nephropathy. Kidney Int. 71: 431-437 (2007). *

• Thomas HJ, Ahmad T, Rajaguru C, Barnardo M, Warren BF, Jewell DP. Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease. Scand. J. Gastroenterol. 44: 1076-1083 (2009). *

• Thomsen M, Molvig J, Zerbib A, de Preval C, Abbal M, Dugoujon JM, Ohayon E, Svejgaard A, Cambon-Thomsen A, Nerup J. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes. Immunogenetics 28: 320-327 (1988).

• Thomson G, Valdes AM. Conditional genotype analysis: detecting secondary disease loci in linkage disequilibrium with a primary disease locus. BMC Proc. 1 Suppl. 1: S163 (2007). *

• Thomson G, Valdes AM, Noble JA, Kockum I, Grote MN, Najman J, Erlich HA, Cucca F, Pugliese A, Steenkiste A, Dorman JS, Caillat-Zucman S, Hermann R, Ilonen J, Lambert AP, Bingley PJ, Gillespie KM, Lernmark A, Sanjeevi CB, Ronningen KS, Undlien DE, et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 70: 110-127 (2007). *

• Thorsby E, Ronningen KS. Role of HLA genes in predisposition to develop insulin-dependent diabetes mellitus. Ann. Med. 24: 523-531 (1992).

• Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 371-377 (1993).

• Tienari PJ, Wikstrom J, Koskimies S, Partanen J, Palo J, Peltonen L. Reappraisal of HLA in multiple sclerosis: close linkage in multiplex families. Eur. J. Hum. Genet. 1: 257-268 (1993).

• Tiercy JM, Gorski J, Jeannet M, Mach B. Identification and distribution of three serologically undetected alleles of HLA-DR by oligonucleotide.DNA typing analysis. Proc. Natl. Acad. Sci. U.S.A. 85: 198-202 (1988). *

• Tiercy JM, Jeannet M, Mach B. A new HLA-DRB1 allele within the DRw52 supertypic specificity (DRw13-DwHAG): sequencing and direct identification by oligonucleotide typing. Eur. J. Immunol. 20: 237-241 (1990).

• Tighe MR, Hall MA, Ashkenazi A, Siegler E, Lanchbury JS, Ciclitira PJ. Celiac disease among Ashkenazi Jews from Israel. A study of the HLA class II alleles and their associations with disease susceptibility. Hum. Immunol. 38: 270-276 (1993).

• Tighe MR, Hall MA, Barbado M, Cardi E, Welsh KI, Ciclitira PJ. HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens 40: 90-97 (1992).

• Tighe MR, Hall MA, Cardi E, Ashkenazi A, Lanchbury JS, Ciclitira PJ. Associations between alleles of the major histocompatibility complex-encoded ABC transporter gene TAP2, HLA class II alleles, and celiac disease susceptibility. Hum. Immunol. 39: 9-16 (1994).

• Tikkakoski S, Savilahti E, Kolho KL. Undiagnosed coeliac disease and nutritional deficiencies in adults screened in primary health care. Scand. J. Gastroenterol. 42: 60-65 (2007). *

• Ting YT, Temme S, Koch N, McLellan AD. A new monoclonal antibody recognizing a linear determinant on the HLA-DRalpha chain N-terminus. Hybridoma (Larchmt.) 28: 423-429 (2009).

• Tinto N, Ciacci C, Calcagno G, Gennarelli D, Spampanato A, Farinaro E, Tortora R, Sacchetti L. Increased prevalence of celiac disease without gastrointestinal symptoms in adults MICA 5.1 homozygous subjects from the Campania area. Dig. Liver Dis. 40: 248-252 (2008).

• Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604 (1987). *

• Todd JA, Fukui Y, Kitagawa T, Sasazuki T. The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese. Proc. Natl. Acad. Sci. U.S.A. 87: 1094-1098 (1990). *

• Tollefsen S, Arentz-Hansen H, Fleckenstein B, Molberg O, Raki M, Kwok WW, Jung G, Lundin KE, Sollid LM. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J. Clin. Invest. 116: 2226-2236 (2006). *

• Ton TG, Longstreth WT Jr, Koepsell T. Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: a population-based case-control study. Neuroepidemiology 32: 114-121 (2008).

• Tong JC, Tan TW, Sinha AA, Ranganathan S. Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6- associated pemphigus vulgaris. BMC Bioinformatics 7 Suppl. 5: S7 (2006). *

• Torn C, Gupta M, Nikitina Zake L, Sanjeevi CB, Landin-Olsson M. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults. Hum. Immunol. 64: 902-909 (2003).

• Torn C, Gupta M, Sanjeevi CB, Aberg A, Frid A, Landin-Olsson M. Different HLA-DR-DQ and MHC class I chain-related gene A (MICA) genotypes in autoimmune and nonautoimmune gestational diabetes in a Swedish population. Hum. Immunol. 65: 1443-1450 (2004).

• Torn C, Hillman M, Sanjeevi CB, Landin-Olsson M. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus - a study in 609 Swedish subjects. Hum. Immunol. 67: 527-534 (2006).

• Torres MI, Lopez Casado MA, Rios A. New aspects in celiac disease. World J. Gastroenterol. 13: 1156-1161 (2007). *

• Torres MI, Lopez-Casado MA, Luque J, Pena J, Rios A. New advances in coeliac disease: serum and intestinal expression of HLA-G. Int. Immunol. 18: 713-718 (2006). *

• Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, McElree CK, Pressman SR, Shanahan F, Targan SR, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 104: 741-748 (1993).

• Trachtenberg E, Vinson M, Hayes E, Hsu YM, Houtchens K, Erlich H, Klitz W, Hsia Y, Hollenbach J. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens 70: 455-463 (2007). *

• Trachtenberg EA, Yang H, Hayes E, Vinson M, Lin C, Targan SR, Tyan D, Erlich H, Rotter JI. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish Caucasian populations. Hum. Immunol. 61: 326-333 (2000).

• Traherne JA, Barcellos LF, Sawcer SJ, Compston DA, Ramsay PP, Hauser SL, Oksenberg JR, Trowsdale J. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Hum. Mol. Genet. 15: 155-161 (2006). *

• Traherne JA, Horton R, Roberts AN, Miretti MM, Hurles ME, Stewart CA, Ashurst JL, Atrazhev AM, Coggill P, Palmer S, Almeida J, Sims S, Wilming LG, Rogers J, de Jong PJ, Carrington M, Elliott JF, Sawcer S, Todd JA, Trowsdale J, Beck S. Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet. 2: e9 (2006). *

• Treem WR. Emerging concepts in celiac disease. Curr. Opin. Pediatr. 16: 552-559 (2004).

• Tripathy AS, Shankarkumar U, Chadha MS, Ghosh K, Arankalle VA. Association of HLA alleles with hepatitis C infection in Maharashtra, western India. Indian J. Med. Res. 130: 550-555 (2009).

• Trucco G, Fritsch R, Giorda R, Trucco M. Rapid detection of IDDM susceptibility with HLA-DQ beta-alleles as markers. Diabetes 38:1617-1622 (1989).

• Truedsson L, Sturfelt G, Johansen P, Nived O, Thuresson B. Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01, DR17] J. Rheumatol. 22: 1852-1861 (1995).

• Truyen I, De Grijse J, Van Schravendijk C, De Smet D, Decochez K, Vandemeulebroucke E, Giri M, Keymeulen B, Mathieu C, Van Gaal L, De Pauw P, Weets I, Pipeleers DG, Gorus FK; Belgian Diabetes Registry. Adiponectin levels do not predict clinical onset of type 1 diabetes in antibody-positive relatives. Diabetologia 50: 2143-2146 (2007). *

• Tsuchiya K. Immunogenetic analysis of rheumatoid arthritis in the Japanese population. Fukuoka Igaku Zasshi 84: 68-78 (1993).

• Tsuchiya N, Kobayashi S, Hashimoto H, Ozaki S, Tokunaga K. Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese. Genes Immun. 7: 81-84 (2006). *

• Tsujimura A, Ota M, Katsuyama Y, Sada M, Miura H, Matsumiya K, Gotoh R, Nakatani T, Okuyama A, Takahara S. Susceptibility gene for non-obstructive azoospermia located near HLA-DR and -DQ loci in the HLA class II region. Hum. Genet. 110: 192-197 (2002). *

• Tuokko J, Nejentsev S, Luukkainen R, Toivanen A, Ilonen J. HLA haplotype analysis in Finnish patients with rheumatoid arthritis. Arthritis Rheum. 44: 315-322 (2001). *

• Tuokko J, Pushnova E, Yli-Kerttula U, Toivanen A, Ilonen J. TAP2 alleles in inflammatory arthritis. Scand. J. Rheumatol. 27: 225-229 (1998).

• Tuokko J, Reijonen H, Ilonen J, Anttila K, Nikkari S, Mottonen T, Yli-Kerttula U, Toivanen A. Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis. Ann. Rheum. Dis. 56: 37-40 (1997). *

• Turesson C. Endothelial expression of MHC class II molecules in autoimmune disease. Curr. Pharm. Des. 10: 129-143 (2004).

• Turesson C, Schaid DJ, Weyand CM, Jacobsson LT, Goronzy JJ, Petersson IF, Sturfelt G, Nyhall-Wahlin BM, Truedsson L, Dechant SA, Matteson EL. The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res. Ther. 7: R1386-R1393 (2005). *

• Turkcapar N, Kinikli G, Sak SD, Duman M. Specific immunotherapy-induced Sjogren's syndrome. Rheumatol. Int. 26: 182-184 (2005). *

• Tuysuz B, Dursun A, Kutlu T, Sokucu S, Cine N, Suoglu O, Erkan T, Erginel-Unaltuna N, Tumay G. HLA-DQ alleles in patients with celiac disease in Turkey. Tissue Antigens 57: 540-542 (2001). *

• Tye-Din J, Anderson R. Immunopathogenesis of celiac disease. Curr. Gastroenterol. Rep. 10: 458-465 (2008).

• Tzang BS, Tsai CC, Shi JY, Hsu TC. Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein. Clin. Chim. Acta 395: 77-83 (2008). *

• Ueda R, Ohkusu-Tsukada K, Fusaki N, Soeda A, Kawase T, Kawakami Y, Toda M. Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy. Int. J. Cancer 126: 919-929 (2009). *

• Ueki A, Isozaki Y, Kusaka M. Anti-caspase-8 autoantibody response in silicosis patients is associated with HLA-DRB1, DQB1 and DPB1 alleles. J. Occup. Health 47: 61-67 (2005). *

• Ueta M, Tokunaga K, Sotozono C, Inatomi T, Yabe T, Matsushita M, Mitsuishi Y, Kinoshita S. HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Mol. Vis. 14: 550-555 (2008). *

• Uibo O, Teesalu K, Metskula K, Reimand T, Saat R, Sillat T, Reimand K, Talvik T, Uibo R. Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies. World J. Gastroenterol. 12: 1430-1434 (2006). *

• Umemura T, Ota M, Hamano H, Katsuyama Y, Muraki T, Arakura N, Kawa S, Kiyosawa K. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am. J. Gastroenterol. 103: 588-594 (2008). *

• Underhill J, Donaldson P, Bray G, Doherty D, Portmann B, Williams R. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology 16: 1404-1408 (1992).

• Underhill JA, Donaldson PT, Doherty DG, Manabe K, Williams R. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 21: 959-962 (1995).

• Undlien DE, Kockum I, Ronningen KS, Lowe R, Saanjeevi CB, Graham J, Lie BA, Akselsen HE, Lernmark A, Thorsby E. HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes. Tissue Antigens 54: 543-551 (1999). *

• Urcelay E, Santiago JL, de la Calle H, Martinez A, Mendez J, Ibarra JM, Maluenda C, Fernandez-Arquero M, de la Concha EG. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4. BMC Genomics 6: 56 (2005). *

• Vacek MM, Schaffer AA, Davis J, Fischer RE, Dale JK, Adams S, Straus SE, Puck JM. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia). Clin. Immunol. 118: 59-65 (2006). *

• Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, Spaenij L, Koning F. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc. Natl. Acad. Sci. U.S.A. 100: 12390-12395 (2003). *

• Valdes AM, Erlich HA, Noble JA. Human leukocyte antigen class I B and C loci contribute to type 1 diabetes (T1D) susceptibility and age at T1D onset. Hum. Immunol. 66: 301-313 (2005).

• Valdes AM, McWeeney S, Thomson G. HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: application of the haplotype method. Am. J. Hum. Genet. 60: 717-728 (1997). *

• Valdes AM, Noble JA, Genin E, Clerget-Darpoux F, Erlich HA, Thomson G. Modeling of HLA class II susceptibility to type I diabetes reveals an effect associated with DPB1. Genet. Epidemiol. 21: 212-223 (2003).

• Valdes AM, Thomson G. Detecting disease-predisposing variants: the haplotype method. Am. J. Hum. Genet. 60: 703-716 (1997). *

• Valdes AM, Thomson G, Barcellos LF. Genetic variation within the HLA class III influences T1D susceptibility conferred by high-risk HLA haplotypes. Genes Immun. Jan 7 [Epub ahead of print] (2010).

• Valdes AM, Thomson G; Diabetes Genetics Consortium. Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1. Diabetes Obes. Metab. 11 Suppl. 1: 46-52 (2009). *

• Vambergue A, Fajardy I, Bianchi F, Cazaubiel M, Verier-Mine O, Goeusse P, Fontaine P, Danze PM. Gestational diabetes mellitus and HLA class II (-DQ, -DR) association: The Digest Study. Eur. J. Immunogenet. 24: 385-394 (1997).

• Van Autreve JE, Koeleman BP, Quartier E, Aminkeng F, Weets I, Gorus FK, Van der Auwera BJ; Belgian Diabetes Registry. MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum. Immunol. 67: 94-101 (2006).

• Van Autreve JE, Weets I, Gulbis B, Vertongen F, Gorus FK, Van Der Auwera BJ; Belgian Diabetes Registry. The rare HLA-DQA1*03-DQB1*02 haplotype confers susceptibility to type 1 diabetes in whites and is preferentially associated with early clinical disease onset in male subjects. Hum. Immunol. 65: 729-736 (2004).

• Van Belzen MJ, Koeleman BP, Crusius JB, Meijer JW, Bardoel AF, Pearson PL, Sandkuijl LA, Houwen RH, Wijmenga C. Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients. Genes Immun. 5: 215-220 (2004). *

• Van Belzen MJ, Meijer JW, Sandkuijl LA, Bardoel AF, Mulder CJ, Pearson PL, Houwen RH, Wijmenga C. A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology 125: 1032-1041 (2003). *

• van Belzen MJ, Vrolijk MM, Meijer JWR, Crusius JBA, Pearson PL, Sandkuijl LA, Houwen RHJ, Wijmenga C. A genomewide screen in a four-generation Dutch family with celiac disease: evidence for linkage to chromosomes 6 and 9. Am. J. Gastroenterol. 99: 466-471 (2004). *

• van de Wal Y, Kooy YM, van Veelen PA, Pena SA, Mearin LM, Molberg O, Lundin KE, Sollid LM, Mutis T, Benckhuijsen WE, Drijfhout JW, Koning F. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc. Natl. Acad. Sci. U.S.A. 95: 10050-10054 (1998). *

• Van der Auwera BJ, Vandewalle CL, Schuit FC, Winnock F, De Leeuw IH, Van Imschoot S, Lamberigts G, Gorus FK. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry. Clin. Exp. Immunol. 110: 98-103 (1997). *

• van der Horst-Bruinsma IE, Visser H, Hazes JM, Breedveld FC, Verduyn W, Schreuder GM, de Vries RR, Zanelli E. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum. Immunol. 60: 152-158 (1999).

• van der Slik AR, van den Eng I, Eerligh P, Doxiadis II, Koeleman BP, Roep BO, Giphart MJ. Sequence variation within the major histocompatibility complex subregion centromeric of HLA class II in type 1 diabetes. Tissue Antigens 69: 348-353 (2007). *

• Van Gaalen FA, Van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, Van Venrooij WJ, Verweij CL, Toes RE, De Vries RR. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 50: 2113-2121 (2004). *

• van Heel DA, Hunt K, Greco L, Wijmenga C. Genetics in coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19: 323-339 (2005).

• van Herpen TW, Goryunova SV, van der Schoot J, Mitreva M, Salentijn E, Vorst O, Schenk MF, van Veelen PA, Koning F, van Soest LJ, Vosman B, Bosch D, Hamer RJ, Gilissen LJ, Smulders MJ. Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes. BMC Genomics 7: 1 (2006). *

• van Lith M, van Ham M, Neefjes J. Novel polymorphisms in HLA-DOA and HLA-DOB in B-cell malignancies. Immunogenetics 54: 591-595 (2002). *

• Van Steenbergen W, De Goede E, Emonds MP, Reinders J, Tilanus M, Fevery J. Primary sclerosing cholangitis in two brothers: report of a family with special emphasis on molecular HLA and MICA genotyping. Eur. J. Gastroenterol. Hepatol. 17: 767-771 (2005).

• Vande Voort JL, Murray JA, Lahr BD, Van Dyke CT, Kroning CM, Moore SB, Wu TT. Lymphocytic duodenosis and the spectrum of celiac disease. Am. J. Gastroenterol. 104: 142-148 (2009). *

• Varga M, Rajczy K, Telkes G, Hidvegi M, Peter A, Remport A, Korbonits M, Fazakas J, Toronyi E, Sarvary E, Kobori L, Jaray J. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients. Nephrol. Dial. Transplant. 23: 2673-2678 (2008).

• Vargas Perez ML, Melero Ruiz J, Fernandez de Mera J, Gonzalez Roiz C, Catalina Fernandez I, Romero Albillos A. Serological and genetic markers in the diagnosis and follow-up of coeliac disease. An. Pediatr. (Barc.) 62: 412-419 (2005).

• Vargas-Alarcon G, Salgado N, Granados J, Gomez-Casado E, Martinez-Laso J, Alcocer-Varela J, Arnaiz-Villena A, Alarcon-Segovia D. Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility. Hum. Immunol. 62: 814-820 (2001).

• Vasconcelos CC, Fernandez O, Leyva L, Thuler LC, Alvarenga RM. Does the DRB1*1501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis. J. Neuroimmunol. 214: 101-103 (2009).

• Vassallo C, Brazzelli V, Cestone E, Castello M, Ciocca O, Borroni RG, Martinetti M, Borroni G. Mycosis fungoides in childhood: description and study of two siblings. Acta Derm. Venereol. 87: 529-532 (2007).

• Vatay A, Rajczy K, Pozsonyi E, Hosszufalusi N, Prohaszka Z, Fust G, Karadi I, Szalai C, Grosz A, Bartfai Z, Panczel P. Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus. Immunol. Lett. 84: 109-115 (2002).

• Vazquez-Garcia MN, Alaez C, Olivo A, Debaz H, Perez-Luque E, Burguete A, Cano S, de la Rosa G, Bautista N, Hernandez A, Bandera J, Torres LF, Kershenobich D, Alvarez F, Gorodezky C. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J. Hepatol. 28: 985-990 (1998). *

• Vegosen LJ, Weinberg CR, O'Hanlon TP, Targoff IN, Miller FW, Rider LG. Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures. Arthritis Rheum. 56: 2719-2728 (2007). *

• Vehe RK, Nepom GT, Wilske KR, Stage D, Begovich AB, Nepom BS. Erosive rheumatoid factor negative and positive rheumatoid arthritis are immunogenetically similar. J. Rheumatol. 21: 194-196 (1994).

• Vehik K, Hamman RF, Lezotte D, Norris JM, Klingensmith GJ, Rewers M, Dabelea D. Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes. Diabetes Care 31: 1392-1396 (2008). *

• Veneri D, De Matteis G, Solero P, Federici F, Zanuso C, Guizzardi E, Arena S, Gaio M, Pontiero P, Ricetti MM, Franchini M. Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets 16: 307-311 (2005).

• Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum. Immunol. 67: 561-567 (2006).

• Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am. J. Gastroenterol. 104: 1587-1594 (2009). *

• Verdu EF, Huang XX, Natividad JM, Lu J, Blennerhassett PA, David CS, McKay DM, Murray JA. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten sensitive HLA-DQ8 transgenic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G217-G225 (2008). *

• Vermeulen BA, Hogen Esch CE, Yuksel Z, Koning F, Verduijn W, Doxiadis II, Schreuder GM, Luisa Mearin M. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect. Scand. J. Gastroenterol. 44: 40-45 (2009). *

• Vidales MC, Zubillaga P, Zubillaga I, Alfonso-Sanchez MA. Allele and haplotype frequencies for HLA class II (DQA1 and DQB1) loci in patients with celiac disease from Spain. Hum. Immunol. 65: 352-358 (2004).

• Vieira ML, Caillat-Zucman S, Gajdos P, Cohen-Kaminsky S, Casteur A, Bach JF. Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. J. Neuroimmunol. 47: 115-122 (1993).

• Vignal C, Bansal AT, Balding DJ, Binks MH, Dickson MC, Montgomery DS, Wilson AG. Genetic association of the major histocompatibility complex with rheumatoid arthritis implicates two non-DRB1 loci. Arthritis Rheum. 60: 53-62 (2009). *

• Viken MK, Blomhoff A, Olsson M, Akselsen HE, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE, Lie BA. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex. Genes Immun. 10: 323-333 (2009). *

• Virtanen SM, Kaila M, Pekkanen J, Kenward MG, Uusitalo U, Pietinen P, Kronberg-Kippila C, Hakulinen T, Simell O, Ilonen J, Veijola R, Knip M. Early introduction of oats associated with decreased risk of persistent asthma and early introduction of fish with decreased risk of allergic rhinitis. Br. J. Nutr. 103: 266-273 (2010). *

• Visser H, Vos K, Zanelli E, Verduyn W, Schreuder GM, Speyer I, Breedveld FC, Hazes JM. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors. Ann. Rheum. Dis. 61: 499-504 (2002). *

• Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity. Ann. N. Y. Acad. Sci. 1165: 195-205 (2009). *

• Volanakis JE, Zhu ZB, Schaffer FM, Macon KJ, Palermos J, Barger BO, Go R, Campbell RD, Schroeder HW Jr, Cooper MD. Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J. Clin. Invest. 89: 1914-1922 (1992). *

• Volz T, Schwarz G, Fleckenstein B, Schepp CP, Haug M, Roth J, Wiesmuller KH, Dannecker GE. Determination of the peptide binding motif and high-affinity ligands for HLA-DQ4 using synthetic peptide libraries. Hum. Immunol. 65: 594-601 (2004).

• Voorter CE, Amicosante M, Berretta F, Groeneveld L, Drent M, van den Berg-Loonen EM. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens 70: 18-27 (2007). *

• Vorechovsky I, Kralovicova J, Laycock MD, Webster AD, Marsh SG, Madrigal A, Hammarstrom L. Short tandem repeat (STR) haplotypes in HLA: an integrated 50-kb STR/linkage disequilibrium/gene map between the RING3 and HLA-B genes and identification of STR haplotype diversification in the class III region. Eur. J. Hum. Genet. 9: 590-598 (2001). *

• Vos K, van der Horst-Bruinsma IE, Hazes JM, Breedveld FC, le Cessie S, Schreuder GM, de Vries RR, Zanelli E. Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis. Rheumatology (Oxford) 40: 133-139 (2001). *

• Vos K, Visser H, Schreuder GM, de Vries RR, Zwinderman AH, Breedveld FC, Hazes JM, Zanelli EH. Human leukocyte antigen-DQ and DR polymorphisms predict rheumatoid arthritis outcome better than DR alone. Hum. Immunol. 62: 1217-1225 (2001).

• Voskuyl AE, Hazes JM, Schreuder GM, Schipper RF, de Vries RR, Breedveld FC. HLA-DRB1, DQA1, and DQB1 genotypes and risk of vasculitis in patients with rheumatoid arthritis. J. Rheumatol. 24: 852-855 (1997).

• Wagner U, Kaltenhauser S, Pierer M, Seidel W, Troltzsch M, Hantzschel H, Kalden JR, Wassmuth R. Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis. Rheumatology (Oxford) 42: 553-562 (2003). *

• Wagner U, Kaltenhauser S, Sauer H, Arnold S, Seidel W, Hantzschel H, Kalden JR, Wassmuth R. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum. 40: 341-351 (1997).

• Wahnschaffe U, Schulzke JD, Zeitz M, Ullrich R. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 5: 844-850 (2007).

• Waldrep ML, Zhuang Y, Schroeder HW Jr. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8. BMC Med. Genet. 10: 100 (2009). *

• Wallace HJ, Vandongen YK, Stacey MC. Tumor necrosis factor-alpha -308 gene polymorphism and venous leg ulceration - comment on possible link with obesity. J. Invest. Dermatol. 127: 1770-1771 (2007). *

• Wallaschofski H, Meyer A, Tuschy U, Lohmann T. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm. Metab. Res. 35: 120-124 (2003).

• Wallden J, Ilonen J, Roivainen M, Ludvigsson J, Vaarala O; & the ABIS Study Group. Effect of HLA genotype or CTLA-4 polymorphism on cytokine response in healthy children. Scand. J. Immunol. 68: 345-350 (2008). *

• Wallin J, Hillert J, Olerup O, Carlsson B, Strom H. Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with T cell receptor beta chain gene alleles or haplotypes. Arthritis Rheum. 34: 1416-1424 (1991).

• Walter M, Albert E, Conrad M, Keller E, Hummel M, Ferber K, Barratt BJ, Todd JA, Ziegler AG, Bonifacio E. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 46: 712-720 (2003). *

• Wan Q, Shah R, Panos JC, Giraldo AA, David CS, Kong YM. HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible. Hum. Immunol. 63: 301-310 (2002).

• Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 39: 978-988 (2004). *

• Wang H, He R. HLA-DQA and DQB alleles contribute to susceptibility to insulin-dependent diabetes mellitus. Chin. Med. Sci. J. 8: 231-234 (1993).

• Wang JP, Zhang C, Lin J, Yuan Y, Zhou HF, Huang G, Zhou M, Zhou ZG. Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus. Zhonghua Yi Xue Za Zhi 87: 2380-2384 (2007).

• Wang JP, Zhou ZG, Lin J, Huang G, Zhang C, Yang L, Yuan Y, Zhou HF, Zhou M, Hou C, Zhou WD, Peng H, Hagopian WA. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives. Tissue Antigens 70: 369-375 (2007). *

• Wang LY, Wang CL, Chu CC, Lee HL, Ho HT, Liang DC, Liu HC, Lin M. Primary autoimmune neutropenia in children in Taiwan. Transfusion 49: 1003-1006 (2009).

• Wang T, Wang TJ, He Q, Zhang YK, Ma JM, Hou WJ, Wang SC, Pan ZC, Zhao YJ. HLA-DQA1 genotyping by using oligonucleotide microarrays. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14: 142-145 (2006).

• Wapenaar MC, Wijmenga C. A combined genetics and genomics approach to unravelling molecular pathways in coeliac disease. Novartis Found. Symp. 267: 113-134 (2005).

• Ward MM, Hendrey MR, Malley JD, Learch TJ, Davis JC Jr, Reveille JD, Weisman MH. Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum. 61: 859-866 (2009). *

• Wasilewska J, Jarocka-Cyrta E, Kaczmarski M. Narcolepsy, metabolic syndrome and obstructive sleep apnea syndrome as the causes of hypersomnia in children. Report of three cases. Adv. Med. Sci. 52 Suppl. 1: 207-211 (2007).

• Wassmuth R, Depner F, Danielsson A, Hultcrantz R, Loof L, Olson R, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindgren S. HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens 59: 381-387 (2002). *

• Wassmuth R, Eastman S, Kockum I, Holmberg E, Starck M, Lindhagen T, Kalden JR, Lernmark A, Sundkvist G, Lindgren S. HLA DR and DQ RFLP analysis in Crohn's disease. Eur. J. Immunogenet. 20: 429-433 (1993).

• Wawrzynowicz-Syczewska M, Underhill JA, Clare MA, Boron-Kaczmarska A, McFarlane IG, Donaldson PT. HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland. Liver 20: 234-239 (2000).

• Wedderburn LR, McHugh NJ, Chinoy H, Cooper RG, Salway F, Ollier WE, McCann LJ, Varsani H, Dunphy J, North J, Davidson JE; on behalf of the Juvenile Dermatomyositis Research Group (JDRG). HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis scleroderma overlap. Rheumatology (Oxford) 46: 1786-1791 (2007). *

• Weinzierl AO, Rudolf D, Maurer D, Wernet D, Rammensee HG, Stevanovic S, Klingel K. Identification of HLA-A*01- and HLA-A*02-restricted CD8+ T-cell epitopes shared among group B enteroviruses. J. Gen. Virol. 89: 2090-2097 (2008). *

• Welsh EA, Clark HH, Epstein SZ, Reveille JD, Duvic M. Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata. J. Invest. Dermatol. 103: 758-763 (1994). *

• Wen GS, Huang YK, Hao P, Li HL, Qi Q, Zhou LF. Immunogenetic analysis of human leukocyte antigen DRB1, DQB1 locus among Han ethnic children with Helicobacter pylori infection in Kunming. Zhonghua Liu Xing Bing Xue Za Zhi 26: 286-289 (2005).

• Wen L, Chen NY, Tang J, Sherwin R, Wong FS. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J. Clin. Invest. 107: 871-880 (2001). *

• Wen L, Wong FS, Tang J, Chen NY, Altieri M, David C, Flavell R, Sherwin R. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J. Exp. Med. 191: 97-104 (2000). *

• Whang DH, Park H, Roh EY, Park MH. TAP1 and TAP2 gene polymorphisms and HLA-TAP haplotypes in Koreans based on 90 families. Hum. Immunol. 66: 998-1007 (2005).

• Wieland I, Wermes C, Eifrig B, Holstein K, Pollmann H, Siegmund B, Bidlingmaier C, Kurnik K, Nimtz-Talaska A, Niekrens C, Eisert R, Tiede A, Ebenebe C, Lakomek M, Hoy L, Welte K, Sykora KW. Inhibitor-immunology-study. Different HLA-types seem to be involved in the inhibitor development in haemophilia A. Hamostaseologie 28 Suppl. 1: S26-S28 (2008).

• Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, Spurkland A. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens 69: 161-169 (2007). *

• Wiesner M, Stepniak D, de Ru AH, Moustakis AK, Drijfhout JW, Papadopoulos GK, van Veelen PA, Koning F. Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule. Immunogenetics 60: 551-555 (2008). *

• Williams AJ, Aitken RJ, Chandler MA, Gillespie KM, Lampasona V, Bingley PJ. Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2. Diabetologia 51: 1444-1448 (2008). *

• Williams R, Chen YF, Endres R, Middleton D, Trucco M, Williams JD, Knowler W. Molecular variation at the HLA-A, B, C, DRB1, DQA1, and DQB1 loci in full heritage American Indians in Arizona: private haplotypes and their evolution. Tissue Antigens Oct 21 [Epub ahead of print] (2009). *

• Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 94: 3195-3199 (1997). *

• Windsor L, Puschendorf M, Allcock R, Scott A, Sayer D, Kucharzak R, Gut I, McCann V, Davis E, Witt C, Christiansen F, Price P. Does a central MHC gene in linkage disequilibrium with HLA-DRB1*0401 affect susceptibility to type 1 diabetes? Genes Immun. 6: 298-304 (2005). *

• Witas HW, Jedrychowska-Danska K, Zawicki P. Extremely high frequency of autoimmune-predisposing alleles in medieval specimens. J. Zhejiang Univ. Sci. B. 8: 512-514 (2007). *

• Witt CS, Price P, Kaur G, Cheong K, Kanga U, Sayer D, Christiansen F, Mehra NK. Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe. Tissue Antigens 60: 474-480 (2002). *

• Witter K, Albert T, Zahn R, Kauke T. HLA-DQB1*0634, a novel DQB1 allele found by high-resolution HLA typing of a sibling pair for potential bone marrow transplantation. Tissue Antigens 71: 486-488 (2008).

• Wolters VM, Verbeek WH, Zhernakova A, Onland-Moret C, Schreurs MW, Monsuur AJ, Verduijn W, Wijmenga C, Mulder CJ. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Clin. Gastroenterol. Hepatol. 5: 1399-1405 (2007).

• Wolters VM, Wijmenga C. Genetic background of celiac disease and its clinical implications. Am. J. Gastroenterol. 103: 190-195 (2008). *

• Woolley N, Mustalahti K, Maki M, Partanen J. Cytokine gene polymorphisms and genetic association with coeliac disease in the Finnish population. Scand. J. Immunol. 61: 51-56 (2005). *

• Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc. Natl. Acad. Sci. U.S.A. 86: 10049-10053 (1989). *

• Wouters J, Weijerman ME, van Furth AM, Schreurs MW, Crusius JB, von Blomberg BM, Baaij LR, Broers CJ, Gemke RJ. Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome. J. Pediatr. 154: 239-242 (2009). *

• Wright DH. The major complications of coeliac disease. Baillieres Clin. Gastroenterol. 9: 351-369 (1995).

• Wu MS, Hsieh RP, Huang SP, Chang YT, Lin MT, Chang MC, Shun CT, Sheu JC, Lin JT. Association of HLA-DQB1*0301 and HLA-DQB1*0602 with different subtypes of gastric cancer in Taiwan. Jpn. J. Cancer Res. 93: 404-410 (2002).

• Wu SK, Lu D, Madden M, Liu CP, Miyokawa N, Bach FH, Saunders TL. Full-length DQ beta cDNA sequences of HLA-DR2/DQw1 subtypes: genetic interactions between two DQ beta loci generate human class II HLA diversity. Hum. Immunol. 27: 305-322 (1990).

• Xia J, Bergseng E, Fleckenstein B, Siegel M, Kim CY, Khosla C, Sollid LM. Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease. Bioorg. Med. Chem. 15: 6565-6573 (2007).

• Xia J, Siegel M, Bergseng E, Sollid LM, Khosla C. Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from alpha2-gliadin. J. Am. Chem. Soc. 128: 1859-1867 (2006). *

• Xia J, Sollid LM, Khosla C. Equilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA-DQ2. Biochemistry 44: 4442-4449 (2005). *

• Xiao FL, Zhou FS, Liu JB, Yan KL, Cui Y, Gao M, Liang YH, Sun LD, Zhou SM, Zhu YG, Zhang XJ, Yang S. Association of HLA-DQA1 and DQB1 alleles with alolpecia areata in Chinese Hans. Arch. Dermatol. Res. 297: 201-209 (2005). *

• Xu Y, Hu Q, Liu Z, Shen Y, Liu X, Lin B, Wu Y, Chen S, Xu A. Sequence variations in the transcriptional regulatory region and intron1 of HLA-DQB1 gene and their linkage in southern Chinese ethnic groups. Immunogenetics 57: 465-478 (2005). *

• Yabuki K, Ohno S, Mizuki N, Ando H, Tabbara KF, Goto K, Nomura E, Nakamura S, Ito N, Ota M, Katsuyama Y, Inoko H. HLA class I and II typing of the patients with Behcet's disease in Saudi Arabia. Tissue Antigens 54: 273-277 (1999). *

• Yahagi K, Ueno Y, Nomura E, Fukushima K, Moritoki Y, Kogure T, Kojima Y, Negoro K, Kinouchi Y, Shimosegawa T. Mapping of a disease susceptibility locus in the HLA region for primary biliary cirrhosis in Japan. Hepatol. Res. 37: 270-275 (2007). *

• Yamagata K, Nakajima H, Hanafusa T, Noguchi T, Miyazaki A, Miyagawa J, Sada M, Amemiya H, Tanaka T, Kono N, et al. Aspartic acid at position 57 of DQ beta chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 32: 762-764 (1989).

• Yamato E, Ikegami H, Kawaguchi Y, Fujisawa T, Hamada Y, Ueda H, Shintani M, Ogihara T. Insulin-dependent diabetes mellitus associated with autoimmune thyroiditis and rheumatoid arthritis. Am. J. Med. Sci. 313: 64-66 (1997).

• Yanagawa T, DeGroot LJ. HLA class II associations in African-American female patients with Graves' disease. Thyroid 6: 37-39 (1996).

• Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab. 80: 41-45 (1995). *

• Yanagawa T, Mangklabruks A, Chang YB, Okamoto Y, Fisfalen ME, Curran PG, DeGroot LJ. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab. 76: 1569-1574 (1993). *

• Yang H, Goluszko E, David C, Okita DK, Conti-Fine B, Chan TS, Poussin MA, Christadoss P. Induction of myasthenia gravis in HLA transgenic mice by immunization with human acetylcholine receptors. Ann. N. Y. Acad. Sci. 998: 375-378 (2003). *

• Yang H, Ren C, Xue L, Yuan H, Xu M, Tai W, Li J, Yang Y, Du J. Association between the polymorphism of HLA-DQA1 alleles and type 2 diabetes in Yi nationality of Yunnan. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22: 702-704 (2005).

• Yang H, Rotter JI, Toyoda H, Landers C, Tyran D, McElree CK, Targan SR. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J. Clin. Invest. 92: 1080-1084 (1993). *

• Yang H, Wu B, Tuzun E, Saini SS, Li J, Allman W, Higgs S, Xiao TL, Christadoss P. A new mouse model of autoimmune ocular myasthenia gravis. Invest. Ophthalmol. Vis. Sci. 48: 5101-5111 (2007). *

• Yang S, Ge HS, Zhang AP, Wei SC, Gao M, Wang HY, Chen JJ, Li M, Liang YH, He PP, Yang J, Zhang XJ. Haplotype associations of the MHC with psoriasis vulgaris in Chinese Hans. Clin. Exp. Dermatol. 29: 399-405 (2004).

• Yao Z, Kimura A, Hartung K, Haas PJ, Volgger A, Brunnler G, Bonisch J, Albert ED. Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. SLE Study Group members. Immunogenetics 38: 421-429 (1993).

• Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 47: 37-48 (1996).

• Ye YM, Hur GY, Park HJ, Kim SH, Kim HM, Park HS. Association of specific IgE to staphylococcal superantigens with the phenotype of chronic urticaria. J. Korean Med. Sci. 23: 845-851 (2008).

• Yee LJ. Host genetic determinants in hepatitis C virus infection. Genes Immun. 5: 237-245 (2004). *

• Yee LJ, Im K, Wahed AS, Bugawan T, Li J, Rhodes SL, Erlich H, Rosen HR, Liang TJ, Yang H; for the Virahep-C Study. Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C. Antimicrob. Agents Chemother. 53: 615-621 (2009). *

• Yelamos J, Garcia-Lozano JR, Moreno I, Aguilera I, Gonzalez MF, Garcia A, Nunez-Roldan A, Sanchez B. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum. 36: 811-814 (1993).

• Yin BC, Yue F, Ye BC. Construction of microarrays for genotyping of DQA using unmodified 45-mer oligonucleotide. Mol. Biotechnol. 36: 142-150 (2007).

• Yk W, L C, Syy F, Mhl N, Ckw H, Sh C, Nls T, Am L. Narcolepsy in Southern Chinese - clinical characteristics, HLA typing and seasonality of birth. J. Neurol. Neurosurg. Psychiatry 79: 1262-1267 (2008).

• Yokosawa S, Yoshizawa K, Ota M, Katsuyama Y, Kawa S, Ichijo T, Umemura T, Tanaka E, Kiyosawa K. A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1. Hepatology 45: 384-390 (2007). *

• Yokoyama S, Watanabe N, Sato N, Perera PY, Filkoski L, Tanaka T, Miyasaka M, Waldmann TA, Hiroi T, Perera LP. Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc. Natl. Acad. Sci. U.S.A. 106: 15849-15854 (2009). *

• Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T. HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens 53: 350-358 (1999).

• Yoshitake S, Okada M, Kimura A, Sasazuki T. Contribution of major histocompatibility complex genes to susceptibility and resistance in Helicobacter pylori related diseases. Eur. J. Gastroenterol. Hepatol. 11: 875-880 (1999).

• Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K. Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis. J. Hepatol. 42: 578-584 (2005). *

• Yousefipour GA, Salami Z, Farjadian S. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients. Iran J. Immunol. 6: 99-102 (2009).

• Yu RB, Hong X, Ding WL, Tan YF, Zhang YX, Sun NX, Wu GL, Zhan SW, Ge DF. The association between the genetic polymorphism of HLA-DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population. J. Gastroenterol. Hepatol. 23: 1394-1402 (2008). *

• Yuan G, Shi G, Li Z. DNA typing for HLA-DR and HLA-DQ alleles in Chinese patients with rheumatoid arthritis. Zhonghua Nei Ke Za Zhi 36: 234-237 (1997).

• Zahn A, Hinz U, Karner M, Ehehalt R, Stremmel W. Health-related quality of life correlates with clinical and endoscopic activity indexes but not with demographic features in patients with ulcerative colitis. Inflamm. Bowel Dis. 12: 1058-1067 (2006). *

• Zalloua PA, Abchee A, Shbaklo H, Zreik TG, Terwedow H, Halaby G, Azar ST. Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. Hum. Immunol. 65: 719-724 (2004).

• Zalloua PA, Shbaklo H, Halaby G, Terwedow H, Xu X, Azar ST. Type-2 diabetes family history delays the onset of type-1 diabetes. J. Clin. Endocrinol. Metab. 87: 3192-3196 (2002). *

• Zamani Ghabanbasani M, Spaepen M, Buyse I, Marynen P, Bex M, Bouillon R, Cassiman JJ. Improved risk assessment for insulin-dependent diabetes mellitus by analysis of amino acids in HLA-DQ and DRB1 loci. Eur. J. Hum. Genet. 2: 177-184 (1994).

• Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ. Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am. J. Med. Genet. 95: 432-437 (2000).

• Zamani M, Spaepen M, Sghar SS, Huang C, Westerhof W, Nieuweboer-Krobotova L, Cassiman JJ. Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br. J. Dermatol. 145: 90-94 (2001). *

• Zanelli E, Breedveld FC, de Vries RR. HLA class II association with rheumatoid arthritis: facts and interpretations. Hum. Immunol. 61: 1254-1261 (2000).

• Zanelli E, Huizinga TW, Guerne PA, Vischer TL, Tiercy JM, Verduyn W, Schreuder GM, Breedveld FC, de Vries RR. An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition. Immunogenetics 48: 394-401 (1998).

• Zanelli E, Krco CJ, Baisch JM, Cheng S, David CS. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 93: 1814-1819 (1996). *

• Zang W, Lin M, Kalache S, Zhang N, Kruger B, Waaga-Gasser AM, Grimm M, Hancock W, Heeger P, Schroppel B, Murphy B. Inhibition of the alloimmune response through the generation of regulatory T cells by a MHC class II-derived peptide. J. Immunol. 181: 7499-7506 (2008).

• Zantut-Wittmann DE, Persoli L, Tambascia MA, Fischer E, Franco Maldonado D, Costa AM, Joao Pavin E. HLA-DRB1*04 and HLA-DQB1*03 association with the atrophic but not with the goitrous form of chronic autoimmune thyroiditis in a Brazilian population. Horm. Metab. Res. 36: 492-500 (2004).

• Zavaglia C, Martinetti M, Silini E, Bottelli R, Daielli C, Asti M, Airoldi A, Salvaneschi L, Mondelli MU, Ideo G. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J. Hepatol. 28: 1-7 (1998).

• Zavattari P, Lampis R, Motzo C, Loddo M, Mulargia A, Whalen M, Maioli M, Angius E, Todd JA, Cucca F. Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1, -DRB1 disease loci. Hum. Mol. Genet. 10: 881-889 (2001). *

• Zeitlin AA, Heward JM, Newby PR, Carr-Smith JD, Franklyn JA, Gough SC, Simmonds MJ. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease. Genes Immun. 9: 358-363 (2008).

• Zelefsky JR, Taylor CJ, Srinivasan M, Galasinski S, Goodman RS, Key T, Watson PG, Cunningham ET Jr. HLA-DR17 and Mooren's ulcer in South India. Br. J. Ophthalmol. 92: 179-181 (2008).

• Zetterquist H, Broome U, Einarsson K, Olerup O. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis. Gut 33: 942-946 (1992). *

• Zhai L, Sun Y, Tang L, Liu H. Polymorphism between loci for human leukocyte antigens DR and DQ in patients with nasal polyps. Ann. Otol. Rhinol. Laryngol. 116: 66-68 (2007).

• Zhang D, Zhou Z, Li L, Weng J, Huang G, Jing P, Zhang C, Peng J, Xiu L. Islet autoimmunity and genetic mutations in Chinese subjects initially thought to have type 1B diabetes. Diabet. Med. 23: 67-71 (2006). *

• Zhang G, Luo J, Bruckel J, Weisman MA, Schumacher HR, Khan MA, Inman RD, Mahowald M, Maksymowych WP, Martin TM, Yu DT, Stone M, Rosenbaum JT, Newman P, Lee J, McClain JA, West OC, Jin L, Reveille JD. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum. 50: 2246-2254 (2004). *

• Zhang X, Wei S, Yang S, Wang Z, Zhang A, He P, Wang H. HLA-DQA1 and DQB1 alleles are associated with genetic susceptibility to psoriasis vulgaris in Chinese Han. Int. J. Dermatol. 43: 181-187 (2004). *

• Zhang XM, Wang HY, Luo YY, Ji LN. HLA-DQ, DR allele polymorphism of type 1 diabetes in the Chinese population: a meta-analysis. Chin. Med. J. (Engl.) 122: 980-986 (2009).

• Zheng GY, Wei SC, Shi TL, Li YX. Association between alcohol, smoking and HLA-DQA1*0201 genotype in psoriasis. Acta Biochim. Biophys. Sin. (Shanghai) 36: 597-602 (2004). *

• Zhernakova A, Eerligh P, Barrera P, Weseloy JZ, Huizinga TW, Roep BO, Wijmenga C, Koeleman BP. CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum. Genet. 118: 58-66 (2005). *

• Zhong F, McCombs CC, Olson JM, Elston RC, Stevens FM, McCarthy CF, Michalski JP. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat. Genet. 14: 329-333 (1996). *

• Ziegler M, Ziegler B. Immunological disorders of type 1 diabetes mellitus. Exp. Clin. Endocrinol. 94: 97-114 (1989).

• Zimmer KP, Fischer I, Mothes T, Weissen-Plenz G, Schmitz M, Wieser H, Mendez E, Buening J, Lerch MM, Ciclitira PC, Weber P, Naim HY. Endocytotic segregation of gliadin peptide 31-49 in enterocytes. Gut Aug 3 [Epub ahead of print] (2009).

• Zipp F, Windemuth C, Pankow H, Dichgans J, Wienker T, Martin R, Muller C. Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2. Hum. Immunol. 61: 1021-1030 (2000).

• Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto SY, Zorzon M. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Int. Rev. Neurobiol. 79C: 521-535 (2007).

• Zivkovic M, Stankovic A, Dincic E, Popovic M, Popovic S, Raicevic R, Alavantic D. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR. Clin. Chim. Acta 406: 27-30 (2009). *

• Zrour SH, Boumiza R, Sakly N, Mannai R, Korbaa W, Younes M, Bejia I, Touzi M, Bergaoui N. The impact of pregnancy on rheumatoid arthritis outcome: the role of maternofetal HLA class II disparity. Joint Bone Spine Dec 21 [Epub ahead of print] (2009).

• Zschaler U, Weber P, Jedrychowski A, Wiedmann KH. Immunohistologic studies of differential HLA expression in patients with various intestinal diseases. Z. Gastroenterol. 29: 92-100 (1991).

• Zubillaga P, Vidales MC, Zubillaga I, Ormaechea V, Garcia-Urkia N, Vitoria JC. HLA-DQA1 and HLA-DQB1 genetic markers and clinical presentation in celiac disease. J. Pediatr. Gastroenterol. Nutr. 34: 548-554 (2002). *

Number of references = 1820

www psc-literature.org